# EDGAR Filing Document

**Accession Number:** 0001413329
**File Stem:** 0001104659-23-036062
**Filing Date:** 2023-3
**Character Count:** 387282
**Document Hash:** a4bb152ca626e9360f9dca706c58cdcd
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001104659-23-036062.hdr.sgml**: 20230323

**ACCESSION NUMBER**: 0001104659-23-036062

**CONFORMED SUBMISSION TYPE**: DEF 14A

**PUBLIC DOCUMENT COUNT**: 83

**FILED AS OF DATE**: 20230323

**DATE AS OF CHANGE**: 20230323

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Philip Morris International Inc.
- **CENTRAL INDEX KEY:** 0001413329
- **STANDARD INDUSTRIAL CLASSIFICATION:** CIGARETTES [2111]
- **IRS NUMBER:** 133435103
- **STATE OF INCORPORATION:** VA
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** DEF 14A
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-33708
- **FILM NUMBER:** 23756345

**BUSINESS ADDRESS:**
- **STREET 1:** 677 WASHINGTON BLVD, STE. 1100
- **CITY:** STAMFORD
- **STATE:** CT
- **ZIP:** 06901
- **BUSINESS PHONE:** 203-905-2410

**MAIL ADDRESS:**
- **STREET 1:** 677 WASHINGTON BLVD, STE. 1100
- **CITY:** STAMFORD
- **STATE:** CT
- **ZIP:** 06901

?xml version="1.0" encoding="ASCII"? tm231786-1_nonfiling - none - 15.625063s

[**TABLE OF CONTENTS**](#TOC)

#### UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549

#### SCHEDULE 14A INFORMATION

#### Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.&nbsp;&nbsp;&nbsp;&nbsp;)
Filed by the Registrant

☒

Filed by a Party other than the Registrant

☐

Check the appropriate box:

☐

Preliminary Proxy Statement

☐

**Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))** 

☒

Definitive Proxy Statement

☐

Definitive Additional Materials

☐

Soliciting Material under Rule 14a-12

### Philip Morris International Inc.

#### (Name of registrant as specified in its charter)

#### (Name of person(s) filing proxy statement, if other than the registrant)
Payment of Filing Fee (Check the appropriate box):

☒

No fee required.

☐

Fee paid previously with preliminary materials.

☐

Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a6(i)(1) and 0-11.

------

[**TABLE OF CONTENTS**](#TOC)

![[MISSING IMAGE: lg_philipmorris-pn.jpg]](lg_philipmorris-pn.jpg)

2023 Annual Meeting of Shareholders and Proxy Statement

Wednesday, May 3, 2023

------

[**TABLE OF CONTENTS**](#TOC)

![[MISSING IMAGE: lg_philipmorris-pn.jpg]](lg_philipmorris-pn.jpg)

---

| | |
|:---|:---|
| ![[MISSING IMAGE: ph_andrecalantzopoulos-bw.jpg]](ph_andrecalantzopoulos-bw.jpg) <br> **ANDRÉ CALANTZOPOULOS** <br> **EXECUTIVE CHAIRMAN OF THE BOARD** <br> ![[MISSING IMAGE: ph_jackolczak-bw.jpg]](ph_jackolczak-bw.jpg) <br> **JACEK OLCZAK** <br> **DIRECTOR AND CHIEF EXECUTIVE OFFICER**  | DEAR FELLOW <br> SHAREHOLDER: <br> You are cordially invited to join us at the 2023 Annual Meeting of Shareholders of Philip Morris International Inc. ("PMI", the "Company" or "we") to be held on Wednesday, May 3, 2023, at 9:00 a.m. Eastern Daylight Time ("EDT"). As such, we are pleased to once again host a virtual meeting this year. Meaningful shareholder engagement is important to us, and our 2022 Virtual Annual Meeting of Shareholders, conducted solely online through a live webcast, facilitated participation of our shareholders worldwide, regardless of their resources, size or physical location, while saving us and our shareholders time and travel expenses, and, importantly, reducing our environmental impact. <br> **2 0 2 2 Y E A R I N R E V I E W** <br> In 2022, PMI delivered an excellent performance despite a challenging operating environment linked to the war in Ukraine, significant supply chain disruptions and global inflationary pressures. This performance reflected the continued strong growth of *IQOS* — enhanced by the roll-out of *ILUMA* in initial launch markets — and positive momentum for the combustible business. <br> We also reached two critical strategic milestones last year: the finalization of an agreement to take full control of *IQOS* in the U.S. as of April 30, 2024, and the successful completion of the Swedish Match acquisition. These developments will accelerate our smoke-free journey and further position PMI to lead the transformation of the wider industry, including in the U.S. <br> The Company's achievements in 2022 were the product of the collective skills, drive, and innovative thinking of the entire organization. We salute our nearly 80,000 employees globally and thank them for another year of their dedication and hard work. <br> **L O O K I N G T O T H E F U T U R E** <br> We are confident in our strong position as the global smoke-free champion and our ability to lead the industry's transformation. Our smoke-free portfolio now includes the world's leading heat-not-burn brand, *IQOS*, and the world's leading nicotine pouch franchise, *ZYN*. We have a rich pipeline of smoke-free innovation, as well as the foundation in place to drive further growth in wellness and healthcare over the long term. We are excited to continue our journey toward a smoke-free future and firmly believe that we are well-positioned to achieve our bold smoke-free ambitions.  |

---

Your vote is important. We encourage you to sign and return your proxy card, or use telephone or Internet voting prior to the meeting, so that your shares of common stock will be represented and voted at the meeting even if you do not attend.

---

| | |
|:---|:---|
| Sincerely, <br> ![[MISSING IMAGE: sg_andrecalantzopoulos-bw.jpg]](sg_andrecalantzopoulos-bw.jpg)  | Sincerely, <br> ![[MISSING IMAGE: sg_jacekolczak-bw.jpg]](sg_jacekolczak-bw.jpg)  |
| **André Calantzopoulos** | **Jacek Olczak** |

---

------

[**TABLE OF CONTENTS**](#TOC)

![[MISSING IMAGE: lg_philipmorris-pn.jpg]](lg_philipmorris-pn.jpg)

## Notice of 2023 Virtual Annual Meeting of Shareholders

#### Meeting Date & Time
May 3, 2023, 9:00 a.m. EDT

#### Record Date
Each shareholder of record as of close of business on March 10, 2023 is entitled to one vote for each share of common stock held. As of the record date, there were 1,552,147,867 shares of

common stock issued and outstanding.

#### Voting Deadline
Proxies submitted by telephone or Internet must be received by 11:59 p.m. EDT, on May 2, 2023.

#### Date of Mailing
On or about March 23, 2023

#### 2022 Annual Report
A copy of our 2022 Annual Report

is enclosed.

 **Important Notice <br> Regarding the Availability of Proxy Materials for the Annual Meeting of Shareholders to be held on May 3, 2023: The Company's Proxy Statement and 2022 Annual Report are available at *www.pmi.com/investor-relations/ overview*.** 

There is no physical location for the shareholders to attend the 2023 Virtual Annual Meeting of Shareholders. Shareholders may instead participate online at *www.virtualshareholdermeeting.com/PM2023*. To participate, you will need to enter the 16-digit control number included on your proxy card, notice of Internet availability of proxy materials, or on the voting instruction form accompanying your proxy materials.

---

| | | | |
|:---|:---|:---|:---|
| **Meeting Agenda**  | **Meeting Agenda**  | **Recommendation**  | **Recommendation**  |
| 1.  | To elect the twelve directors named in this proxy statement to our Board of Directors.  | ![[MISSING IMAGE: tm2136562d1-icon_chkmarkpn.jpg]](tm2136562d1-icon_chkmarkpn.jpg)  | &nbsp;&nbsp;&nbsp; **FOR** each <br> director nominee  |
| 2.  | To vote on an advisory resolution to approve the compensation of our named executive officers.  | ![[MISSING IMAGE: tm2136562d1-icon_chkmarkpn.jpg]](tm2136562d1-icon_chkmarkpn.jpg)  | &nbsp;&nbsp;&nbsp; **FOR**  |
| 3.  | To vote, on an advisory basis, on the frequency of future advisory resolutions to approve the compensation of our named executive officers.  | ![[MISSING IMAGE: tm2136562d1-icon_chkmarkpn.jpg]](tm2136562d1-icon_chkmarkpn.jpg)  | &nbsp;&nbsp;&nbsp; **ONE YEAR**  |
| 4.  | To ratify the selection of PricewaterhouseCoopers SA as independent auditors for the Company for the fiscal year ending December 31, 2023.  | ![[MISSING IMAGE: tm2136562d1-icon_chkmarkpn.jpg]](tm2136562d1-icon_chkmarkpn.jpg)  | &nbsp;&nbsp;&nbsp; **FOR**  |
| 5.  | To vote on a shareholder proposal to make nicotine level information available to customers and begin reducing nicotine levels, if properly presented at the meeting.  | ![[MISSING IMAGE: tm2136562d3-icon_againstbw.jpg]](tm2136562d3-icon_againstbw.jpg)  | &nbsp;&nbsp;&nbsp; **AGAINST**  |
| **6.**  | **To transact other business properly coming before the meeting.**  | **To transact other business properly coming before the meeting.**  | **To transact other business properly coming before the meeting.**  |

---

**Your vote is important.** We urge each shareholder to promptly sign and return the enclosed proxy card or to use telephone or internet voting. See the questions and answers section for information about voting by telephone or Internet, how to revoke a proxy, and how to vote your shares of common stock. If you plan to participate in the 2023 Virtual Annual Meeting of Shareholders, please follow the instructions set forth on page [82](#tEAQA) in response to Question 4.

---

| | | | |
|:---|:---|:---|:---|
| **By Internet**  | **By Phone**  | **By Mail**  | **At the Meeting**  |
| ![[MISSING IMAGE: tm2136562d1-icon_computerpn.jpg]](tm2136562d1-icon_computerpn.jpg)  | ![[MISSING IMAGE: tm2136562d1-icon_phonepn.jpg]](tm2136562d1-icon_phonepn.jpg)  | ![[MISSING IMAGE: tm2136562d1-icon_mailpn.jpg]](tm2136562d1-icon_mailpn.jpg)  | ![[MISSING IMAGE: tm2136562d1-icon_meetingpn.jpg]](tm2136562d1-icon_meetingpn.jpg)  |
| Visit proxyvote.com with your proxy card in hand and follow the instructions to obtain your records and create an electronic voting instruction form. | Call 1-800-690-6903 with your proxy card in hand and follow the instructions to cast your vote. | Mark, sign and date your proxy card and return it in the postage-paid envelope provided or return it to: Vote Processing, <br> c/o Broadridge, 51 Mercedes Way, Edgewood, NY 11717. | During the meeting, visit *virtualshareholder meeting.com/PM2023* with your 16-digit control number found on your proxy card or other proxy materials. |

---

![[MISSING IMAGE: sg_darlenequashiehenry-bw.jpg]](sg_darlenequashiehenry-bw.jpg)

**Darlene Quashie Henry**

Vice President, Associate General Counsel and Corporate Secretary

March 23, 2023

------

[**TABLE OF CONTENTS**](#TOC)

![[MISSING IMAGE: tm2136562d1-icon_topbarpn.jpg]](tm2136562d1-icon_topbarpn.jpg)

## **TABLE OF CONTENTS**

---

| | |
|:---|:---|
| **Proxy Summary**  | [2](#tPRSU) |
| **Board Operations and Governance** | **[5](#tBOAG)** |
| &nbsp;&nbsp;&nbsp; Board Responsibilities and Meetings  | [5](#tBOD) |
| &nbsp;&nbsp;&nbsp; Governance Guidelines, Policies and Codes  | [6](#tGGPA) |
| &nbsp;&nbsp;&nbsp; Leadership Structure  | [6](#tLEST) |
| &nbsp;&nbsp;&nbsp; Committees of the Board  | [8](#tCOTB) |
| &nbsp;&nbsp;&nbsp; Board Risk Oversight  | [15](#tBRO) |
| &nbsp;&nbsp;&nbsp; Communications with the Board  | [16](#tCWTB) |
| &nbsp;&nbsp;&nbsp; Strong Governance Practices  | [17](#tSGP) |
| **Election of Directors** | **[18](#tEOD)** |
| &nbsp;&nbsp;&nbsp; Process for Nominating Directors  | [18](#tPFND) |
| &nbsp;&nbsp;&nbsp; Recommendations of the Board; Director Attributes, Diversity, Refreshment and Tenure  | [19](#tROTB) |
| &nbsp;&nbsp;&nbsp; Independence of Nominees  | [20](#tION) |
| &nbsp;&nbsp;&nbsp; Majority Vote Standard in Uncontested Elections  | [20](#tMVSI) |
| &nbsp;&nbsp;&nbsp; Director Nominees  | [21](#tDINO) |
| **Compensation of Directors** | **[34](#tCOD)** |
| **Stock Ownership Information** | **[36](#tSOI)** |
| &nbsp;&nbsp;&nbsp; Ownership of Equity Securities  | [36](#tOOES) |
| **Compensation Discussion and Analysis** | **[38](#tCDAA)** |
| &nbsp;&nbsp;&nbsp; Executive Summary  | [38](#tEXSU) |
| &nbsp;&nbsp;&nbsp; Additional Compensation Policies and Processes  | [51](#sACPA) |
| &nbsp;&nbsp;&nbsp; Compensation and Leadership Development Committee <br> Report  | [54](#sCALD1) |

---

---

| | |
|:---|:---|
| **Compensation Tables** | **[55](#tSCT)**  |
| &nbsp;&nbsp;&nbsp; Summary Compensation Table  | [55](#tSCT) |
| &nbsp;&nbsp;&nbsp; All Other Compensation  | [56](#tAOC) |
| &nbsp;&nbsp;&nbsp; Grants of Plan-Based Awards During 2022  | [57](#tGOPA) |
| &nbsp;&nbsp;&nbsp; Outstanding Equity Awards as of December 31, 2022  | [58](#tOEAA) |
| &nbsp;&nbsp;&nbsp; Stock Option Exercises and Stock Vested During 2022  | [60](#tSOEA) |
| &nbsp;&nbsp;&nbsp; Pension Benefits  | [61](#tPEBE) |
| &nbsp;&nbsp;&nbsp; Employment Contracts, Termination of Employment and <br> Change in Control Arrangements  | [63](#tECTO) |
| **Pay Ratio** | **[66](#tPARA)** |
| **Pay versus Performance** | **[68](#tPVP)** |
| **Advisory Vote Approving Executive Compensation** | **[71](#tAVAE)** |
| **Advisory Vote on Frequency of Executive Compensation Approvals** | **[72](#tAVOT)** |
| **Audit Committee Matters** | **[73](#tACM)** |
| **Ratification of the Selection of Independent Auditors** | **[75](#tROTS)** |
| **Shareholder Proposal** | **[76](#tSHPR)** |
| **Related Person Transactions and Code of Conduct** | **[79](#tRPTA)** |
| **Availability of Reports, Other Matters and 2024 Annual <br> Meeting** | **[80](#tAORO)** |
| **Exhibit A: Questions & Answers** | **[82](#tEAQA)** |
| **Exhibit B: Reconciliations** | **[88](#tEBR)** |
| **Exhibit C: Glossary of Terms** | **[91](#tECGO)**  |

---

P M I **2 0 2 3** P r o x y S t a t e m e n t<sub>1</sub>

------

[**TABLE OF CONTENTS**](#TOC)

![[MISSING IMAGE: tm2136562d1-box_sidebarpn.jpg]](tm2136562d1-box_sidebarpn.jpg)

P R O X Y S U M M A R Y

![[MISSING IMAGE: tm2136562d1-icon_topbarpn.jpg]](tm2136562d1-icon_topbarpn.jpg)

## PROXY SUMMARY
 **This proxy statement contains proposals to be voted on at our Annual Meeting of Shareholders and other information about Philip Morris International Inc. (the "Company", "PMI", "we" or "our") and our corporate governance practices. Below is a brief summary of certain information contained in this proxy statement. The summary does not contain all of the information you should consider. Please read the entire proxy statement carefully before voting.** 

## Who We Are

---

| |
|:---|
| **PMI <br> at a Glance**  |
| PMI, one of the world's leading international tobacco companies, is working to deliver a smoke-free future and evolving its portfolio for the long-term to include products outside of the tobacco and nicotine sector. PMI's principal executive offices are located at 677 Washington Blvd., Suite 1100, Stamford, Connecticut 06901 and it is listed on the New York Stock Exchange (NYSE: PM). |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ![[MISSING IMAGE: tm2136562d3-tbl_glancepn.jpg]](tm2136562d3-tbl_glancepn.jpg) <br> (a) <br>Reflects PMI smoke-free product net revenues of $10.2 billion as a percentage of PMI total net revenues of $31.8 billion <br>|

---

---

| |
|:---|
| **2022 Annual Performance <br> Targets and Results**  |
| PMI met or exceeded all but one of the annual performance-based targets pre-established by the Compensation and Leadership Development Committee ("Compensation Committee") for annual cash incentive compensation awards. Against an overall target of 100, the Compensation Committee certified a performance rating of 120. See below for achievements against individual performance targets and their relative weights. More information is available on pages 45-46. |

---

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Growth <br> Measure<sup>(a)</sup>** <br>**Share of Top 28 OI Markets<sup>(b)</sup>**  | **Target** <br>**13-15**  | **Achieved <br> Result** <br>**20**  | **Weight** <br>**15%**  | **Performance <br> Rating** <br>**125**  |
| **Smoke-Free ("HTU") <br> Shipment <br> Volume** | **89.2-91.2**  | **89.3**  | **20%**  | **100**  |
| **Adjusted Net Revenues<sup>(c)</sup>**  | 4.3-5.1%  | 7.7%  | **15%**  | 150  |
| **Adjusted OI<sup>(c)</sup>**  | 6.7-8.2%  | 6.2%  | **15%**  | 88  |
| **Operating Cash Flow<sup>(d)</sup>**  | (1.5)-(0.3)%  | 5.1%  | **20%**  | 133  |
| **Strategic Initiatives**  | 100%  | 130%  | **15%**  | 130  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp; (a) <br>See Exhibit B for a reconciliation of non-GAAP to the most directly comparable U.S. GAAP financial numbers. All amounts exclude Russia and Ukraine <br>&nbsp;&nbsp;&nbsp;&nbsp; (b) <br>Number of top 28 OI markets (reflecting the deconsolidation of RBH) in which total share of heated tobacco units and cigarettes was growing or stable <br>&nbsp;&nbsp;&nbsp;&nbsp; (c) <br>Organic growth <br>&nbsp;&nbsp;&nbsp;&nbsp; (d) <br>Ex-currency growth  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp; (a) <br>See Exhibit B for a reconciliation of non-GAAP to the most directly comparable U.S. GAAP financial numbers. All amounts exclude Russia and Ukraine <br>&nbsp;&nbsp;&nbsp;&nbsp; (b) <br>Number of top 28 OI markets (reflecting the deconsolidation of RBH) in which total share of heated tobacco units and cigarettes was growing or stable <br>&nbsp;&nbsp;&nbsp;&nbsp; (c) <br>Organic growth <br>&nbsp;&nbsp;&nbsp;&nbsp; (d) <br>Ex-currency growth  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp; (a) <br>See Exhibit B for a reconciliation of non-GAAP to the most directly comparable U.S. GAAP financial numbers. All amounts exclude Russia and Ukraine <br>&nbsp;&nbsp;&nbsp;&nbsp; (b) <br>Number of top 28 OI markets (reflecting the deconsolidation of RBH) in which total share of heated tobacco units and cigarettes was growing or stable <br>&nbsp;&nbsp;&nbsp;&nbsp; (c) <br>Organic growth <br>&nbsp;&nbsp;&nbsp;&nbsp; (d) <br>Ex-currency growth  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp; (a) <br>See Exhibit B for a reconciliation of non-GAAP to the most directly comparable U.S. GAAP financial numbers. All amounts exclude Russia and Ukraine <br>&nbsp;&nbsp;&nbsp;&nbsp; (b) <br>Number of top 28 OI markets (reflecting the deconsolidation of RBH) in which total share of heated tobacco units and cigarettes was growing or stable <br>&nbsp;&nbsp;&nbsp;&nbsp; (c) <br>Organic growth <br>&nbsp;&nbsp;&nbsp;&nbsp; (d) <br>Ex-currency growth  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp; (a) <br>See Exhibit B for a reconciliation of non-GAAP to the most directly comparable U.S. GAAP financial numbers. All amounts exclude Russia and Ukraine <br>&nbsp;&nbsp;&nbsp;&nbsp; (b) <br>Number of top 28 OI markets (reflecting the deconsolidation of RBH) in which total share of heated tobacco units and cigarettes was growing or stable <br>&nbsp;&nbsp;&nbsp;&nbsp; (c) <br>Organic growth <br>&nbsp;&nbsp;&nbsp;&nbsp; (d) <br>Ex-currency growth  |

---

---

| | |
|:---|:---|
| **2** | ***D e l i v e r i n g a S m o k e - F r e e F u t u r e***  |

---

------

[**TABLE OF CONTENTS**](#TOC)

![[MISSING IMAGE: tm2136562d1-box_sidebarpn.jpg]](tm2136562d1-box_sidebarpn.jpg)

P R O X Y S U M M A R Y

## Investor Outreach
Consistent with past practice, throughout 2022, the Company engaged in an extensive shareholder outreach program during which it sought input on a range of matters, including business performance, executive compensation, as well as environmental, social and governance ("ESG") programs.

---

| | | |
|:---|:---|:---|
| ![[MISSING IMAGE: tm2136562d1-icon_whopn.jpg]](tm2136562d1-icon_whopn.jpg)  | ![[MISSING IMAGE: tm2136562d1-icon_meetingpn.jpg]](tm2136562d1-icon_meetingpn.jpg)  | ![[MISSING IMAGE: tm2136562d1-icon_whatpn.jpg]](tm2136562d1-icon_whatpn.jpg)  |
| **Who we engaged**  | **How we engaged**  | **What we learned**  |
| &nbsp;&nbsp; In 2022, we met with <br> **55 of our top 100** <br> institutional investors, either in person or virtually, representing approximately <br> **70%** <br> of our available global shareholder base (which excludes index and pension funds that typically do not meet with management).  | &nbsp;&nbsp;&nbsp; In addition to these regular Investor Relations engagements, we invited <br> **91** of our largest shareholders (including their governance and ESG decision makers), <br> holding approximately **60%** of our outstanding shares to participate in individual conference calls.  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp; • Engagements provided us with a better understanding of our shareholders' priorities, perspectives and positions. <br>&nbsp;&nbsp;&nbsp;&nbsp; • The substance of these engagements was reported to our Compensation Committee, our Nominating and Corporate Governance Committee, and our entire Board of Directors. <br>|

---

In 2022, the Company also commissioned an investor perception study to understand the attitudes of our key sell-side and buy-side analysts toward the Company so that we can better address investor expectations in future communications.

Those surveyed have expressed confidence in the overall effectiveness of our smoke-free strategy, including the earnings growth potential, the deployment of capital and the sustainability of our business. The results of this survey were presented to our senior management and to our Board of Directors.

In light of our say-on-pay vote at the 2022 Annual Meeting of Shareholders, where 70.00% of our shareholders supported the proposal, we also conducted a targeted engagement campaign with our shareholders regarding our executive compensation program. We reached out to shareholders representing approximately 40% of our total shares outstanding to invite them to participate in calls to discuss our executive compensation programs and shareholders representing approximately 20% of our outstanding shares accepted our offer to provide feedback. Additional information about this outreach can be found on page 40.

P M I **2 0 2 3** P r o x y S t a t e m e n t<sub>3</sub>

------

[**TABLE OF CONTENTS**](#TOC)

![[MISSING IMAGE: tm2136562d1-box_sidebarpn.jpg]](tm2136562d1-box_sidebarpn.jpg)

P R O X Y S U M M A R Y

## Human Capital

---

| | | |
|:---|:---|:---|
| ![[MISSING IMAGE: ic_work-pn.jpg]](ic_work-pn.jpg)  | ![[MISSING IMAGE: tm2136562d3-icon_internalpn.jpg]](tm2136562d3-icon_internalpn.jpg)  | ![[MISSING IMAGE: ic_inclusion-pn.jpg]](ic_inclusion-pn.jpg)  |
| **Our Workforce**  | **Our Internal <br> Transformation**  | **Inclusion & <br> Diversity**  |
| More than 130 Nationalities <br> As of December 31, 2022, we employed approximately 79,800 people worldwide of more than 130 different nationalities, including full-time, temporary and part-time staff.  | Smoke-Free Future <br> To be successful, we must continue transforming our culture and ways of working, align our talent with our business needs and innovate to become a truly consumer-centric business.  | EEO-1 Report <br> Influenced by our engagement with shareholders, we will begin publishing PMI's EEO-1 Report in 2023.  |
| Global Company <br> We are subject to numerous different laws and regulations relating to our relationship with our employees. We engage with legally recognized employee representative bodies and we have collective bargaining agreements in many of the countries in which we operate.  | Talent <br> We attract, retain and motivate the best global talent with the right degree of diversity, experience, competencies and skills. We seek expertise in areas that are new to us such as digital and technical solutions while also developing our existing talent in those areas.  | Gender Balance <br> In 2022, we achieved our global target of 40% female representation in management positions. We were also re-certified as a global EQUAL-SALARY organization for the second time, affirming our commitment to pay female and male employees equally for equal work everywhere we operate.  |
| European Works Council <br> In accordance with European Union requirements, we have established a European Works Council composed of management and elected members of our workforce.  | Compensation <br> We set the levels of our compensation and benefit programs that we believe are necessary to achieve these goals and remain competitive with other consumer product companies.  | Continued Commitment <br> In 2022, we commissioned an independent academic study exploring the methods organizations can adopt to drive lasting cultural change. Findings of this study informed the development of practices and programs focused on employee inclusion.  |

---

---

| | |
|:---|:---|
| ![[MISSING IMAGE: ic_over-pn.jpg]](ic_over-pn.jpg)  | **Oversight and Management** <br> Our Board of Directors (the "Board") provides oversight of various matters pertaining to our workforce, and the Compensation Committee of the Board is responsible for executive compensation matters and oversight of the risks and programs related to talent management. Our Code of Conduct highlights our commitment to ethical business conduct and honesty, respect, and fairness in our ways of working.  |

---

---

| | |
|:---|:---|
| **4** | ***D e l i v e r i n g a S m o k e - F r e e F u t u r e***  |

---

------

[**TABLE OF CONTENTS**](#TOC)

B O A R D O P E R A T I O N S A N D G O V E R N A N C E

![[MISSING IMAGE: tm2136562d1-icon_topbarpn.jpg]](tm2136562d1-icon_topbarpn.jpg)

## BOARD OPERATIONS AND GOVERNANCE

## Board of Directors

---

| | |
|:---|:---|
| **Responsibilities:**  | **Meetings:**  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; • Fosters the long-term success of the Company, consistent with its fiduciary duty to shareholders. <br>• Establishes broad corporate policies, setting strategic direction, and oversees management, which is responsible for the day-to-day operations of the Company. <br>• Oversees the Company's enterprise risk assessment program (as described on pages [15](#tBRO)-[16](#tBRO2)). In fulfilling this role, each director must exercise his or her good faith business judgment in the best interests of the Company. <br>• Approves the Company's annual budget each year and receives updates of the Company's performance against the budget throughout the year. <br>• Reviews and approves the Company's three-year plan each year, typically in a two-day session. The Board regularly receives presentations on the Company's longer-term objectives and plans. <br>| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; • The Board holds regular meetings, typically during the months of February, March, May, June, September and December, and additional meetings when necessary. The organizational meeting follows immediately after the Annual Meeting of Shareholders. <br>• The Board held 8 regular meetings in 2022. The Lead Independent Director presides over regular executive sessions of the Board with no members of management present. <br>• Directors are expected to attend Board meetings, the Annual Meeting of Shareholders and meetings of the committees on which they serve, with the understanding that on occasion a director may be unable to attend. <br>• During 2022, all nominees for director then in office attended at least 91% of the aggregate number of meetings of the Board and all committees on which they served, and all director nominees then in office attended the 2022 Annual Meeting of Shareholders. <br>|

---

P M I **2 0 2 3** P r o x y S t a t e m e n t<sub>5</sub>

------

[**TABLE OF CONTENTS**](#TOC)

B O A R D O P E R A T I O N S A N D G O V E R N A N C E

## Governance Guidelines, Policies and Codes

---

| | |
|:---|:---|
| **The Code of Conduct:**  | **Other Governance <br> Guidelines:**  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; • The Board has adopted a Code of Conduct. <br>• The Code of Conduct is an interactive, plain language tool that describes the fundamental beliefs and attributes that unite and guide us in pursuing PMI's goals, illustrates how to meet our commitments to these beliefs and attributes, and explains why it is critical to do so. <br>• The Code of Conduct is our code of ethics and it applies to all employees, including the Company's Chief Executive Officer, Chief Financial Officer, and Chief Accounting Officer or Controller. <br>• The Code of Conduct is available free of charge on the Company's website, *www.pmi.com/our-views-and-standards/standards/compliance-and-integrity*, and will be provided free of charge to any shareholder requesting a copy by writing to the Vice President, Associate General Counsel and Corporate Secretary of Philip Morris International Inc. at Avenue de Rhodanie 50, 1007 Lausanne, Switzerland. <br>| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; • The Board has also adopted a Code of Business Conduct and Ethics that applies to directors. <br>• In addition, the Board has adopted a Policy on Related Person Transactions for the review of certain transactions in which the Company is a participant, and an officer or director, or nominees therefor as applicable, has, had, or may have a direct or indirect material interest. <br>• All of these corporate governance documents are available free of charge on the Company's website, *www.pmi.com/corporate-governance/overview*, and will be provided free of charge to any shareholder requesting a copy by writing to the Vice President, Associate General Counsel and Corporate Secretary of Philip Morris International Inc. at Avenue de Rhodanie 50, 1007 Lausanne, Switzerland. <br>|

---

The information on the Company's websites, including the Company's 2022 Integrated Report as referenced in this proxy statement, is not, and shall not be deemed to be, a part of this proxy statement or incorporated into any other filings the Company makes with the U.S. Securities and Exchange Commission (the "SEC").

## Leadership Structure
The Board believes that no particular leadership structure is inherently superior to all others under all circumstances. It determines from time to time the structure that best serves the interests of the Company and its shareholders under the then-prevailing circumstances.

In 2021, André Calantzopoulos, our former Chief Executive Officer, became our Executive Chairman, and Jacek Olczak, the Company's then Chief Operating Officer, became our Chief Executive Officer. The Board appointed Mr. Calantzopoulos Executive Chairman to ensure a seamless transition of leadership and has determined that it is in the Company's best interest for him to remain Executive Chairman until the 2024 Annual Meeting of Shareholders, following which the Board expects Mr. Calantzopoulos will become the non-executive Chairman of the Company.

As previously reported in the Company's Current Report on Form 8-K filed on January 11, 2023, Lucio A. Noto, our Lead Independent Director, announced that he will not stand for re-election to the Board at the 2023 Annual Meeting of the Shareholders. On March 9, 2023, the Board elected Lisa A. Hook to serve as Lead Independent Director upon Mr. Noto's departure, effective immediately following our Annual Meeting of Shareholders.

---

| | |
|:---|:---|
| **6** | ***D e l i v e r i n g a S m o k e - F r e e F u t u r e***  |

---

------

[**TABLE OF CONTENTS**](#TOC)

B O A R D O P E R A T I O N S A N D G O V E R N A N C E

---

| | |
|:---|:---|
| &nbsp;&nbsp; **Executive <br> Chairman**  | &nbsp;&nbsp; **Lead Independent <br> Director**  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **ANDRÉ CALANTZOPOULOS** <br> As Executive Chairman, Mr. Calantzopoulos: <br> • facilitates communication between the Board and management; <br>• assists the Chief Executive Officer with long-term strategy and serves as his sounding board; <br>• presides at all meetings of shareholders and of the Board; and <br>• assists in the preparation of agendas and materials for Board meetings, working together with the Lead Independent Director, who approves the agendas before they are disseminated to the Board. <br>As always, input will be sought from all directors as to topics they wish to review. Because Mr. Calantzopoulos is an Executive Chairman and not independent, the Board will continue to have a Lead Independent Director.  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The non-management directors elect at the annual organizational meeting one independent director as the Lead Independent Director. Our current Lead Independent Director, Mr. Noto, will not stand for re-election at our Annual Meeting of Shareholders this year. On March 9, 2023, the non-management directors of the Board elected Lisa A. Hook as Mr. Noto's successor, effective immediately following the Annual Meeting of Shareholders. As Lead Independent Director, Ms. Hook will have the same responsibilities as those exercised by Mr. Noto. Our Lead Independent Director's responsibilities are to: <br> • preside over executive sessions of the non- management directors and at all meetings at which the Executive Chairman is not present; <br>• call meetings of the non-management directors as he or she deems necessary; <br>• serve as liaison between the Chief Executive Officer and the non-management directors; <br>• approve agendas and schedules for Board meetings; <br>• advise the Executive Chairman and the Chief Executive Officer of the Board's informational needs and approve information sent to the Board; <br>• together with the Executive Chairman and the Chair of the Compensation Committee, communicate goals and objectives to the Chief Executive Officer and the results of the evaluation of his performance; and <br>• be available for consultation and communication if requested by major shareholders. <br>|
|  | The Lead Independent Director is invited to attend all meetings of the committees of the Board. |

---

P M I **2 0 2 3** P r o x y S t a t e m e n t<sub>7</sub>

------

[**TABLE OF CONTENTS**](#TOC)

B O A R D O P E R A T I O N S A N D G O V E R N A N C E

## Committees of the Board
The Board has established various standing committees to assist with the performance of its responsibilities. These committees and their current members are listed below. The Board designates the members of these committees and the Chairs thereof at its organizational meeting following the Annual Meeting of Shareholders, based on the recommendations of the Nominating and Corporate Governance Committee. The Board has adopted written charters for each of these committees, and these charters are available on the Company's website at *www.pmi.com/corporate-governance/board-committees*. The Chair of each committee develops the agenda for that committee and determines the frequency and length of committee meetings. Each committee meets as often as it deems appropriate, but at least the minimum amount required by applicable law or its respective charter, and each has sole authority to retain its own legal counsel, experts and consultants.

The Audit Committee, the Compensation Committee, and the Nominating and Corporate Governance Committee each consists entirely of non-management directors, all of whom the Board has determined are independent within the meaning of the Securities Exchange Act of 1934, as amended (the "Exchange Act"). The Board has determined that all members of the Audit Committee are financially literate, and that each of Lucio A. Noto, Michel Combes, Juan José Daboub, Werner Geissler, Lisa A. Hook, and Dessi Temperley is an "audit committee financial expert" within the meaning set forth in the regulations of the SEC. The Board has determined that Ms. Temperley's ability to effectively serve on the Company's Audit Committee is not impaired by simultaneously serving on the audit committees of four public companies, including PMI. No member of the Audit Committee, the Compensation Committee or the Nominating and Corporate Governance Committee received any payments or other compensation in 2022 from the Company or its subsidiaries, other than compensation received as a director.

---

| | |
|:---|:---|
| **8** | ***D e l i v e r i n g a S m o k e - F r e e F u t u r e***  |

---

------

[**TABLE OF CONTENTS**](#TOC)

B O A R D O P E R A T I O N S A N D G O V E R N A N C E

---

| | | | | |
|:---|:---|:---|:---|:---|
| **AUDIT COMMITTEE SUMMARY**  | **AUDIT COMMITTEE SUMMARY**  | **AUDIT COMMITTEE SUMMARY**  | **AUDIT COMMITTEE SUMMARY**  | **Meetings in 2022: 8**  |
| ![[MISSING IMAGE: ph_lucionoto-bw.jpg]](ph_lucionoto-bw.jpg)  | ![[MISSING IMAGE: ph_michelcombes-bwlr.jpg]](ph_michelcombes-bwlr.jpg)  | ![[MISSING IMAGE: ph_wernergeissler-bwlr.jpg]](ph_wernergeissler-bwlr.jpg)  | ![[MISSING IMAGE: ph_lisaahook-bwlr.jpg]](ph_lisaahook-bwlr.jpg)  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **COMMITTEE PURPOSE:** <br> • oversee the integrity of the financial statements and monitor financial reporting processes and systems of internal control; <br>• monitor the qualifications, independence and performance of the independent auditors; <br>• monitor the qualifications and performance of the internal auditors and internal audit function; <br>• monitor the Company's compliance with legal and regulatory requirements; and <br>• provide an avenue of communication among management, the independent auditors, the internal auditors, the chief compliance officer and the Board  |
| **Lucio A. Noto <br> (Chair)\***  | **Michel Combes**  | **Werner Geissler**  | **Lisa A. Hook**  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **COMMITTEE PURPOSE:** <br> • oversee the integrity of the financial statements and monitor financial reporting processes and systems of internal control; <br>• monitor the qualifications, independence and performance of the independent auditors; <br>• monitor the qualifications and performance of the internal auditors and internal audit function; <br>• monitor the Company's compliance with legal and regulatory requirements; and <br>• provide an avenue of communication among management, the independent auditors, the internal auditors, the chief compliance officer and the Board  |
|  |  |  |  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **COMMITTEE PURPOSE:** <br> • oversee the integrity of the financial statements and monitor financial reporting processes and systems of internal control; <br>• monitor the qualifications, independence and performance of the independent auditors; <br>• monitor the qualifications and performance of the internal auditors and internal audit function; <br>• monitor the Company's compliance with legal and regulatory requirements; and <br>• provide an avenue of communication among management, the independent auditors, the internal auditors, the chief compliance officer and the Board  |
| **Jun Makihara**  | **Dessi <br> Temperley**  |  |  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **COMMITTEE PURPOSE:** <br> • oversee the integrity of the financial statements and monitor financial reporting processes and systems of internal control; <br>• monitor the qualifications, independence and performance of the independent auditors; <br>• monitor the qualifications and performance of the internal auditors and internal audit function; <br>• monitor the Company's compliance with legal and regulatory requirements; and <br>• provide an avenue of communication among management, the independent auditors, the internal auditors, the chief compliance officer and the Board  |

---

\*

Our current Audit Committee Chair, Mr. Noto, will not stand for re-election at our Annual Meeting of Shareholders this year. Our Board elected Michel Combes as Mr. Noto's successor on March 9, 2023, effective immediately following the Annual Meeting of Shareholders.

#### KEY RESPONSIBILITIES:
• recommend to the Board whether the Company's financial statements should be included in the Company's annual filings with the SEC;

• sole recommendation power to the Board for the appointment, and, compensating, retaining and overseeing the work, of the independent auditors;

• evaluate the internal audit function, including the oversight of internal audit's assurance and advisory services designed to assess the adequacy and effectiveness of the Company's internal control systems, use of resources, and maturity of governance processes over the Company's strategies;

• evaluate the performance of the Company's compliance function and review the plan, activities, responsibilities and staffing of the compliance function;

• review and oversee the Company's policies and practices with respect to risk assessment and management thereof, including major financial risk exposures, and a review of the risk management of the following: cybersecurity and data privacy risks, as well as data governance; business continuity risks; excessive or discriminatory taxation; illicit trade; risks associated with device reliability; and the dilution of the rule of law;

• review and recommend to the Board for its approval of the Company's Code of Conduct;

• review the implementation and effectiveness of the Company's compliance program, including violations of the Code of Conduct and responses thereto and the adequacy of resources for compliance;

• establish "whistleblower" procedures and review complaints or submissions regarding accounting, internal accounting controls or auditing matters;

• oversee the review of the expense reports of the Chief Executive Officer ("CEO") and the directors; and

• produce a report to shareholders for inclusion in the proxy statement.

P M I **2 0 2 3** P r o x y S t a t e m e n t<sub>9</sub>

------

[**TABLE OF CONTENTS**](#TOC)

B O A R D O P E R A T I O N S A N D G O V E R N A N C E

---

| | | | | |
|:---|:---|:---|:---|:---|
| **COMPENSATION AND LEADERSHIP DEVELOPMENT <br> COMMITTEE SUMMARY** | **COMPENSATION AND LEADERSHIP DEVELOPMENT <br> COMMITTEE SUMMARY** | **COMPENSATION AND LEADERSHIP DEVELOPMENT <br> COMMITTEE SUMMARY** | **COMPENSATION AND LEADERSHIP DEVELOPMENT <br> COMMITTEE SUMMARY** | **Meetings in 2022: 5**  |
| ![[MISSING IMAGE: ph_wernergeissler-bwlr.jpg]](ph_wernergeissler-bwlr.jpg)  | ![[MISSING IMAGE: ph_juanjosedaboub-bwlr.jpg]](ph_juanjosedaboub-bwlr.jpg)  | ![[MISSING IMAGE: ph_lisaahook-bwlr.jpg]](ph_lisaahook-bwlr.jpg)  | ![[MISSING IMAGE: ph_junmakihara-bwlr.jpg]](ph_junmakihara-bwlr.jpg)  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **COMMITTEE PURPOSE:** <br> • discharge the Board's responsibilities relating to executive compensation; <br>• produce a report for inclusion in the proxy statement; and <br>• review talent management succession plans for the CEO and other senior executives.  |
| **Werner <br> Geissler (Chair)**  | **Dr. Juan José <br> Daboub**  | **Lisa A. Hook**  | **Jun Makihara**  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **COMMITTEE PURPOSE:** <br> • discharge the Board's responsibilities relating to executive compensation; <br>• produce a report for inclusion in the proxy statement; and <br>• review talent management succession plans for the CEO and other senior executives.  |
|  |  |  |  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **COMMITTEE PURPOSE:** <br> • discharge the Board's responsibilities relating to executive compensation; <br>• produce a report for inclusion in the proxy statement; and <br>• review talent management succession plans for the CEO and other senior executives.  |
| **Lucio A. Noto\***  | **Robert B. Polet**  |  |  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **COMMITTEE PURPOSE:** <br> • discharge the Board's responsibilities relating to executive compensation; <br>• produce a report for inclusion in the proxy statement; and <br>• review talent management succession plans for the CEO and other senior executives.  |

---

\*

Mr. Noto will not stand for re-election at our Annual Meeting of Shareholders this year.

• review and approve the Company's overall compensation philosophy and design;

• review and recommend to the Board for approval corporate goals and objectives relevant to the compensation of the CEO and Executive Chairman, and evaluate their performance;

• determine and recommend to the Board for approval the compensation of the CEO;

• review and recommend to the Board for approval the compensation for executive officers, except that any compensation decisions for the CEO and the Executive Chairman will be presented to the non-management members of the Board for approval;

• recommend to the Board incentive compensation plans and equity-based plans, and administer and make awards under such plans and review the cumulative effect of its actions;

• monitor compliance by executives with our share ownership requirements;

• review and assist with the development of executive succession plans, evaluate and make recommendations to the Board regarding potential CEO candidates and evaluate candidates to fill other corporate officer positions;

• oversee the management of risks related to the Company's compensation policies and practices;

• oversee the management of risks related to talent management, including the risk that the Company is unable to attract and retain the necessary talent with the right degree of diversity, experience and skills to achieve its ongoing business transformation;

• review and discuss with management proposed annual disclosures regarding executive compensation matters;

• oversee human capital management, including leadership and talent development programs; and

• recommend to the Board whether the Company's Compensation Discussion and Analysis should be accepted for inclusion in the proxy statement.

---

| | |
|:---|:---|
| **10** | ***D e l i v e r i n g a S m o k e - F r e e F u t u r e***  |

---

------

[**TABLE OF CONTENTS**](#TOC)

B O A R D O P E R A T I O N S A N D G O V E R N A N C E

---

| | | | | |
|:---|:---|:---|:---|:---|
| **CONSUMER RELATIONSHIPS AND REGULATION <br> COMMITTEE SUMMARY** | **CONSUMER RELATIONSHIPS AND REGULATION <br> COMMITTEE SUMMARY** | **CONSUMER RELATIONSHIPS AND REGULATION <br> COMMITTEE SUMMARY** | **CONSUMER RELATIONSHIPS AND REGULATION <br> COMMITTEE SUMMARY** | **Meetings in 2022: 3**  |
| ![[MISSING IMAGE: ph_lisaahook-bwlr.jpg]](ph_lisaahook-bwlr.jpg)  | ![[MISSING IMAGE: ph_brantbonin-bw.jpg]](ph_brantbonin-bw.jpg)  | ![[MISSING IMAGE: ph_andrecalantzopoulos-bw.jpg]](ph_andrecalantzopoulos-bw.jpg)  | ![[MISSING IMAGE: ph_michelcombes-bwlr.jpg]](ph_michelcombes-bwlr.jpg)  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **COMMITTEE PURPOSE:** <br> • oversee the commercialization of the Company's RRP, combustible cigarette and Wellness & Healthcare businesses; and <br>• monitor key legislative, regulatory, and public policy issues and trends related to the post-market regulatory environment that may limit access to RRPs and affect the Company's Wellness & Healthcare businesses.  |
| **Lisa A. Hook <br> (Chair)**  | **Bonin Bough**  | **André <br> Calantzopoulos**  | **Michel Combes**  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **COMMITTEE PURPOSE:** <br> • oversee the commercialization of the Company's RRP, combustible cigarette and Wellness & Healthcare businesses; and <br>• monitor key legislative, regulatory, and public policy issues and trends related to the post-market regulatory environment that may limit access to RRPs and affect the Company's Wellness & Healthcare businesses.  |
|  |  |  |  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **COMMITTEE PURPOSE:** <br> • oversee the commercialization of the Company's RRP, combustible cigarette and Wellness & Healthcare businesses; and <br>• monitor key legislative, regulatory, and public policy issues and trends related to the post-market regulatory environment that may limit access to RRPs and affect the Company's Wellness & Healthcare businesses.  |
| **Werner Geissler**  | **Jun Makihara**  | **Lucio A. Noto\***  | **Jacek Olczak**  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **COMMITTEE PURPOSE:** <br> • oversee the commercialization of the Company's RRP, combustible cigarette and Wellness & Healthcare businesses; and <br>• monitor key legislative, regulatory, and public policy issues and trends related to the post-market regulatory environment that may limit access to RRPs and affect the Company's Wellness & Healthcare businesses.  |
|  |  |  |  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **COMMITTEE PURPOSE:** <br> • oversee the commercialization of the Company's RRP, combustible cigarette and Wellness & Healthcare businesses; and <br>• monitor key legislative, regulatory, and public policy issues and trends related to the post-market regulatory environment that may limit access to RRPs and affect the Company's Wellness & Healthcare businesses.  |
| **Robert B. Polet**  | **Dessi Temperley**  |  |  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **COMMITTEE PURPOSE:** <br> • oversee the commercialization of the Company's RRP, combustible cigarette and Wellness & Healthcare businesses; and <br>• monitor key legislative, regulatory, and public policy issues and trends related to the post-market regulatory environment that may limit access to RRPs and affect the Company's Wellness & Healthcare businesses.  |

---

\*

Mr. Noto will not stand for re-election at our Annual Meeting of Shareholders this year.

• oversee the Company's combustible cigarette strategy, including branding, positioning, and pricing;

• oversee the consumer-centricity strategy for the RRP business, including the establishment and maintenance of digital channels and digital consumer engagement, and enabling data-driven decision-making;

• oversee adult consumer acquisition and retention strategies, consumer journey programs and customer care infrastructure;

• oversee the management of risks related to RRP and the combustible cigarette competitive environment;

• oversee the geographic expansion of the Company's RRPs;

• the management of risks related to industry regulatory developments, including the risk that regulation may not differentiate between combustible products and RRPs or will discriminate against RRPs;

• oversee the Company's RRP product innovation calendar post-Gate 3 (i.e., the transition from concept to commercial development);

• oversee the management of risks related to consumer perceptions, including the risk that certain new market entrants may alienate consumers from the Company's RRPs through marketing campaigns and messaging, and inferior product satisfaction, while not relying on substantiated science and appropriate R&D protocols and standards;

• oversee the management of reputation risks, including the risk that credibility and reputational issues may stand in the way of promoting the benefits of RRPs as a necessary pillar of tobacco control and impair their commercial success; and

• oversee the commercialization of products that are launched under the Company's Wellness & Healthcare business, including the marketing strategy and market opportunity for such products, the pricing strategy, post-commercialization payments, any applicable regulations, any risks, and product competitors.

P M I **2 0 2 3** P r o x y S t a t e m e n t<sub>11</sub>

------

**[**TABLE OF CONTENTS**](#TOC)

B O A R D O P E R A T I O N S A N D G O V E R N A N C E

---

| | | | | |
|:---|:---|:---|:---|:---|
| FINANCE COMMITTEE SUMMARY  | FINANCE COMMITTEE SUMMARY  | FINANCE COMMITTEE SUMMARY  | FINANCE COMMITTEE SUMMARY  | Meetings in 2022: 5  |
| ![[MISSING IMAGE: ph_junmakihara-bwlr.jpg]](ph_junmakihara-bwlr.jpg)  | ![[MISSING IMAGE: ph_andrecalantzopoulos-bw.jpg]](ph_andrecalantzopoulos-bw.jpg)  | ![[MISSING IMAGE: ph_michelcombes-bwlr.jpg]](ph_michelcombes-bwlr.jpg)  | ![[MISSING IMAGE: ph_juanjosedaboub-bwlr.jpg]](ph_juanjosedaboub-bwlr.jpg)  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; COMMITTEE PURPOSE: <br> • monitor the Company's financial performance and condition, including financial policies, capital structure, and strategic transactions; and <br>• review with management all material matters relating to capital structure, financial policies, and capital investments, and make recommendations to the Board relating to such matters.  |
| Jun Makihara (Chair)  | André Calantzopoulos  | Michel Combes  | Dr. Juan José Daboub  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; COMMITTEE PURPOSE: <br> • monitor the Company's financial performance and condition, including financial policies, capital structure, and strategic transactions; and <br>• review with management all material matters relating to capital structure, financial policies, and capital investments, and make recommendations to the Board relating to such matters.  |
| ![[MISSING IMAGE: ph_kalpanamorparia-bw.jpg]](ph_kalpanamorparia-bw.jpg)  | ![[MISSING IMAGE: ph_lucionoto-bw.jpg]](ph_lucionoto-bw.jpg)  | ![[MISSING IMAGE: ph_jackolczak-bw.jpg]](ph_jackolczak-bw.jpg)  | ![[MISSING IMAGE: ph_dessitemperley-bwlr.jpg]](ph_dessitemperley-bwlr.jpg)  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; COMMITTEE PURPOSE: <br> • monitor the Company's financial performance and condition, including financial policies, capital structure, and strategic transactions; and <br>• review with management all material matters relating to capital structure, financial policies, and capital investments, and make recommendations to the Board relating to such matters.  |
| Kalpana Morparia  | Lucio A. Noto\*  | Jacek Olczak  | Dessi Temperley  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; COMMITTEE PURPOSE: <br> • monitor the Company's financial performance and condition, including financial policies, capital structure, and strategic transactions; and <br>• review with management all material matters relating to capital structure, financial policies, and capital investments, and make recommendations to the Board relating to such matters.  |

---

\*

Mr. Noto will not stand for re-election at our Annual Meeting of Shareholders this year.

KEY RESPONSIBILITIES:

• monitor the Company's financial condition, including relationships with rating agencies;

• review with management the Company's capital structure and financing plans, including share repurchases, dividend strategy, and changes to equity and debt structure;

• review tax strategy, pension plans, and insurance policies;

• review and approve capital expenditures over $120 million, but do not exceed $500 million, per project;

• review and approve acquisitions, divestitures, collaborations, joint ventures and other strategic transactions that exceed $120 million, but do not exceed $500 million;

• review investor relations strategy and institutional investor composition;

• oversee financial risk management policies;

• oversee risk management of the Company's pricing strategies, business development strategies, and currency volatility; and

• oversee risk management of the Company's competitive position, including risks arising from global macro-economic uncertainty and geopolitical instability.

12 *D e l i v e r i n g a S m o k e - F r e e F u t u r e*

------**

[**TABLE OF CONTENTS**](#TOC)

B O A R D O P E R A T I O N S A N D G O V E R N A N C E

---

| | | | | |
|:---|:---|:---|:---|:---|
| **NOMINATING AND CORPORATE GOVERNANCE <br> COMMITTEE SUMMARY** | **NOMINATING AND CORPORATE GOVERNANCE <br> COMMITTEE SUMMARY** | **NOMINATING AND CORPORATE GOVERNANCE <br> COMMITTEE SUMMARY** | **NOMINATING AND CORPORATE GOVERNANCE <br> COMMITTEE SUMMARY** | **Meetings in 2022: 5**  |
| **![[MISSING IMAGE: ph_kalpanamorparia-bw.jpg]](ph_kalpanamorparia-bw.jpg) <br> Kalpana <br> Morparia <br> (Chair)**  | **![[MISSING IMAGE: ph_juanjosedaboub-bwlr.jpg]](ph_juanjosedaboub-bwlr.jpg) <br> Dr. Juan José <br> Daboub**  | **![[MISSING IMAGE: ph_lucionoto-bw.jpg]](ph_lucionoto-bw.jpg) <br> Lucio A. Noto\***  | **![[MISSING IMAGE: ph_robertpolet-bw.jpg]](ph_robertpolet-bw.jpg) <br> Robert B. Polet**  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **COMMITTEE PURPOSE: <br> • identify qualified candidates for Board membership; <br>• recommend nominees for election or re-election at the annual meeting and candidates, as necessary, to fill vacancies and new directorships; <br>• advise the Board on corporate governance and sustainability matters; and <br>• oversee self-evaluation of the Board and each committee of the Board. <br>**  |
| **![[MISSING IMAGE: ph_shlomoyanai-bwlr.jpg]](ph_shlomoyanai-bwlr.jpg) <br> Shlomo Yanai**  |  |  |  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **COMMITTEE PURPOSE: <br> • identify qualified candidates for Board membership; <br>• recommend nominees for election or re-election at the annual meeting and candidates, as necessary, to fill vacancies and new directorships; <br>• advise the Board on corporate governance and sustainability matters; and <br>• oversee self-evaluation of the Board and each committee of the Board. <br>**  |

---

\*

Mr. Noto will not stand for re-election at our Annual Meeting of Shareholders this year.

• review qualifications of prospective director candidates in accordance with criteria recommended by the Nominating and Corporate Governance Committee and approved by the Board, such criteria to include, among other considerations, ethnic, racial, and gender diversity;

• consider performance of incumbent directors and other relevant factors in determining whether to nominate such directors for re-elections;

• oversee the Company's ESG and sustainability strategies and performance, and related risks;

• make recommendations to the Board regarding director independence and the function, composition and structure of the Board and its committees;

• recommend retirement policies for directors;

• oversee the Company's lobbying and trade association activities and expenditures;

• develop and recommend to the Board for approval the corporate governance guidelines and any changes thereto, as necessary;

• oversee the Company's lobbying and trade association activities and expenditures;

• develop and recommend to the Board the annual self-evaluation process of the Board and its committees; and

• review director compensation and recommend changes in compensation to the Board.

P M I **2 0 2 3** P r o x y S t a t e m e n t<sub>13</sub>

------

[**TABLE OF CONTENTS**](#TOC)

B O A R D O P E R A T I O N S A N D G O V E R N A N C E

---

| | | | | |
|:---|:---|:---|:---|:---|
| **PRODUCT INNOVATION AND REGULATORY AFFAIRS <br> COMMITTEE SUMMARY** | **PRODUCT INNOVATION AND REGULATORY AFFAIRS <br> COMMITTEE SUMMARY** | **PRODUCT INNOVATION AND REGULATORY AFFAIRS <br> COMMITTEE SUMMARY** | **PRODUCT INNOVATION AND REGULATORY AFFAIRS <br> COMMITTEE SUMMARY** | **Meetings in 2022: 4**  |
| ![[MISSING IMAGE: ph_frederickpaulsen-bw.jpg]](ph_frederickpaulsen-bw.jpg)  | ![[MISSING IMAGE: ph_brantbonin-bw.jpg]](ph_brantbonin-bw.jpg)  | ![[MISSING IMAGE: ph_andrecalantzopoulos-bw.jpg]](ph_andrecalantzopoulos-bw.jpg)  | ![[MISSING IMAGE: ph_juanjosedaboub-bwlr.jpg]](ph_juanjosedaboub-bwlr.jpg)  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **COMMITTEE PURPOSE:** <br> • oversee the long-term product portfolio strategy of the Company, focusing on research and development of new products and services, and improvements to existing products and services, including RRPs and the Company's Wellness & Healthcare business; and <br>• monitor and review key legislative, regulatory and public policy issues and trends related to the research and development of RRPs.  |
| **Frederik Paulsen <br> (Chair)\***  | **Bonin Bough**  | **André <br> Calantzopoulos**  | **Dr. Juan José Daboub**  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **COMMITTEE PURPOSE:** <br> • oversee the long-term product portfolio strategy of the Company, focusing on research and development of new products and services, and improvements to existing products and services, including RRPs and the Company's Wellness & Healthcare business; and <br>• monitor and review key legislative, regulatory and public policy issues and trends related to the research and development of RRPs.  |
|  |  |  |  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **COMMITTEE PURPOSE:** <br> • oversee the long-term product portfolio strategy of the Company, focusing on research and development of new products and services, and improvements to existing products and services, including RRPs and the Company's Wellness & Healthcare business; and <br>• monitor and review key legislative, regulatory and public policy issues and trends related to the research and development of RRPs.  |
| **Lisa A. Hook**  | **Kalpana Morparia**  | **Lucio A. Noto\*\***  | **Jacek Olczak**  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **COMMITTEE PURPOSE:** <br> • oversee the long-term product portfolio strategy of the Company, focusing on research and development of new products and services, and improvements to existing products and services, including RRPs and the Company's Wellness & Healthcare business; and <br>• monitor and review key legislative, regulatory and public policy issues and trends related to the research and development of RRPs.  |
| **![[MISSING IMAGE: ph_shlomoyanai-bwlr.jpg]](ph_shlomoyanai-bwlr.jpg) <br> Shlomo Yanai**  |  |  |  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **COMMITTEE PURPOSE:** <br> • oversee the long-term product portfolio strategy of the Company, focusing on research and development of new products and services, and improvements to existing products and services, including RRPs and the Company's Wellness & Healthcare business; and <br>• monitor and review key legislative, regulatory and public policy issues and trends related to the research and development of RRPs.  |

---

\*

Our current Product Innovation and Regulatory Affairs Committee chair, Dr. Paulsen, will not stand for re-election at our Annual Meeting of Shareholders this year. On March 9, 2023, the Board elected Shlomo Yanai as Dr. Paulsen's successor, effective immediately following the Annual Meeting of Shareholders.

\*\*

Mr. Noto will not stand for re-election at our Annual Meeting of Shareholders this year.

• review and report to the Board the overall research and development and innovation strategy of the Company;

• review the Company's pipeline of innovative products and services, including future RRPs and products produced by the Company's Wellness & Healthcare business, and associated benefits and risks, such as product superiority, product reliability, and time to market;

• review the competitive landscape and future innovations in RRPs and the Wellness & Healthcare business;

• oversee the risk management of the Company's research and development efforts, including risks related to innovation IP and research related to RRPs;

• monitor the Company's management of its intellectual property;

• review management's decisions regarding the allocation, deployment, utilization of and investment in the Company's scientific and development assets and product offerings; and

• review management's decisions regarding acquiring or divesting scientific technology or otherwise investing in research or development programs.

---

| | |
|:---|:---|
| **14** | ***D e l i v e r i n g a S m o k e - F r e e F u t u r e***  |

---

------

[**TABLE OF CONTENTS**](#TOC)

B O A R D O P E R A T I O N S A N D G O V E R N A N C E

## Board Risk Oversight
Risk oversight is conducted both by the committees of the Board with respect to their areas of responsibility as well as by the full Board.

Management has identified and prioritized key enterprise risks based on four risk dimensions:

---

| | | | | |
|:---|:---|:---|:---|:---|
| 1  | the **impact** a risk could have on the organization if it occurs,<sub>2</sub> | the **likelihood** a risk will occur,<sub>3</sub> | the **velocity** with which a risk would affect the organization if it occurs,<sub>4</sub> | and the **interconnectivity** of a risk with other risks.  |

---

Furthermore, management distinguishes its risks into either strategic or operational (critical) risks. Strategic risks have a direct influence and bearing over the Company's strategic priorities, business objectives and the long-term direction the Company is pursuing. Management's operational (critical) risks are significant in terms of their immediate, short- or medium-term business disruptive effect. Strategic risks and critical operational risks that are deemed significant are communicated by management to the Board or respective Board committee exercising subject matter oversight as appropriate.

As part of its risk management practices, the Company has established a Corporate Risk Governance Committee ("CRGC") made up of senior executive officers, including the Chief Financial Officer, Senior Vice President and General Counsel, Chief Digital & Information Officer, Vice President & Controller PMI, Vice President, Risk & Assurance, Chief Information Security Officer, and Vice President and Chief Compliance Officer among others. In addition, the CEO and Vice President, Associate General Counsel & Corporate Secretary are informed of the risk management observations and insights shared with the CRGC. Ownership of each of the prioritized risks is assigned to a member of senior management, and oversight of the management of each risk is assigned to a particular committee of our Board or to the full Board. Management reports on these risks to the appropriate committee and to the full Board throughout the year. Certain members of the CRGC, including the Chief Financial Officer, Senior Vice President and General Counsel, Vice President & Controller PMI, and Vice President, Risk & Assurance, are also members of our management-level disclosure committee and, along with the participation of risk and assurance functions such as Risk & Controls and internal audit, ensure that relevant risks identified by the CRGC are incorporated into our disclosure controls and procedures.

Our Risk & Controls function facilitates the governance processes pertaining to the Company's strategic risk management and periodically reports the results of this assessment to the Audit Committee.

Assessments of cybersecurity and data privacy risks are provided to the Audit Committee and the full Board at regularly scheduled meetings. In 2022, these assessments were provided four times to the Audit Committee and once to the full Board.

In addition, the Board believes that having a Lead Independent Director enhances the Board's independent oversight of our risk mitigation and response efforts by enabling consultation between the CEO and Lead Independent Director on time-sensitive or urgent risks.

The full Board oversees the management of risks relating to the Company's strategic priorities, business objectives, and legal risks, including litigation. The roles the various governance bodies fulfill as part of the Company's approach towards enterprise risk management are shown below.

The risk management oversight by each committee is included in the committee summaries found on pages [9](#tACSUM1)-[14](#tACSUM2).

---

| | |
|:---|:---|
| P M I **2 0 2 3** P r o x y S t a t e m e n t  | **15**  |

---

------

[**TABLE OF CONTENTS**](#TOC)

B O A R D O P E R A T I O N S A N D G O V E R N A N C E

![[MISSING IMAGE: fc_pyramid-pn.jpg]](fc_pyramid-pn.jpg)

## Communications with the Board
Shareholders and other interested parties who wish to communicate with the Board may do so by writing to the Lead Independent Director, Board of Directors of Philip Morris International Inc., 677 Washington Blvd., Suite 1100, Stamford, Connecticut 06901. The non-management directors have established the following procedures for the handling of communications from shareholders and other interested parties, and has directed the Vice President, Associate General Counsel and Corporate Secretary to act as their agent in processing any communications received: all communications that relate to matters within the scope of the responsibilities of the Board and any of its committees are to be forwarded to the Lead Independent Director; communications that relate to matters within the responsibility of one of the committees are also to be forwarded to the Chair of the appropriate committee; and communications that relate to ordinary business matters that are not within the scope of the Board's responsibilities, such as customer complaints, are to be sent to the appropriate function. Solicitations, junk mail and obviously frivolous or inappropriate communications will not be forwarded, unless a non-management director wishes to review them.

---

| | |
|:---|:---|
| **16** | ***D e l i v e r i n g a S m o k e - F r e e F u t u r e***  |

---

------

[**TABLE OF CONTENTS**](#TOC)

B O A R D O P E R A T I O N S A N D G O V E R N A N C E

## Strong Governance Practices
The Nominating and Corporate Governance Committee of the Board reviews our corporate governance practices regularly and proposes modifications to our principles and other key governance practices as warranted for adoption by the Board. In 2020, the Board formed the Consumer Relationships and Regulation Committee, and reassigned responsibilities among the six committees to further align the responsibilities of the Board and its committees with the Company's strategies. In light of the increasing importance of talent in our transformation, the Board also added the responsibility for the oversight of risks and programs related to talent management to the Compensation Committee. The responsibilities of these committees are described in pages 9-14. The following summarizes our key principles and practices and refers you to the pages of this proxy statement where you will find a more detailed discussion of various items:

---

| | |
|:---|:---|
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp; • Majority voting standard for uncontested election of directors (page [20](#tMVSI)) <br>&nbsp;&nbsp;&nbsp;&nbsp; • Proxy access by-laws (page [19](#tROTB)) <br>&nbsp;&nbsp;&nbsp;&nbsp; • Non-management directors elect Lead Independent Director annually (page 7) <br>&nbsp;&nbsp;&nbsp;&nbsp; • Directors may be removed with or without cause <br>&nbsp;&nbsp;&nbsp;&nbsp; • Non-management directors meet regularly without management being present <br>&nbsp;&nbsp;&nbsp;&nbsp; • No "poison pill" rights plan <br>&nbsp;&nbsp;&nbsp;&nbsp; • Board-adopted "clawback" policy (page 52) <br>| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp; • Rigorous share ownership requirements and anti-hedging and anti-pledging policies (page 52) <br>&nbsp;&nbsp;&nbsp;&nbsp; • Post-termination share holding requirement (page 52) <br>&nbsp;&nbsp;&nbsp;&nbsp; • No tax gross-up on limited perquisites <br>&nbsp;&nbsp;&nbsp;&nbsp; • Double-trigger vesting policy on change in control (pages 63-64) <br>&nbsp;&nbsp;&nbsp;&nbsp; • Board committee oversight of political spending and lobbying (page 13) <br>&nbsp;&nbsp;&nbsp;&nbsp; • Board and Board committee oversight of cybersecurity and data privacy risks (pages 9 and 15) <br>&nbsp;&nbsp;&nbsp;&nbsp; • Board committee oversight of ESG and sustainability strategy and performance (page 13) <br>|

---

---

| | |
|:---|:---|
| P M I **2 0 2 3** P r o x y S t a t e m e n t  | **17**  |

---

------

[**TABLE OF CONTENTS**](#TOC)

E L E C T I O N O F D I R E C T O R S

![[MISSING IMAGE: tm2136562d1-icon_topbarpn.jpg]](tm2136562d1-icon_topbarpn.jpg)

## ELECTION OF DIRECTORS

## Process for Nominating Directors
The Nominating and Corporate Governance Committee (the "Governance Committee") is responsible for identifying and evaluating prospective director candidates and for recommending to the Board a slate of director nominees for election or re-election at the Annual Meeting of Shareholders.

---

| | |
|:---|:---|
| ![[MISSING IMAGE: tm2136562d1-txt_onepn.jpg]](tm2136562d1-txt_onepn.jpg)  | **SUCCESSION PLANNING** <br> The Governance Committee works with the Board of Directors to determine the appropriate characteristics, skills and experience for the Board as a whole and its individual members. The Governance Committee uses these criteria to identify potential candidates to fill vacancies in existing or new director positions.  |
| ![[MISSING IMAGE: tm2136562d1-txt_twopn.jpg]](tm2136562d1-txt_twopn.jpg)  | **IDENTIFICATION OF CANDIDATES** <br> The Governance Committee reviews qualifications of candidates for director identified by the Governance Committee or suggested by Board members, shareholders, management or others in accordance with the director qualification criteria.  |
| ![[MISSING IMAGE: tm2136562d1-txt_threepn.jpg]](tm2136562d1-txt_threepn.jpg)  | **DECISION AND NOMINATION** <br> The Governance Committee considers (i) the qualification of candidates for nomination to the Board for appointment or election or (ii) the performance of incumbent directors in determining nomination for re-election, and recommends to the Board the slate of nominees for re-election to the Board at the Annual Meeting of Shareholders.  |
| ![[MISSING IMAGE: tm2136562d1-txt_fourpn.jpg]](tm2136562d1-txt_fourpn.jpg)  | **ELECTION** <br> All director nominees are annually elected or re-elected at the Annual Meeting of Shareholders. Any incumbent director who is not re-elected in accordance with our bylaws must offer his or her resignation on which the Board, with the recommendation of the Governance Committee, will make a determination and publicly disclose its decision.  |

---

In evaluating the suitability of individuals for Board membership, the Governance Committee takes into account many factors. These include:

• whether the individual meets requirements for independence;

• the individual's general understanding of the various disciplines relevant to the success of a large publicly traded company in today's global business environment; and

• the individual's understanding of the Company's global business and markets; the individual's professional expertise and educational background, and other factors, including ethnicity, race, nationality, gender, sexual orientation and military service, that promote diversity of views and experience.

The Governance Committee evaluates each individual in the context of the Board as a whole, with the objective of recommending a group of directors that can best shepherd the success of the business and represent long-term shareholder interests through the exercise of sound judgment, using its breadth of knowledge and experience. In determining whether it is appropriate to nominate an individual for election or re-election, the Governance Committee will take into account the nature and extent of an individual's other commitments, including membership on other public company boards. In determining whether to recommend a director for re-election, the Governance Committee also considers the director's attendance at meetings and participation in and contributions to the activities of the Board. The Governance Committee has not established any specific minimum qualification standards for nominees to the Board, although from time to time the Governance Committee may identify certain skills or attributes, such as financial experience, global business experience, consumer-centricity, digital transformation and scientific expertise, as being particularly desirable to help meet specific Board needs.

In identifying candidates for Board membership, the Governance Committee relies on suggestions and recommendations from the Board, shareholders, management and others. The Governance Committee does not distinguish between nominees recommended by shareholders and other nominees. From time to time, the Governance Committee also retains search

---

| | |
|:---|:---|
| **18** | ***D e l i v e r i n g a S m o k e - F r e e F u t u r e***  |

---

------

[**TABLE OF CONTENTS**](#TOC)

E L E C T I O N O F D I R E C T O R S

firms to assist in identifying candidates for director, gathering information about their background and experience, and acting as an intermediary with such candidates.

Shareholders wishing to suggest director candidates to the Governance Committee for consideration must submit a written notice to the Vice President, Associate General Counsel and Corporate Secretary, who will present it to the Governance Committee.

In addition, our by-laws permit an eligible shareholder or group of shareholders who have owned 3% or more of PMI's outstanding shares for at least three years to nominate and include in our proxy statement director candidates to occupy up to 20% of the authorized Board seats. In order to appropriately nominate a director candidate or candidates in accordance with Rule 14a-19 under the Exchange Act, the SEC's universal proxy rule, a shareholder must comply with the procedures set forth in our by-laws and Rule 14a-19 under the Exchange Act.

Our director nomination procedures are summarized in this proxy statement, under the caption "2024 Annual Meeting."

## Recommendations of the Board; Director Attributes, Diversity, Refreshment and Tenure
It is proposed that twelve directors be elected to hold office until the next Annual Meeting of Shareholders and until their successors have been elected. The Governance Committee has recommended to the Board, and the Board has approved, the persons named and, unless otherwise marked, a proxy will be voted for such persons. Each of the nominees was elected by the shareholders at the 2022 Annual Meeting of Shareholders. The Board believes that the experience, qualifications, attributes and skills of each of the nominees presented qualify them to oversee the complex global, regulatory, business, and financial issues facing the Company, and that the Board as a whole provides a breadth of knowledge, international experience, intellectual rigor and willingness to face challenging issues.

Our Board comprises a diverse group of individuals. Three nominees are women and four are persons of color. Eleven different nationalities are represented, underscoring the global perspective of the Board taken as a whole. With two of our Board members deciding not to stand for re-election this year, 25% of our nominees are women. The Governance Committee has set a goal of increasing the Board's gender diversity to at least 30% and is actively working to identify potential qualified candidates who would help us meet that goal. Our Board commits that the next director appointment or nomination, as applicable, will be a female director.

The Board has experienced a significant amount of director refreshment since our spin-off in March 2008. Following the 2023 Annual Meeting of Shareholders, we will not have any directors who have served continuously since our spin-off. Our two longest tenured Board members joined in 2011, followed by one in 2013, two in 2014, one in 2015, one in 2018, one in 2020 and four in 2021. No new Board members joined in 2022 and there are no first-time nominees to the Board at the 2023 Annual Meeting of Shareholders. The average tenure of the Company's nominees is 5.75 years. As new Board members gain experience, the Board rotates its various committee chairs. Our nominees for the 2023 Annual Meeting of Shareholders have the following characteristics:

![[MISSING IMAGE: pc_recomen-pn.jpg]](pc_recomen-pn.jpg)

---

| | |
|:---|:---|
| P M I **2 0 2 3** P r o x y S t a t e m e n t  | **19**  |

---

------

[**TABLE OF CONTENTS**](#TOC)

E L E C T I O N O F D I R E C T O R S

#### DIRECTOR ADDITIONS
![[MISSING IMAGE: fc_addition-pn.jpg]](fc_addition-pn.jpg)

Although it is not anticipated that any of the persons named below will be unable or unwilling to stand for election, a proxy, in the event of such an occurrence, may be voted for a substitute designated by the Board. However, in lieu of designating a substitute, the Board may reduce its number of directors.

## Independence of Nominees
After receiving the recommendation of the Governance Committee, the Board has determined that each of the following director nominees is independent of, and has no material relationship with, the Company: Bonin Bough, Michel Combes, Juan José Daboub, Werner Geissler, Lisa A. Hook, Jun Makihara, Kalpana Morparia, Robert B. Polet, Dessi Temperley, and Shlomo Yanai. The Board also determined that Lucio A. Noto and Frederik Paulsen, who will not stand for re-election at the 2023 Annual Meeting of Shareholders, were independent under NYSE listing standards during fiscal 2022. To assist it in making these determinations, the Board has adopted categorical standards of director independence that are set forth in the Corporate Governance Guidelines. The Corporate Governance Guidelines are available on the Company's website at *www.pmi.com/corporate-governance/overview*. Each of the above-named nominees qualifies as independent under these standards.

## Majority Vote Standard in Uncontested Elections
All directors are elected annually. The Company's by-laws provide that, where the number of nominees for director does not exceed the number of directors to be elected, directors shall be elected by a majority rather than by a plurality vote. Under applicable law, a director's term extends until his or her successor is duly elected and qualified. Thus, an incumbent director who fails to receive a majority vote would continue to serve as a holdover director. To address that possibility, our Corporate Governance Guidelines require a director who receives less than a majority of the votes cast to offer to resign. The Governance Committee would then consider, and recommend to the Board, whether to accept or reject the offer.

---

| | |
|:---|:---|
| **20** | ***D e l i v e r i n g a S m o k e - F r e e F u t u r e***  |

---

------

**[**TABLE OF CONTENTS**](#TOC)

E L E C T I O N O F D I R E C T O R S

## Director Nominees

---

| | | |
|:---|:---|:---|
| ![[MISSING IMAGE: tm2136562d1-txt_onepn.jpg]](tm2136562d1-txt_onepn.jpg)  | PROPOSAL 1: ELECTION OF DIRECTORS <br> The Board recommends that you vote FOR each of the twelve director nominees.  | "FOR" <br> ![[MISSING IMAGE: tm2136562d1-icon_chkmarkpn.gif]](tm2136562d1-icon_chkmarkpn.gif)  |

---

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| | | | | Committees  | Committees  | Committees  | Committees  |
| Nominees  | Citizenship  | Independence  | Audit  | Compensation & Leadership Development  | Consumer Relationships & Regulation <br> Finance  | Nominating & Corporate Governance  | Product Innovation & Regulatory Affairs  |
| BONIN BOUGH Age: 45 Director Since: 2021  | USA  | ● |  |  | M  |  | M  |
| ANDRÉ CALANTZOPOULOS Age: 65 Director Since: 2013  | Greece/ Switzerland  |  |  |  | M  |  | M  |
| MICHEL COMBES Age: 60 Director Since: 2020  | France  | ● | C  |  | M  |  |  |
| JUAN JOSÉ DABOUB Age: 59 Director Since: 2021  | El Salvador/ USA | ● |  | M  | M  | M  | M  |
| WERNER GEISSLER Age: 69 Director Since: 2015  | Germany  | ● | M  | C  | M  |  |  |
| LISA A. HOOK Age: 65 Director Since: 2018  | USA  | ● | M  | M  | C  |  | M  |
| JUN MAKIHARA Age: 65 Director Since: 2014  | Japan  | ● | M  | M  | M <br> C  |  |  |
| KALPANA MORPARIA Age: 73 Director Since: 2011  | India  | ● |  |  | M  | C  | M  |
| JACEK OLCZAK Age: 58 Director Since: 2021  | Poland  |  |  |  | M  |  | M  |
| ROBERT B. POLET Age: 67 Director Since: 2011  | Netherlands  | ● |  | M  | M  | M  |  |
| DESSI TEMPERLEY Age: 50 Director Since: 2021  | Bulgaria/UK  | ● | M  |  | M  |  |  |
| SHLOMO YANAI Age: 70 Director Since: 2021  | Israel  | ● |  |  |  | M  | C  |

---

C = Committee Chair M = Committee Member

Our current Audit Committee Chair, Mr. Noto, and our current Product Innovation & Regulatory Affairs Chair, Dr. Paulsen, will not stand for re-election at our Annual Meeting of Shareholders this year. On March 9, 2023, our Board elected Michel Combes and Shlomo Yanai, as Mr. Noto's and Dr. Paulsen's successors, respectively, effective immediately following the Annual Meeting of Shareholders.

P M I 2 0 2 3 P r o x y S t a t e m e n t 21

------**

[**TABLE OF CONTENTS**](#TOC)

E L E C T I O N O F D I R E C T O R S

## Director Qualifications
Our Board is a diverse, highly engaged group that provides strong and effective oversight of our Company. Both individually and collectively, our directors have the qualifications, skills and experience needed to inform and oversee the Company's long-term strategic growth. Each director has or has had senior executive experience, in many cases with large, complex organizations with significant global operations. Several directors have leadership experience in the global consumer products sector, and others bring expertise in financial information technology, cybersecurity, digital transformation, sustainability, and ESG matters. These and the other skills and attributes discussed below are key considerations in evaluating the composition of our Board and inform our Board succession planning and director selection process.

 **K E Y A T T R I B U T E S O F A L L D I R E C T O R S** 

---

| | | |
|:---|:---|:---|
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; • High Integrity <br>• Proven Record of Success <br>• Leadership <br>• Understanding of our Global Business and Markets <br>| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; • Strength of Character and Judgment <br>• Corporate Governance Experience <br>• Talent Management/ Succession Planning <br>| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; • Diversity of Perspectives <br>• Intellectual/ Analytical Skills <br>• Strategic Planning <br>• Risk Assessment and Oversight <br>|

---

#### G L O B A L P E R S P E C T I V E
Our board is representative of the multicultural and diverse society we find ourselves in.

![[MISSING IMAGE: tm2136562d1-map_globalpn.jpg]](tm2136562d1-map_globalpn.jpg)

\*

3 director nominees are citizens of the United States

\*\*

André Calantzopoulos is a citizen of both Greece and Switzerland

\*\*\*

Dessi Temperley is a citizen of both Bulgaria and the United Kingdom

\*\*\*\*

Juan José Daboub is a citizen of both El Salvador and the United States

---

| | |
|:---|:---|
| **22** | ***D e l i v e r i n g a S m o k e - F r e e F u t u r e***  |

---

------

[**TABLE OF CONTENTS**](#TOC)

E L E C T I O N O F D I R E C T O R S

#### K E Y S K I L L S O F O U R B O A R D
Our director nominees' individual experiences, qualifications, attributes and skills are highlighted in the following matrix. The matrix is intended as a high-level summary and not an exhaustive list of each nominee's skills or contributions to the Board. Further biographical information about each director standing for re-election is set forth on the following pages.

---

| | | | | | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **EXPERIENCE**  | **EXPERIENCE**  | **Bough**  | **Calantzopoulos**  | **Combes**  | **Daboub**  | **Geissler**  | **Hook**  | **Makihara**  | **Morparia**  | **Olczak**  | **Polet**  | **Temperley**  | **Yanai**  |
| ![[MISSING IMAGE: tm2136562d1-icon_executivpn.jpg]](tm2136562d1-icon_executivpn.jpg)  | **Senior <br> Executive**  | ● | ● | ● | ● | ● | ● | ● | ● | ● | ● | ● | ● |
| ![[MISSING IMAGE: tm2136562d1-icon_leavespn.jpg]](tm2136562d1-icon_leavespn.jpg)  | **Tobacco <br> Industry**  |  | ● |  |  |  |  |  |  | ● |  |  |  |
| ![[MISSING IMAGE: tm2136562d1-icon_consumerpn.jpg]](tm2136562d1-icon_consumerpn.jpg)  | **Global <br> Consumer-Centric <br> Engagement**  | ● | ● | ● |  | ● | ● |  |  | ● | ● |  | ● |
| ![[MISSING IMAGE: tm2136562d1-icon_operatpn.jpg]](tm2136562d1-icon_operatpn.jpg)  | **Operations**  |  | ● | ● | ● | ● | ● |  |  | ● |  |  | ● |
| ![[MISSING IMAGE: tm2136562d1-icon_privacypn.jpg]](tm2136562d1-icon_privacypn.jpg)  | **Information Technology and Privacy**  | ● |  | ● |  |  | ● |  |  |  |  | ● |  |
| ![[MISSING IMAGE: tm2136562d1-icon_sustainpn.jpg]](tm2136562d1-icon_sustainpn.jpg)  | **Sustainability/<br>ESG**  |  | ● |  | ● | ● | ● |  | ● | ● |  |  |  |
| ![[MISSING IMAGE: tm2136562d1-map_riskpn.jpg]](tm2136562d1-map_riskpn.jpg)  | **Risk Assessment and Oversight**  |  | ● | ● | ● | ● | ● | ● | ● | ● | ● | ● | ● |
| ![[MISSING IMAGE: tm2136562d1-icon_bankingpn.jpg]](tm2136562d1-icon_bankingpn.jpg)  | **CFO or Banking**  |  |  | ● | ● |  |  | ● | ● | ● |  | ● | ● |
| ![[MISSING IMAGE: tm2136562d1-icon_civicpn.jpg]](tm2136562d1-icon_civicpn.jpg)  | **Civic Leadership**  | ● |  | ● | ● | ● | ● |  |  |  |  |  | ● |
| ![[MISSING IMAGE: tm2136562d1-icon_pharmacypn.jpg]](tm2136562d1-icon_pharmacypn.jpg)  | **Global Pharmaceutical**  |  |  |  |  |  |  |  |  |  |  |  | ● |
| ![[MISSING IMAGE: tm2136562d1-icon_retailpn.jpg]](tm2136562d1-icon_retailpn.jpg)  | **Marketing and Retail**  | ● | ● | ● |  | ● |  |  |  | ● | ● |  |  |

---

---

| | |
|:---|:---|
| P M I **2 0 2 3** P r o x y S t a t e m e n t  | **23**  |

---

------

[**TABLE OF CONTENTS**](#TOC)

E L E C T I O N O F D I R E C T O R S

---

| | | | |
|:---|:---|:---|:---|
| ![[MISSING IMAGE: ph_brantbonin-bw.jpg]](ph_brantbonin-bw.jpg) <br> **Occupation:** <br> Founder and Chief Growth Officer, Diligence, LLC (also known as Bonin Ventures) <br> **Committees:** <br> Consumer Relationships and Regulation, and Product Innovation and Regulatory Affairs  | **BONIN BOUGH**  | **Director Since: <br> 2021**  | **Age:** 45  |
| ![[MISSING IMAGE: ph_brantbonin-bw.jpg]](ph_brantbonin-bw.jpg) <br> **Occupation:** <br> Founder and Chief Growth Officer, Diligence, LLC (also known as Bonin Ventures) <br> **Committees:** <br> Consumer Relationships and Regulation, and Product Innovation and Regulatory Affairs  | **CAREER HIGHLIGHTS**  |  |  |
| ![[MISSING IMAGE: ph_brantbonin-bw.jpg]](ph_brantbonin-bw.jpg) <br> **Occupation:** <br> Founder and Chief Growth Officer, Diligence, LLC (also known as Bonin Ventures) <br> **Committees:** <br> Consumer Relationships and Regulation, and Product Innovation and Regulatory Affairs  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **Diligence, LLC (also known as Bonin Ventures), an entity focused on accelerating growth of innovative start-up companies** <br> &nbsp;&nbsp;&nbsp;&nbsp; • Founder and Chief Growth Officer, since 2014. <br>**Triller, a global social media company** <br> &nbsp;&nbsp;&nbsp;&nbsp; • Chief Growth Officer, since 2020. <br>**SheaMoisture** <br> &nbsp;&nbsp;&nbsp;&nbsp; • Chief Growth Officer, from 2016 to 2017. <br>| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **Mondelèz International, Inc.** <br> &nbsp;&nbsp;&nbsp;&nbsp; • Chief Media and E-Commerce Officer, from 2015 to 2016. <br>&nbsp;&nbsp;&nbsp;&nbsp; • Vice President, Global Media and Consumer Engagement, from 2012 to 2015. <br>**The Kraft Heinz Company** <br> &nbsp;&nbsp;&nbsp;&nbsp; • Vice President, Global Media and Consumer Engagement, from 2012 to 2015. <br>**PepsiCo, Inc.** <br> &nbsp;&nbsp;&nbsp;&nbsp; • Chief Digital Officer, from 2008 to 2012.  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **Mondelèz International, Inc.** <br> &nbsp;&nbsp;&nbsp;&nbsp; • Chief Media and E-Commerce Officer, from 2015 to 2016. <br>&nbsp;&nbsp;&nbsp;&nbsp; • Vice President, Global Media and Consumer Engagement, from 2012 to 2015. <br>**The Kraft Heinz Company** <br> &nbsp;&nbsp;&nbsp;&nbsp; • Vice President, Global Media and Consumer Engagement, from 2012 to 2015. <br>**PepsiCo, Inc.** <br> &nbsp;&nbsp;&nbsp;&nbsp; • Chief Digital Officer, from 2008 to 2012.  |
| ![[MISSING IMAGE: ph_brantbonin-bw.jpg]](ph_brantbonin-bw.jpg) <br> **Occupation:** <br> Founder and Chief Growth Officer, Diligence, LLC (also known as Bonin Ventures) <br> **Committees:** <br> Consumer Relationships and Regulation, and Product Innovation and Regulatory Affairs  | **Director Qualifications:** <br> With his unique executive marketing experience, Mr. Bough brings to the Board his considerable entrepreneurial expertise, particularly with respect to e-commerce, innovative technologies and acceleration of brand equity, as well as valuable insights for transforming and growing large, multinational businesses and start-ups. <br> **Other Directorships and Associations:** <br> Mr. Bough previously sat on the board of directors of SITO Mobile Ltd., a U.S. based mobile solution provider and mobile advertising platform, from 2018 to 2020.  | **Director Qualifications:** <br> With his unique executive marketing experience, Mr. Bough brings to the Board his considerable entrepreneurial expertise, particularly with respect to e-commerce, innovative technologies and acceleration of brand equity, as well as valuable insights for transforming and growing large, multinational businesses and start-ups. <br> **Other Directorships and Associations:** <br> Mr. Bough previously sat on the board of directors of SITO Mobile Ltd., a U.S. based mobile solution provider and mobile advertising platform, from 2018 to 2020.  | **Director Qualifications:** <br> With his unique executive marketing experience, Mr. Bough brings to the Board his considerable entrepreneurial expertise, particularly with respect to e-commerce, innovative technologies and acceleration of brand equity, as well as valuable insights for transforming and growing large, multinational businesses and start-ups. <br> **Other Directorships and Associations:** <br> Mr. Bough previously sat on the board of directors of SITO Mobile Ltd., a U.S. based mobile solution provider and mobile advertising platform, from 2018 to 2020.  |

---

---

| | | | |
|:---|:---|:---|:---|
| ![[MISSING IMAGE: ph_andrecalantzopoulos-bw.jpg]](ph_andrecalantzopoulos-bw.jpg) <br> **Occupation:** <br> Executive Chairman, Philip Morris International Inc. <br> **Committees:** <br> Consumer Relationships and Regulation, Finance and Product Innovation and Regulatory Affairs  | **ANDRÉ CALANTZOPOULOS**  | **Director Since: <br> 2013**  | **Age: 65**  |
| ![[MISSING IMAGE: ph_andrecalantzopoulos-bw.jpg]](ph_andrecalantzopoulos-bw.jpg) <br> **Occupation:** <br> Executive Chairman, Philip Morris International Inc. <br> **Committees:** <br> Consumer Relationships and Regulation, Finance and Product Innovation and Regulatory Affairs  | **CAREER HIGHLIGHTS**  | | |
| ![[MISSING IMAGE: ph_andrecalantzopoulos-bw.jpg]](ph_andrecalantzopoulos-bw.jpg) <br> **Occupation:** <br> Executive Chairman, Philip Morris International Inc. <br> **Committees:** <br> Consumer Relationships and Regulation, Finance and Product Innovation and Regulatory Affairs  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **Philip Morris International Inc.** <br> &nbsp;&nbsp;&nbsp;&nbsp; • Executive Chairman of the Board of Directors, since May 2021. <br>&nbsp;&nbsp;&nbsp;&nbsp; • Chief Executive Officer ("CEO"), from 2013 until May 5, 2021. <br>&nbsp;&nbsp;&nbsp;&nbsp; • Chief Operating Officer from March 2008, following the spin-off from Altria, until becoming CEO in May 2013. <br>| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp; • President and CEO, from April 2002 until the spin-off in March 2008. <br>&nbsp;&nbsp;&nbsp;&nbsp; • Various roles across Central Europe, including Managing Director of PM Poland and President of the EE Region, from February 1985 to April 2002.  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp; • President and CEO, from April 2002 until the spin-off in March 2008. <br>&nbsp;&nbsp;&nbsp;&nbsp; • Various roles across Central Europe, including Managing Director of PM Poland and President of the EE Region, from February 1985 to April 2002.  |
| ![[MISSING IMAGE: ph_andrecalantzopoulos-bw.jpg]](ph_andrecalantzopoulos-bw.jpg) <br> **Occupation:** <br> Executive Chairman, Philip Morris International Inc. <br> **Committees:** <br> Consumer Relationships and Regulation, Finance and Product Innovation and Regulatory Affairs  | **Director Qualifications:** <br> In his role as Executive Chairman, Mr. Calantzopoulos's all-encompassing knowledge of the Company and the tobacco industry serves the Company and the Board well. He has played an instrumental role in numerous key initiatives, leading the Company with his bold vision of a smoke-free future, and through its related evolution into a consumer-centric technology and science-driven business.  | **Director Qualifications:** <br> In his role as Executive Chairman, Mr. Calantzopoulos's all-encompassing knowledge of the Company and the tobacco industry serves the Company and the Board well. He has played an instrumental role in numerous key initiatives, leading the Company with his bold vision of a smoke-free future, and through its related evolution into a consumer-centric technology and science-driven business.  | **Director Qualifications:** <br> In his role as Executive Chairman, Mr. Calantzopoulos's all-encompassing knowledge of the Company and the tobacco industry serves the Company and the Board well. He has played an instrumental role in numerous key initiatives, leading the Company with his bold vision of a smoke-free future, and through its related evolution into a consumer-centric technology and science-driven business.  |

---

---

| | |
|:---|:---|
| **24** | ***D e l i v e r i n g a S m o k e - F r e e F u t u r e***  |

---

------

[**TABLE OF CONTENTS**](#TOC)

E L E C T I O N O F D I R E C T O R S

---

| | | | |
|:---|:---|:---|:---|
| ![[MISSING IMAGE: ph_michelcombes-bwlr.jpg]](ph_michelcombes-bwlr.jpg) <br> **Occupation:** <br> Executive Vice President, Claure Group LLP <br> **Committees:** <br> Audit (Financial Expert), Finance, and Consumer Relationships and Regulation  | **MICHEL COMBES**  | **Director Since: <br> 2020**  | **Age:** 60  |
| ![[MISSING IMAGE: ph_michelcombes-bwlr.jpg]](ph_michelcombes-bwlr.jpg) <br> **Occupation:** <br> Executive Vice President, Claure Group LLP <br> **Committees:** <br> Audit (Financial Expert), Finance, and Consumer Relationships and Regulation  | **CAREER HIGHLIGHTS**  |  |  |
| ![[MISSING IMAGE: ph_michelcombes-bwlr.jpg]](ph_michelcombes-bwlr.jpg) <br> **Occupation:** <br> Executive Vice President, Claure Group LLP <br> **Committees:** <br> Audit (Financial Expert), Finance, and Consumer Relationships and Regulation  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **Claure Group LLP**, a multi-billion-dollar global investment firm focused on multiple high growth sectors in Latin America <br> &nbsp;&nbsp;&nbsp;&nbsp; • Executive Vice President, since October 2022. <br>**SoftBank Group International,** a privately held subsidiary of SoftBank Group Corp and oversees several SoftBank portfolio companies <br> &nbsp;&nbsp;&nbsp;&nbsp; • Director, from September 2020 to June 2022. <br>&nbsp;&nbsp;&nbsp;&nbsp; • Chief Executive Officer, from January 2021 to June 2022. <br>&nbsp;&nbsp;&nbsp;&nbsp; • President and Director, from April 2020 to January 2021. <br>**Sprint Corporation** <br> &nbsp;&nbsp;&nbsp;&nbsp; • President from January 2018, Chief Financial Officer from January 2018 to May 2018 and CEO from May 2018 to 2020 and a member of the Board of Directors, from 2018 to 2020. <br>| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **Altice USA, Inc.** <br> &nbsp;&nbsp;&nbsp;&nbsp; • CEO and Chief Operating Officer, from 2015 to 2017. <br>**SFR Group** <br> &nbsp;&nbsp;&nbsp;&nbsp; • Chairman and CEO, from 2015 to 2017. <br>**Alcatel-Lucent** <br> &nbsp;&nbsp;&nbsp;&nbsp; • CEO, from 2013 to 2015. <br>**Vodafone Europe** <br> &nbsp;&nbsp;&nbsp;&nbsp; • CEO <br>**TDF Group (Télédiffusion de France)** <br> &nbsp;&nbsp;&nbsp;&nbsp; • Chairman and CEO <br>**France Telecom** <br> &nbsp;&nbsp;&nbsp;&nbsp; • Executive <br>**French Government** <br> &nbsp;&nbsp;&nbsp;&nbsp; • Several roles  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **Altice USA, Inc.** <br> &nbsp;&nbsp;&nbsp;&nbsp; • CEO and Chief Operating Officer, from 2015 to 2017. <br>**SFR Group** <br> &nbsp;&nbsp;&nbsp;&nbsp; • Chairman and CEO, from 2015 to 2017. <br>**Alcatel-Lucent** <br> &nbsp;&nbsp;&nbsp;&nbsp; • CEO, from 2013 to 2015. <br>**Vodafone Europe** <br> &nbsp;&nbsp;&nbsp;&nbsp; • CEO <br>**TDF Group (Télédiffusion de France)** <br> &nbsp;&nbsp;&nbsp;&nbsp; • Chairman and CEO <br>**France Telecom** <br> &nbsp;&nbsp;&nbsp;&nbsp; • Executive <br>**French Government** <br> &nbsp;&nbsp;&nbsp;&nbsp; • Several roles  |
| ![[MISSING IMAGE: ph_michelcombes-bwlr.jpg]](ph_michelcombes-bwlr.jpg) <br> **Occupation:** <br> Executive Vice President, Claure Group LLP <br> **Committees:** <br> Audit (Financial Expert), Finance, and Consumer Relationships and Regulation  | **Director Qualifications:** <br> With his experience as a chief executive and chief financial officer in a number of large, multinational companies in the telephonic and digital communications, banking and portfolio strategy industries, Mr. Combes brings to the Board his considerable entrepreneurial business experience, extensive knowledge of international markets in highly regulated industries, and valuable insights in innovation and consumer centricity. Furthermore, as a former CFO, the Board has also determined that Mr. Combes qualifies as an audit committee financial expert. <br> **Other Directorships and Associations:** <br> Mr. Combes currently sits on the board of directors of two other public companies: Assystem SA, a French publicly traded company, since 2018; and Etisalat UAE, headquartered in the United Arab Emirates, since March 2021. He previously served on the boards of directors of MTS (Mobile TeleSystems) from 2013 to 2018, Sprint Corporation from 2018 to 2020, Altice Group from 2016 to 2017, F5 Networks from 2018 to 2021, SoFi Technologies, Inc. from 2021 to 2022, and WeWork Inc. from 2020 to 2022. <br> Mr. Combes also currently sits on the board of directors of four private companies: V.tal since November 2022; Alliance Magnesium, Inc. since October 2022; Swile since October 2021; and Contentsquare since May 2021.  | **Director Qualifications:** <br> With his experience as a chief executive and chief financial officer in a number of large, multinational companies in the telephonic and digital communications, banking and portfolio strategy industries, Mr. Combes brings to the Board his considerable entrepreneurial business experience, extensive knowledge of international markets in highly regulated industries, and valuable insights in innovation and consumer centricity. Furthermore, as a former CFO, the Board has also determined that Mr. Combes qualifies as an audit committee financial expert. <br> **Other Directorships and Associations:** <br> Mr. Combes currently sits on the board of directors of two other public companies: Assystem SA, a French publicly traded company, since 2018; and Etisalat UAE, headquartered in the United Arab Emirates, since March 2021. He previously served on the boards of directors of MTS (Mobile TeleSystems) from 2013 to 2018, Sprint Corporation from 2018 to 2020, Altice Group from 2016 to 2017, F5 Networks from 2018 to 2021, SoFi Technologies, Inc. from 2021 to 2022, and WeWork Inc. from 2020 to 2022. <br> Mr. Combes also currently sits on the board of directors of four private companies: V.tal since November 2022; Alliance Magnesium, Inc. since October 2022; Swile since October 2021; and Contentsquare since May 2021.  | **Director Qualifications:** <br> With his experience as a chief executive and chief financial officer in a number of large, multinational companies in the telephonic and digital communications, banking and portfolio strategy industries, Mr. Combes brings to the Board his considerable entrepreneurial business experience, extensive knowledge of international markets in highly regulated industries, and valuable insights in innovation and consumer centricity. Furthermore, as a former CFO, the Board has also determined that Mr. Combes qualifies as an audit committee financial expert. <br> **Other Directorships and Associations:** <br> Mr. Combes currently sits on the board of directors of two other public companies: Assystem SA, a French publicly traded company, since 2018; and Etisalat UAE, headquartered in the United Arab Emirates, since March 2021. He previously served on the boards of directors of MTS (Mobile TeleSystems) from 2013 to 2018, Sprint Corporation from 2018 to 2020, Altice Group from 2016 to 2017, F5 Networks from 2018 to 2021, SoFi Technologies, Inc. from 2021 to 2022, and WeWork Inc. from 2020 to 2022. <br> Mr. Combes also currently sits on the board of directors of four private companies: V.tal since November 2022; Alliance Magnesium, Inc. since October 2022; Swile since October 2021; and Contentsquare since May 2021.  |

---

---

| | |
|:---|:---|
| P M I **2 0 2 3** P r o x y S t a t e m e n t  | **25**  |

---

------

[**TABLE OF CONTENTS**](#TOC)

E L E C T I O N O F D I R E C T O R S

---

| | | | |
|:---|:---|:---|:---|
| ![[MISSING IMAGE: ph_juanjosedaboub-bwlr.jpg]](ph_juanjosedaboub-bwlr.jpg) <br> **Occupation:** <br> Chairman, President and CEO, The Daboub Partnership of Arcis, LLC <br> **Committees:** <br> Compensation and Leadership Development, Finance, Nominating and Corporate Governance, and Product Innovation and Regulatory Affairs  | **JUAN JOSÉ DABOUB**  | **Director Since: <br> 2021**  | **Age: 59**  |
| ![[MISSING IMAGE: ph_juanjosedaboub-bwlr.jpg]](ph_juanjosedaboub-bwlr.jpg) <br> **Occupation:** <br> Chairman, President and CEO, The Daboub Partnership of Arcis, LLC <br> **Committees:** <br> Compensation and Leadership Development, Finance, Nominating and Corporate Governance, and Product Innovation and Regulatory Affairs  | **CAREER HIGHLIGHTS**  |  |  |
| ![[MISSING IMAGE: ph_juanjosedaboub-bwlr.jpg]](ph_juanjosedaboub-bwlr.jpg) <br> **Occupation:** <br> Chairman, President and CEO, The Daboub Partnership of Arcis, LLC <br> **Committees:** <br> Compensation and Leadership Development, Finance, Nominating and Corporate Governance, and Product Innovation and Regulatory Affairs  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **The Daboub Partnership of Arcis, LLC,** a business consulting company <br> &nbsp;&nbsp;&nbsp;&nbsp; • Chairman, President and CEO, since 2010. <br>**Dorado Partners LLC,** a private investment company <br> &nbsp;&nbsp;&nbsp;&nbsp; • Vice Chairman, since 2014. <br>**Arcis, LLC** <br> &nbsp;&nbsp;&nbsp;&nbsp; • Chairman and CEO, since 2010. <br>**Global Adaptation Institute**, a foundation dedicated to the understanding of climate change <br> &nbsp;&nbsp;&nbsp;&nbsp; • CEO, from 2010 to 2013. <br>&nbsp;&nbsp;&nbsp;&nbsp; • Director since 2010. <br>| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **World Economic Forum's Global Agenda Council on Climate Change** <br> &nbsp;&nbsp;&nbsp;&nbsp; • Co-Chair, from 2012 to 2014. <br>**World Bank Group** <br> &nbsp;&nbsp;&nbsp;&nbsp; • Managing Director, from 2006 to 2010. <br>**Government of El Salvador** <br> &nbsp;&nbsp;&nbsp;&nbsp; • Several senior positions, including Minister of Finance and Chief-of-Staff to the President, from 1992 to 2004.  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **World Economic Forum's Global Agenda Council on Climate Change** <br> &nbsp;&nbsp;&nbsp;&nbsp; • Co-Chair, from 2012 to 2014. <br>**World Bank Group** <br> &nbsp;&nbsp;&nbsp;&nbsp; • Managing Director, from 2006 to 2010. <br>**Government of El Salvador** <br> &nbsp;&nbsp;&nbsp;&nbsp; • Several senior positions, including Minister of Finance and Chief-of-Staff to the President, from 1992 to 2004.  |
| ![[MISSING IMAGE: ph_juanjosedaboub-bwlr.jpg]](ph_juanjosedaboub-bwlr.jpg) <br> **Occupation:** <br> Chairman, President and CEO, The Daboub Partnership of Arcis, LLC <br> **Committees:** <br> Compensation and Leadership Development, Finance, Nominating and Corporate Governance, and Product Innovation and Regulatory Affairs  | **Director Qualifications:** <br> Dr. Daboub's substantial business leadership experience, deep governance expertise, and outstanding government, multilateral organization and humanitarian service on a worldwide scale, bring a unique perspective to the Company's ESG strategy, and its efforts to advocate for the development of science-based regulatory frameworks in connection with the development and commercialization of RRPs. The Board has also determined that Dr. Daboub qualifies as an audit committee financial expert. <br> **Other Directorships and Associations:** <br> Dr. Daboub currently sits on the boards of directors of TortoiseEcofin Acquisition Corp. III, a private special purpose acquisition company and Grupo Financiero Ficohsa, S.A., a private Central American banking and financial services company. From September 2020 to August 2021, Dr. Daboub served as a director of Tortoise Acquisition Corp. II, a special purpose acquisition company in the sustainable energy sector.  | **Director Qualifications:** <br> Dr. Daboub's substantial business leadership experience, deep governance expertise, and outstanding government, multilateral organization and humanitarian service on a worldwide scale, bring a unique perspective to the Company's ESG strategy, and its efforts to advocate for the development of science-based regulatory frameworks in connection with the development and commercialization of RRPs. The Board has also determined that Dr. Daboub qualifies as an audit committee financial expert. <br> **Other Directorships and Associations:** <br> Dr. Daboub currently sits on the boards of directors of TortoiseEcofin Acquisition Corp. III, a private special purpose acquisition company and Grupo Financiero Ficohsa, S.A., a private Central American banking and financial services company. From September 2020 to August 2021, Dr. Daboub served as a director of Tortoise Acquisition Corp. II, a special purpose acquisition company in the sustainable energy sector.  | **Director Qualifications:** <br> Dr. Daboub's substantial business leadership experience, deep governance expertise, and outstanding government, multilateral organization and humanitarian service on a worldwide scale, bring a unique perspective to the Company's ESG strategy, and its efforts to advocate for the development of science-based regulatory frameworks in connection with the development and commercialization of RRPs. The Board has also determined that Dr. Daboub qualifies as an audit committee financial expert. <br> **Other Directorships and Associations:** <br> Dr. Daboub currently sits on the boards of directors of TortoiseEcofin Acquisition Corp. III, a private special purpose acquisition company and Grupo Financiero Ficohsa, S.A., a private Central American banking and financial services company. From September 2020 to August 2021, Dr. Daboub served as a director of Tortoise Acquisition Corp. II, a special purpose acquisition company in the sustainable energy sector.  |

---

---

| | |
|:---|:---|
| **26** | ***D e l i v e r i n g a S m o k e - F r e e F u t u r e***  |

---

------

[**TABLE OF CONTENTS**](#TOC)

E L E C T I O N O F D I R E C T O R S

---

| | | | |
|:---|:---|:---|:---|
| ![[MISSING IMAGE: ph_wernergeissler-bwlr.jpg]](ph_wernergeissler-bwlr.jpg) <br> **Occupation:** <br> Operating Partner, Advent International <br> **Committees:** <br> Compensation and Leadership Development (Chair), Audit (Financial Expert), and Consumer Relationships and Regulation  | **WERNER GEISSLER**  | **Director Since: <br> 2015**  | **Age:** 69  |
| ![[MISSING IMAGE: ph_wernergeissler-bwlr.jpg]](ph_wernergeissler-bwlr.jpg) <br> **Occupation:** <br> Operating Partner, Advent International <br> **Committees:** <br> Compensation and Leadership Development (Chair), Audit (Financial Expert), and Consumer Relationships and Regulation  | **CAREER HIGHLIGHTS**  | | |
| ![[MISSING IMAGE: ph_wernergeissler-bwlr.jpg]](ph_wernergeissler-bwlr.jpg) <br> **Occupation:** <br> Operating Partner, Advent International <br> **Committees:** <br> Compensation and Leadership Development (Chair), Audit (Financial Expert), and Consumer Relationships and Regulation  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **Advent International, a private equity firm** <br> &nbsp;&nbsp;&nbsp;&nbsp; • Operating Partner, since 2015. <br>**Procter & Gamble**, a consumer goods corporation <br> &nbsp;&nbsp;&nbsp;&nbsp; • Vice Chairman and Special Advisor to the Chairman and CEO, prior to his retirement in 2015. <br>&nbsp;&nbsp;&nbsp;&nbsp; • Vice Chairman, Global Operations, from 2007 to 2014. <br>| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp; • Group President, Central and Eastern Europe, Middle East and Africa, from 2004 to 2007. <br>&nbsp;&nbsp;&nbsp;&nbsp; • President, Northeast Asia, from 2001 to 2004.  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp; • Group President, Central and Eastern Europe, Middle East and Africa, from 2004 to 2007. <br>&nbsp;&nbsp;&nbsp;&nbsp; • President, Northeast Asia, from 2001 to 2004.  |
| ![[MISSING IMAGE: ph_wernergeissler-bwlr.jpg]](ph_wernergeissler-bwlr.jpg) <br> **Occupation:** <br> Operating Partner, Advent International <br> **Committees:** <br> Compensation and Leadership Development (Chair), Audit (Financial Expert), and Consumer Relationships and Regulation  | **Director Qualifications:** <br> Mr. Geissler has a keen knowledge of the global consumer products business, having served as a senior consumer products executive in many of the markets and regions most important to the Company. His deep senior executive experience benefits the Company, the Board, and the Compensation and Leadership Development Committee, which he chairs. Mr. Geissler has also had substantial P&L responsibility in his roles at Procter & Gamble and has an MBA in Finance, which experience and expertise he brings to his role as a member of the Audit Committee. <br> **Other Directorships and Associations:** <br> Mr. Geissler currently also sits on the board of directors of the Goodyear Tire & Rubber Company, a U.S. publicly traded company since July 2011.  | **Director Qualifications:** <br> Mr. Geissler has a keen knowledge of the global consumer products business, having served as a senior consumer products executive in many of the markets and regions most important to the Company. His deep senior executive experience benefits the Company, the Board, and the Compensation and Leadership Development Committee, which he chairs. Mr. Geissler has also had substantial P&L responsibility in his roles at Procter & Gamble and has an MBA in Finance, which experience and expertise he brings to his role as a member of the Audit Committee. <br> **Other Directorships and Associations:** <br> Mr. Geissler currently also sits on the board of directors of the Goodyear Tire & Rubber Company, a U.S. publicly traded company since July 2011.  | **Director Qualifications:** <br> Mr. Geissler has a keen knowledge of the global consumer products business, having served as a senior consumer products executive in many of the markets and regions most important to the Company. His deep senior executive experience benefits the Company, the Board, and the Compensation and Leadership Development Committee, which he chairs. Mr. Geissler has also had substantial P&L responsibility in his roles at Procter & Gamble and has an MBA in Finance, which experience and expertise he brings to his role as a member of the Audit Committee. <br> **Other Directorships and Associations:** <br> Mr. Geissler currently also sits on the board of directors of the Goodyear Tire & Rubber Company, a U.S. publicly traded company since July 2011.  |

---

---

| | |
|:---|:---|
| P M I **2 0 2 3** P r o x y S t a t e m e n t  | **27**  |

---

------

[**TABLE OF CONTENTS**](#TOC)

E L E C T I O N O F D I R E C T O R S

---

| | | | |
|:---|:---|:---|:---|
| ![[MISSING IMAGE: ph_lisaahook-bwlr.jpg]](ph_lisaahook-bwlr.jpg) <br> **Occupation:** <br> Managing Partner, Two Island Partners LLC <br> **Committees:** <br> Consumer Relationships and Regulation (Chair), Audit (Financial Expert), Compensation and Leadership Development, and Product Innovation and Regulatory Affairs  | **LISA A. HOOK**  | **Director Since: <br> 2018**  | **Age: 65**  |
| ![[MISSING IMAGE: ph_lisaahook-bwlr.jpg]](ph_lisaahook-bwlr.jpg) <br> **Occupation:** <br> Managing Partner, Two Island Partners LLC <br> **Committees:** <br> Consumer Relationships and Regulation (Chair), Audit (Financial Expert), Compensation and Leadership Development, and Product Innovation and Regulatory Affairs  | **CAREER HIGHLIGHTS**  |  |  |
| ![[MISSING IMAGE: ph_lisaahook-bwlr.jpg]](ph_lisaahook-bwlr.jpg) <br> **Occupation:** <br> Managing Partner, Two Island Partners LLC <br> **Committees:** <br> Consumer Relationships and Regulation (Chair), Audit (Financial Expert), Compensation and Leadership Development, and Product Innovation and Regulatory Affairs  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **Two Island Partners LLC**, a private equity and consulting firm <br> &nbsp;&nbsp;&nbsp;&nbsp; • Managing Partner, since 2018. <br>**Neustar, Inc.**, a global information services company focused on cloud-based workflow solutions for marketing, risk and security analytics <br> &nbsp;&nbsp;&nbsp;&nbsp; • Member of the Board, from 2010 to 2019. <br>&nbsp;&nbsp;&nbsp;&nbsp; • President & Chief Executive Officer, from 2010 to 2018. <br>&nbsp;&nbsp;&nbsp;&nbsp; • President & Chief Operating Officer, from 2008 to 2010. <br>**Sunrocket, Inc.**, a cloud-based voice communications company <br> &nbsp;&nbsp;&nbsp;&nbsp; • President & Chief Executive Officer, from 2006 to 2007. <br>| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **America Online Inc.**, a web portal and online service provider <br> &nbsp;&nbsp;&nbsp;&nbsp; • Several executive positions, from 2001 to 2004. <br>**Brera Capital Partners**, a global private equity investment firm <br> &nbsp;&nbsp;&nbsp;&nbsp; • Partner <br>**Alpine Capital Group, LLC**, an investment banking firm <br> &nbsp;&nbsp;&nbsp;&nbsp; • Managing Director <br>**Time Warner, Inc., a media company** <br> &nbsp;&nbsp;&nbsp;&nbsp; • Executive  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **America Online Inc.**, a web portal and online service provider <br> &nbsp;&nbsp;&nbsp;&nbsp; • Several executive positions, from 2001 to 2004. <br>**Brera Capital Partners**, a global private equity investment firm <br> &nbsp;&nbsp;&nbsp;&nbsp; • Partner <br>**Alpine Capital Group, LLC**, an investment banking firm <br> &nbsp;&nbsp;&nbsp;&nbsp; • Managing Director <br>**Time Warner, Inc., a media company** <br> &nbsp;&nbsp;&nbsp;&nbsp; • Executive  |
| ![[MISSING IMAGE: ph_lisaahook-bwlr.jpg]](ph_lisaahook-bwlr.jpg) <br> **Occupation:** <br> Managing Partner, Two Island Partners LLC <br> **Committees:** <br> Consumer Relationships and Regulation (Chair), Audit (Financial Expert), Compensation and Leadership Development, and Product Innovation and Regulatory Affairs  | **Director Qualifications:** <br> Ms. Hook's past experience as CEO of a U.S. publicly traded company, her past senior management roles and government appointments relating to telecommunications, plus her holistic understanding of digital identity, are key to deploying actionable insights that grow and guard many of the world's largest corporations. In addition, with her extensive public board experience, Ms. Hook brings to the Board valuable insights in the areas of cybersecurity, data privacy, and digital transformation at a time when the Company is transitioning to a consumer-centric, highly digitalized business model. The Board has also determined that Ms. Hook qualifies as an audit committee financial expert. <br> **Other Directorships and Associations:** <br> Ms. Hook currently sits on the board of directors of three other public companies: Fidelity National Information Services, Inc., a U.S. multinational corporation and global leader in banking and payment solutions, Ritchie Bros Auctioneers Incorporated, a Canadian global asset management and disposition company listed on the NYSE, and Nokia Corporation, a technology leader across mobile, fixed and cloud networks, headquartered in Finland. <br> Ms. Hook served on the boards of directors of Ping Identity Holding Corp., a pioneer in digital identity solutions, from 2019 to 2022, Partners Group Holding AG, a global asset management company, from 2020 to 2021, Unisys Corporation, a global information technology company, from 2019 to 2021, and RELX PLC and RELX NV, providers of information solutions, as Senior Independent Director from 2006 to 2016. Previously, she served as a director of Covad Communications and Time Warner Telecom, Inc. In 2012, she was appointed by President Obama to serve on the National Security Telecommunications Advisory Committee.  | **Director Qualifications:** <br> Ms. Hook's past experience as CEO of a U.S. publicly traded company, her past senior management roles and government appointments relating to telecommunications, plus her holistic understanding of digital identity, are key to deploying actionable insights that grow and guard many of the world's largest corporations. In addition, with her extensive public board experience, Ms. Hook brings to the Board valuable insights in the areas of cybersecurity, data privacy, and digital transformation at a time when the Company is transitioning to a consumer-centric, highly digitalized business model. The Board has also determined that Ms. Hook qualifies as an audit committee financial expert. <br> **Other Directorships and Associations:** <br> Ms. Hook currently sits on the board of directors of three other public companies: Fidelity National Information Services, Inc., a U.S. multinational corporation and global leader in banking and payment solutions, Ritchie Bros Auctioneers Incorporated, a Canadian global asset management and disposition company listed on the NYSE, and Nokia Corporation, a technology leader across mobile, fixed and cloud networks, headquartered in Finland. <br> Ms. Hook served on the boards of directors of Ping Identity Holding Corp., a pioneer in digital identity solutions, from 2019 to 2022, Partners Group Holding AG, a global asset management company, from 2020 to 2021, Unisys Corporation, a global information technology company, from 2019 to 2021, and RELX PLC and RELX NV, providers of information solutions, as Senior Independent Director from 2006 to 2016. Previously, she served as a director of Covad Communications and Time Warner Telecom, Inc. In 2012, she was appointed by President Obama to serve on the National Security Telecommunications Advisory Committee.  | **Director Qualifications:** <br> Ms. Hook's past experience as CEO of a U.S. publicly traded company, her past senior management roles and government appointments relating to telecommunications, plus her holistic understanding of digital identity, are key to deploying actionable insights that grow and guard many of the world's largest corporations. In addition, with her extensive public board experience, Ms. Hook brings to the Board valuable insights in the areas of cybersecurity, data privacy, and digital transformation at a time when the Company is transitioning to a consumer-centric, highly digitalized business model. The Board has also determined that Ms. Hook qualifies as an audit committee financial expert. <br> **Other Directorships and Associations:** <br> Ms. Hook currently sits on the board of directors of three other public companies: Fidelity National Information Services, Inc., a U.S. multinational corporation and global leader in banking and payment solutions, Ritchie Bros Auctioneers Incorporated, a Canadian global asset management and disposition company listed on the NYSE, and Nokia Corporation, a technology leader across mobile, fixed and cloud networks, headquartered in Finland. <br> Ms. Hook served on the boards of directors of Ping Identity Holding Corp., a pioneer in digital identity solutions, from 2019 to 2022, Partners Group Holding AG, a global asset management company, from 2020 to 2021, Unisys Corporation, a global information technology company, from 2019 to 2021, and RELX PLC and RELX NV, providers of information solutions, as Senior Independent Director from 2006 to 2016. Previously, she served as a director of Covad Communications and Time Warner Telecom, Inc. In 2012, she was appointed by President Obama to serve on the National Security Telecommunications Advisory Committee.  |

---

---

| | |
|:---|:---|
| **28** | ***D e l i v e r i n g a S m o k e - F r e e F u t u r e***  |

---

------

[**TABLE OF CONTENTS**](#TOC)

E L E C T I O N O F D I R E C T O R S

---

| | | | |
|:---|:---|:---|:---|
| ![[MISSING IMAGE: ph_junmakihara-bwlr.jpg]](ph_junmakihara-bwlr.jpg) <br> **Occupation:** <br> Retired Businessman <br> **Committees:** <br> Finance (Chair), Audit, <br> Compensation and Leadership Development, and Consumer Relationships and Regulation  | **JUN MAKIHARA**  | **Director Since: <br> 2014**  | **Age: 65**  |
| ![[MISSING IMAGE: ph_junmakihara-bwlr.jpg]](ph_junmakihara-bwlr.jpg) <br> **Occupation:** <br> Retired Businessman <br> **Committees:** <br> Finance (Chair), Audit, <br> Compensation and Leadership Development, and Consumer Relationships and Regulation  | **CAREER HIGHLIGHTS**  |  |  |
| ![[MISSING IMAGE: ph_junmakihara-bwlr.jpg]](ph_junmakihara-bwlr.jpg) <br> **Occupation:** <br> Retired Businessman <br> **Committees:** <br> Finance (Chair), Audit, <br> Compensation and Leadership Development, and Consumer Relationships and Regulation  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **Neoteny Co. Ltd.**, a Japanese venture incubator <br> &nbsp;&nbsp;&nbsp;&nbsp; • Chairman, from 2000 until 2015. <br>| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **Goldman, Sachs & Co.**, a multinational investment bank and financial services company, from 1981 to 2000 <br> &nbsp;&nbsp;&nbsp;&nbsp; • General Partner, from 1992 to 1998. <br>&nbsp;&nbsp;&nbsp;&nbsp; • Co-Head Japanese Equities Group and Co-Branch Manager, from 1995 to 1998. <br>&nbsp;&nbsp;&nbsp;&nbsp; • Co-Head Japanese Investment Banking Group, from 1992 to 1995.  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **Goldman, Sachs & Co.**, a multinational investment bank and financial services company, from 1981 to 2000 <br> &nbsp;&nbsp;&nbsp;&nbsp; • General Partner, from 1992 to 1998. <br>&nbsp;&nbsp;&nbsp;&nbsp; • Co-Head Japanese Equities Group and Co-Branch Manager, from 1995 to 1998. <br>&nbsp;&nbsp;&nbsp;&nbsp; • Co-Head Japanese Investment Banking Group, from 1992 to 1995.  |
| ![[MISSING IMAGE: ph_junmakihara-bwlr.jpg]](ph_junmakihara-bwlr.jpg) <br> **Occupation:** <br> Retired Businessman <br> **Committees:** <br> Finance (Chair), Audit, <br> Compensation and Leadership Development, and Consumer Relationships and Regulation  | **Director Qualifications:** <br> Mr. Makihara brings his deep experience in finance to his position as Chair of the Finance Committee. The Board also benefits from his entrepreneurial spirit and a thorough knowledge of business in Asia, which is of great importance to the Company's business as we continue to launch new products and execute our strategic initiatives in various Asian markets. <br> **Other Directorships and Associations:** <br> Mr. Makihara currently sits on the board of directors of Monex Group, Inc., a Japanese financial services company publicly traded on the Tokyo Stock Exchange, and TradeStation Group, Inc., an online brokerage and wholly-owned subsidiary of Monex Group, Inc. He has served on the boards of directors of Shinsei Bank, Ltd., a Japanese based commercial, leasing and consumer finance bank, from 2011 to 2022 and at its wholly-owned subsidiary, UDC Finance Limited (Auckland NZ), the largest non-bank finance company in New Zealand from 2020 to 2022. He was a trustee of the Protestant Episcopal Cathedral Foundation in Washington, D.C. from 2016 to 2022 and is a member of the board of directors of Japan Society in New York. He also served on the board of directors of RHJ International S.A., a financial services company, from 2005 to 2014.  | **Director Qualifications:** <br> Mr. Makihara brings his deep experience in finance to his position as Chair of the Finance Committee. The Board also benefits from his entrepreneurial spirit and a thorough knowledge of business in Asia, which is of great importance to the Company's business as we continue to launch new products and execute our strategic initiatives in various Asian markets. <br> **Other Directorships and Associations:** <br> Mr. Makihara currently sits on the board of directors of Monex Group, Inc., a Japanese financial services company publicly traded on the Tokyo Stock Exchange, and TradeStation Group, Inc., an online brokerage and wholly-owned subsidiary of Monex Group, Inc. He has served on the boards of directors of Shinsei Bank, Ltd., a Japanese based commercial, leasing and consumer finance bank, from 2011 to 2022 and at its wholly-owned subsidiary, UDC Finance Limited (Auckland NZ), the largest non-bank finance company in New Zealand from 2020 to 2022. He was a trustee of the Protestant Episcopal Cathedral Foundation in Washington, D.C. from 2016 to 2022 and is a member of the board of directors of Japan Society in New York. He also served on the board of directors of RHJ International S.A., a financial services company, from 2005 to 2014.  | **Director Qualifications:** <br> Mr. Makihara brings his deep experience in finance to his position as Chair of the Finance Committee. The Board also benefits from his entrepreneurial spirit and a thorough knowledge of business in Asia, which is of great importance to the Company's business as we continue to launch new products and execute our strategic initiatives in various Asian markets. <br> **Other Directorships and Associations:** <br> Mr. Makihara currently sits on the board of directors of Monex Group, Inc., a Japanese financial services company publicly traded on the Tokyo Stock Exchange, and TradeStation Group, Inc., an online brokerage and wholly-owned subsidiary of Monex Group, Inc. He has served on the boards of directors of Shinsei Bank, Ltd., a Japanese based commercial, leasing and consumer finance bank, from 2011 to 2022 and at its wholly-owned subsidiary, UDC Finance Limited (Auckland NZ), the largest non-bank finance company in New Zealand from 2020 to 2022. He was a trustee of the Protestant Episcopal Cathedral Foundation in Washington, D.C. from 2016 to 2022 and is a member of the board of directors of Japan Society in New York. He also served on the board of directors of RHJ International S.A., a financial services company, from 2005 to 2014.  |

---

---

| | |
|:---|:---|
| P M I **2 0 2 3** P r o x y S t a t e m e n t  | **29**  |

---

------

[**TABLE OF CONTENTS**](#TOC)

E L E C T I O N O F D I R E C T O R S

---

| | | | |
|:---|:---|:---|:---|
| ![[MISSING IMAGE: ph_kalpanamorparia-bw.jpg]](ph_kalpanamorparia-bw.jpg) <br> **Occupation:** <br> Founder & Managing Partner, KalMor Advisors LLP <br> **Committees:** <br> Nominating and Corporate Governance (Chair), Finance, and Product Innovation and Regulatory Affairs  | **KALPANA MORPARIA**  | **Director Since: <br> 2011**  | **Age: 73**  |
| ![[MISSING IMAGE: ph_kalpanamorparia-bw.jpg]](ph_kalpanamorparia-bw.jpg) <br> **Occupation:** <br> Founder & Managing Partner, KalMor Advisors LLP <br> **Committees:** <br> Nominating and Corporate Governance (Chair), Finance, and Product Innovation and Regulatory Affairs  | **CAREER HIGHLIGHTS**  |  |  |
| ![[MISSING IMAGE: ph_kalpanamorparia-bw.jpg]](ph_kalpanamorparia-bw.jpg) <br> **Occupation:** <br> Founder & Managing Partner, KalMor Advisors LLP <br> **Committees:** <br> Nominating and Corporate Governance (Chair), Finance, and Product Innovation and Regulatory Affairs  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **KalMor Advisors LLP,** a strategy and corporate advisory firm <br> &nbsp;&nbsp;&nbsp;&nbsp; • Founder and Managing Partner, since 2021. <br>**JPMorgan Chase & Co.,** a multinational investment bank and financial services holding company <br> &nbsp;&nbsp;&nbsp;&nbsp; • Chairman of South and South-East Asia, from March 2019 until her retirement in February 2021. <br>&nbsp;&nbsp;&nbsp;&nbsp; • CEO of South and South-East Asia from April 2016 until March 2019. <br>&nbsp;&nbsp;&nbsp;&nbsp; • CEO of J.P. Morgan India, from 2008 to 2016. <br>| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **ICICI Bank, India's second-largest bank** <br> &nbsp;&nbsp;&nbsp;&nbsp; • Vice Chair of ICICI's insurance and asset management business, from 2007 to 2008. <br>&nbsp;&nbsp;&nbsp;&nbsp; • Joint Managing Director, from 2001 to 2007.  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **ICICI Bank, India's second-largest bank** <br> &nbsp;&nbsp;&nbsp;&nbsp; • Vice Chair of ICICI's insurance and asset management business, from 2007 to 2008. <br>&nbsp;&nbsp;&nbsp;&nbsp; • Joint Managing Director, from 2001 to 2007.  |
| ![[MISSING IMAGE: ph_kalpanamorparia-bw.jpg]](ph_kalpanamorparia-bw.jpg) <br> **Occupation:** <br> Founder & Managing Partner, KalMor Advisors LLP <br> **Committees:** <br> Nominating and Corporate Governance (Chair), Finance, and Product Innovation and Regulatory Affairs  | **Director Qualifications:** <br> With her strong executive leadership experience in finance, and her deep knowledge of international business, Ms. Morparia provides a keen perspective on economies in Asia, while her legal background and deep experience in highly regulated industries help her serve the Company and the Board well as Chair of the Nominating and Corporate Governance Committee. <br> **Other Directorships and Associations:** <br> Ms. Morparia currently sits on the board of directors of three other public companies: HSBC Holdings plc, a British multinational universal bank and financial services holding company, Dr. Reddy's Laboratories Ltd., an Indian multinational pharmaceutical company, and Hindustan Unilever Limited, an Indian consumer goods company. She previously served on the board of directors of Delhivery Limited. Ms. Morparia also serves on the Governing Board of Bharti Foundation, the Foundation for Audit Quality and the Generation India Foundation, each of which is a not-for-profit company.  | **Director Qualifications:** <br> With her strong executive leadership experience in finance, and her deep knowledge of international business, Ms. Morparia provides a keen perspective on economies in Asia, while her legal background and deep experience in highly regulated industries help her serve the Company and the Board well as Chair of the Nominating and Corporate Governance Committee. <br> **Other Directorships and Associations:** <br> Ms. Morparia currently sits on the board of directors of three other public companies: HSBC Holdings plc, a British multinational universal bank and financial services holding company, Dr. Reddy's Laboratories Ltd., an Indian multinational pharmaceutical company, and Hindustan Unilever Limited, an Indian consumer goods company. She previously served on the board of directors of Delhivery Limited. Ms. Morparia also serves on the Governing Board of Bharti Foundation, the Foundation for Audit Quality and the Generation India Foundation, each of which is a not-for-profit company.  | **Director Qualifications:** <br> With her strong executive leadership experience in finance, and her deep knowledge of international business, Ms. Morparia provides a keen perspective on economies in Asia, while her legal background and deep experience in highly regulated industries help her serve the Company and the Board well as Chair of the Nominating and Corporate Governance Committee. <br> **Other Directorships and Associations:** <br> Ms. Morparia currently sits on the board of directors of three other public companies: HSBC Holdings plc, a British multinational universal bank and financial services holding company, Dr. Reddy's Laboratories Ltd., an Indian multinational pharmaceutical company, and Hindustan Unilever Limited, an Indian consumer goods company. She previously served on the board of directors of Delhivery Limited. Ms. Morparia also serves on the Governing Board of Bharti Foundation, the Foundation for Audit Quality and the Generation India Foundation, each of which is a not-for-profit company.  |

---

---

| | | | |
|:---|:---|:---|:---|
| ![[MISSING IMAGE: ph_jackolczak-bw.jpg]](ph_jackolczak-bw.jpg) <br> **Occupation:** <br> Chief Executive Officer, Philip Morris International, Inc. <br> **Committees:** <br> Consumer Relationships and Regulation, Finance, and Product Innovation and Regulatory Affairs  | **JACEK OLCZAK**  | **Director Since: <br> 2021**  | **Age: 58**  |
| ![[MISSING IMAGE: ph_jackolczak-bw.jpg]](ph_jackolczak-bw.jpg) <br> **Occupation:** <br> Chief Executive Officer, Philip Morris International, Inc. <br> **Committees:** <br> Consumer Relationships and Regulation, Finance, and Product Innovation and Regulatory Affairs  | **CAREER HIGHLIGHTS**  | | |
| ![[MISSING IMAGE: ph_jackolczak-bw.jpg]](ph_jackolczak-bw.jpg) <br> **Occupation:** <br> Chief Executive Officer, Philip Morris International, Inc. <br> **Committees:** <br> Consumer Relationships and Regulation, Finance, and Product Innovation and Regulatory Affairs  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **Philip Morris International Inc.** <br> &nbsp;&nbsp;&nbsp;&nbsp; • Chief Executive Officer, since May 2021. <br>&nbsp;&nbsp;&nbsp;&nbsp; • Chief Operating Officer, from January 2018 until May 2021. <br>| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp; • Chief Financial Officer, from August 2012 until December 2017. <br>&nbsp;&nbsp;&nbsp;&nbsp; • Various roles in finance and general management positions across Europe, including Managing Director of PMI's markets in Poland and Germany, and as President of the European Union Region, from 1993 until January 2018.  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp; • Chief Financial Officer, from August 2012 until December 2017. <br>&nbsp;&nbsp;&nbsp;&nbsp; • Various roles in finance and general management positions across Europe, including Managing Director of PMI's markets in Poland and Germany, and as President of the European Union Region, from 1993 until January 2018.  |
| ![[MISSING IMAGE: ph_jackolczak-bw.jpg]](ph_jackolczak-bw.jpg) <br> **Occupation:** <br> Chief Executive Officer, Philip Morris International, Inc. <br> **Committees:** <br> Consumer Relationships and Regulation, Finance, and Product Innovation and Regulatory Affairs  | **Director Qualifications:** <br> Mr. Olczak's intellect and all-encompassing knowledge of the Company serves him well as CEO of the Company and as member of the Board. As COO, he played an instrumental role in the Company's transformation and the superior performance of our regions and markets, particularly, in his commitment to consumer centricity, digitalized consumer engagement, and manufacturing optimization, while remaining focused on the growth of our combustible capacities brand portfolio and the seamless deployment of RRPs in over 70 markets worldwide.  | **Director Qualifications:** <br> Mr. Olczak's intellect and all-encompassing knowledge of the Company serves him well as CEO of the Company and as member of the Board. As COO, he played an instrumental role in the Company's transformation and the superior performance of our regions and markets, particularly, in his commitment to consumer centricity, digitalized consumer engagement, and manufacturing optimization, while remaining focused on the growth of our combustible capacities brand portfolio and the seamless deployment of RRPs in over 70 markets worldwide.  | **Director Qualifications:** <br> Mr. Olczak's intellect and all-encompassing knowledge of the Company serves him well as CEO of the Company and as member of the Board. As COO, he played an instrumental role in the Company's transformation and the superior performance of our regions and markets, particularly, in his commitment to consumer centricity, digitalized consumer engagement, and manufacturing optimization, while remaining focused on the growth of our combustible capacities brand portfolio and the seamless deployment of RRPs in over 70 markets worldwide.  |

---

---

| | |
|:---|:---|
| **30** | ***D e l i v e r i n g a S m o k e - F r e e F u t u r e***  |

---

------

[**TABLE OF CONTENTS**](#TOC)

E L E C T I O N O F D I R E C T O R S

---

| | | | |
|:---|:---|:---|:---|
| ![[MISSING IMAGE: ph_robertpolet-bw.jpg]](ph_robertpolet-bw.jpg) <br> **Occupation:** <br> Chairman, Rituals Cosmetics Enterprise B.V. <br> Chairman, Arica Holding B.V. <br> Chairman, SFMS B.V. <br> **Committees:** <br> Compensation and Leadership Development, Consumer Relationships and Regulation, and Nominating and Corporate Governance  | **ROBERT B. POLET**  | **Director Since: <br> 2011**  | **Age: 67**  |
| ![[MISSING IMAGE: ph_robertpolet-bw.jpg]](ph_robertpolet-bw.jpg) <br> **Occupation:** <br> Chairman, Rituals Cosmetics Enterprise B.V. <br> Chairman, Arica Holding B.V. <br> Chairman, SFMS B.V. <br> **Committees:** <br> Compensation and Leadership Development, Consumer Relationships and Regulation, and Nominating and Corporate Governance  | **CAREER HIGHLIGHTS**  |  |  |
| ![[MISSING IMAGE: ph_robertpolet-bw.jpg]](ph_robertpolet-bw.jpg) <br> **Occupation:** <br> Chairman, Rituals Cosmetics Enterprise B.V. <br> Chairman, Arica Holding B.V. <br> Chairman, SFMS B.V. <br> **Committees:** <br> Compensation and Leadership Development, Consumer Relationships and Regulation, and Nominating and Corporate Governance  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **Rituals Cosmetics Enterprise B.V.**, a retail cosmetics company <br> &nbsp;&nbsp;&nbsp;&nbsp; • Chairman, since 2017. <br>**SFMS B.V.**, a retail consumer staples company <br> &nbsp;&nbsp;&nbsp;&nbsp; • Chairman <br>**Arica Holding B.V.**, parent holding company of SFMS B.V. <br> &nbsp;&nbsp;&nbsp;&nbsp; • Chairman, since 2019. <br>| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **Gucci Group, a luxury fashion house** <br> &nbsp;&nbsp;&nbsp;&nbsp; • President, Chief Executive Officer and Chairman of the Management Board, from 2004 until 2011. <br>**Unilever Group**, a multinational consumer goods company <br> &nbsp;&nbsp;&nbsp;&nbsp; • 26 years in a variety of executive roles, including President of Unilever's Worldwide Ice Cream and Frozen Foods division, Chairman of Unilever Malaysia, Chairman of Van den Bergh and Executive Vice President of Unilever's European Home and Personal Care division.  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **Gucci Group, a luxury fashion house** <br> &nbsp;&nbsp;&nbsp;&nbsp; • President, Chief Executive Officer and Chairman of the Management Board, from 2004 until 2011. <br>**Unilever Group**, a multinational consumer goods company <br> &nbsp;&nbsp;&nbsp;&nbsp; • 26 years in a variety of executive roles, including President of Unilever's Worldwide Ice Cream and Frozen Foods division, Chairman of Unilever Malaysia, Chairman of Van den Bergh and Executive Vice President of Unilever's European Home and Personal Care division.  |
| ![[MISSING IMAGE: ph_robertpolet-bw.jpg]](ph_robertpolet-bw.jpg) <br> **Occupation:** <br> Chairman, Rituals Cosmetics Enterprise B.V. <br> Chairman, Arica Holding B.V. <br> Chairman, SFMS B.V. <br> **Committees:** <br> Compensation and Leadership Development, Consumer Relationships and Regulation, and Nominating and Corporate Governance  | **Director Qualifications:** <br> As a chief executive officer of Gucci Group, Mr. Polet was responsible for managing global luxury brands such as Gucci, Bottega Veneta, Yves Saint Laurent, Boucheron, Balenciaga, Sergio Rossi, Alexander McQueen and Stella McCartney. He brings to the Board his considerable entrepreneurial business experience in the global luxury business. Furthermore, he has extensive executive experience overseeing major consumer packaged goods businesses, as well as an extensive knowledge of global markets. <br> **Other Directorships and Associations:** <br> Mr. Polet currently sits on the board of directors of Safilo Group S.p.A., an Italian publicly held eyewear company, where he also served as Chairman from 2011 to 2017. Mr. Polet previously served as a non-executive director of RELX PLC and RELX NV, providers of information solutions, and each a publicly held entity, from 2007 to 2016. <br> He also previously sat on the board of directors of William Grant & Sons Ltd., an independent, family-owned, Scottish premium spirits company, from 2011 to 2022, most recently as senior independent director.  | **Director Qualifications:** <br> As a chief executive officer of Gucci Group, Mr. Polet was responsible for managing global luxury brands such as Gucci, Bottega Veneta, Yves Saint Laurent, Boucheron, Balenciaga, Sergio Rossi, Alexander McQueen and Stella McCartney. He brings to the Board his considerable entrepreneurial business experience in the global luxury business. Furthermore, he has extensive executive experience overseeing major consumer packaged goods businesses, as well as an extensive knowledge of global markets. <br> **Other Directorships and Associations:** <br> Mr. Polet currently sits on the board of directors of Safilo Group S.p.A., an Italian publicly held eyewear company, where he also served as Chairman from 2011 to 2017. Mr. Polet previously served as a non-executive director of RELX PLC and RELX NV, providers of information solutions, and each a publicly held entity, from 2007 to 2016. <br> He also previously sat on the board of directors of William Grant & Sons Ltd., an independent, family-owned, Scottish premium spirits company, from 2011 to 2022, most recently as senior independent director.  | **Director Qualifications:** <br> As a chief executive officer of Gucci Group, Mr. Polet was responsible for managing global luxury brands such as Gucci, Bottega Veneta, Yves Saint Laurent, Boucheron, Balenciaga, Sergio Rossi, Alexander McQueen and Stella McCartney. He brings to the Board his considerable entrepreneurial business experience in the global luxury business. Furthermore, he has extensive executive experience overseeing major consumer packaged goods businesses, as well as an extensive knowledge of global markets. <br> **Other Directorships and Associations:** <br> Mr. Polet currently sits on the board of directors of Safilo Group S.p.A., an Italian publicly held eyewear company, where he also served as Chairman from 2011 to 2017. Mr. Polet previously served as a non-executive director of RELX PLC and RELX NV, providers of information solutions, and each a publicly held entity, from 2007 to 2016. <br> He also previously sat on the board of directors of William Grant & Sons Ltd., an independent, family-owned, Scottish premium spirits company, from 2011 to 2022, most recently as senior independent director.  |

---

---

| | |
|:---|:---|
| P M I **2 0 2 3** P r o x y S t a t e m e n t  | **31**  |

---

------

[**TABLE OF CONTENTS**](#TOC)

E L E C T I O N O F D I R E C T O R S

---

| | | | |
|:---|:---|:---|:---|
| ![[MISSING IMAGE: ph_dessitemperley-bwlr.jpg]](ph_dessitemperley-bwlr.jpg) <br> **Occupation:** <br> Former Group CFO and Executive Board Member, Beiersdorf AG <br> **Committees:** <br> Audit (Financial Expert), Consumer Relationships and Regulation, and Finance  | **DESSI TEMPERLEY**  | **Director Since: <br> 2021**  | **Age: 50**  |
| ![[MISSING IMAGE: ph_dessitemperley-bwlr.jpg]](ph_dessitemperley-bwlr.jpg) <br> **Occupation:** <br> Former Group CFO and Executive Board Member, Beiersdorf AG <br> **Committees:** <br> Audit (Financial Expert), Consumer Relationships and Regulation, and Finance  | **CAREER HIGHLIGHTS**  |  |  |
| ![[MISSING IMAGE: ph_dessitemperley-bwlr.jpg]](ph_dessitemperley-bwlr.jpg) <br> **Occupation:** <br> Former Group CFO and Executive Board Member, Beiersdorf AG <br> **Committees:** <br> Audit (Financial Expert), Consumer Relationships and Regulation, and Finance  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **Beiersdorf AG**, a manufacturer and retailer of personal-care products and pressure- sensitive adhesives <br> &nbsp;&nbsp;&nbsp;&nbsp; • Group Chief Financial Officer and Executive Board Member, from 2018 until her retirement in April 2021. <br>**Nestle S.A., a food & beverage company** <br> &nbsp;&nbsp;&nbsp;&nbsp; • Head of Investor Relations, CFO of Nestle Purina Petcare EMENA, Head of Global Planning and Performance Analysis, CFO of Nestle South East Europe Zone, Controller for CEE, and Supply Chain Controller NPPE, from April 2004 to June 2018. <br>|  |  |
| ![[MISSING IMAGE: ph_dessitemperley-bwlr.jpg]](ph_dessitemperley-bwlr.jpg) <br> **Occupation:** <br> Former Group CFO and Executive Board Member, Beiersdorf AG <br> **Committees:** <br> Audit (Financial Expert), Consumer Relationships and Regulation, and Finance  | **Director Qualifications:** <br> Ms. Temperley is a recently retired chief financial officer of a global public company with over 25 years of experience across a variety of sectors with several blue-chip multinationals. She has a proven track record of delivering strategic change with strong operational leadership resulting in superior financial results. The Board has also determined that Ms. Temperley qualifies as an audit committee financial expert. <br> **Other Directorships and Associations:** <br> In May 2020, Ms. Temperley joined the board of directors of Coca-Cola Europacific Partners, a U.S. publicly held bottling company, where she also serves on the Audit Committee. In May 2021, following retirement from her executive career, Ms. Temperley also joined the board of directors of Corbion, a public food and biochemical company headquartered in the Netherlands, where she also serves on the Audit Committee and the Sustainability Committee. In September 2021, Ms. Temperley joined the board of directors of Cimpress, a publicly held U.S. company domiciled in Ireland that invests in and operates a wide variety of businesses that use mass customization to configure and produce small quantities of individually customized goods, where she also serves on the Audit Committee.  | **Director Qualifications:** <br> Ms. Temperley is a recently retired chief financial officer of a global public company with over 25 years of experience across a variety of sectors with several blue-chip multinationals. She has a proven track record of delivering strategic change with strong operational leadership resulting in superior financial results. The Board has also determined that Ms. Temperley qualifies as an audit committee financial expert. <br> **Other Directorships and Associations:** <br> In May 2020, Ms. Temperley joined the board of directors of Coca-Cola Europacific Partners, a U.S. publicly held bottling company, where she also serves on the Audit Committee. In May 2021, following retirement from her executive career, Ms. Temperley also joined the board of directors of Corbion, a public food and biochemical company headquartered in the Netherlands, where she also serves on the Audit Committee and the Sustainability Committee. In September 2021, Ms. Temperley joined the board of directors of Cimpress, a publicly held U.S. company domiciled in Ireland that invests in and operates a wide variety of businesses that use mass customization to configure and produce small quantities of individually customized goods, where she also serves on the Audit Committee.  | **Director Qualifications:** <br> Ms. Temperley is a recently retired chief financial officer of a global public company with over 25 years of experience across a variety of sectors with several blue-chip multinationals. She has a proven track record of delivering strategic change with strong operational leadership resulting in superior financial results. The Board has also determined that Ms. Temperley qualifies as an audit committee financial expert. <br> **Other Directorships and Associations:** <br> In May 2020, Ms. Temperley joined the board of directors of Coca-Cola Europacific Partners, a U.S. publicly held bottling company, where she also serves on the Audit Committee. In May 2021, following retirement from her executive career, Ms. Temperley also joined the board of directors of Corbion, a public food and biochemical company headquartered in the Netherlands, where she also serves on the Audit Committee and the Sustainability Committee. In September 2021, Ms. Temperley joined the board of directors of Cimpress, a publicly held U.S. company domiciled in Ireland that invests in and operates a wide variety of businesses that use mass customization to configure and produce small quantities of individually customized goods, where she also serves on the Audit Committee.  |

---

---

| | |
|:---|:---|
| **32** | ***D e l i v e r i n g a S m o k e - F r e e F u t u r e***  |

---

------

[**TABLE OF CONTENTS**](#TOC)

E L E C T I O N O F D I R E C T O R S

---

| | | | |
|:---|:---|:---|:---|
| ![[MISSING IMAGE: ph_shlomoyanai-bwlr.jpg]](ph_shlomoyanai-bwlr.jpg) <br> **Occupation:** <br> Chairman of the Board, Lumenis Ltd. <br> **Committees:** <br> Nominating and Corporate Governance, and Product Innovation and Regulatory Affairs  | **SHLOMO YANAI**  | **Director Since: <br> 2021**  | **Age: 70**  |
| ![[MISSING IMAGE: ph_shlomoyanai-bwlr.jpg]](ph_shlomoyanai-bwlr.jpg) <br> **Occupation:** <br> Chairman of the Board, Lumenis Ltd. <br> **Committees:** <br> Nominating and Corporate Governance, and Product Innovation and Regulatory Affairs  | **CAREER HIGHLIGHTS**  |  |  |
| ![[MISSING IMAGE: ph_shlomoyanai-bwlr.jpg]](ph_shlomoyanai-bwlr.jpg) <br> **Occupation:** <br> Chairman of the Board, Lumenis Ltd. <br> **Committees:** <br> Nominating and Corporate Governance, and Product Innovation and Regulatory Affairs  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **Lumenis Ltd., a medical devices company** <br> &nbsp;&nbsp;&nbsp;&nbsp; • Chairman of the Board, since 2020. <br>**Moelis & Company, an investment bank** <br> &nbsp;&nbsp;&nbsp;&nbsp; • Senior Advisor, since 2016. <br>**Cambrex Corp.,** a global pharmaceutical contract development and manufacturing company <br> &nbsp;&nbsp;&nbsp;&nbsp; • Chairman, from 2013 to 2019. <br>| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **Teva Pharmaceuticals Industries Ltd.**,a pharmaceutical company <br> &nbsp;&nbsp;&nbsp;&nbsp; • President and Chief Executive Officer, from 2007 to 2012. <br>**Adama Industries**, a global crop protection company <br> &nbsp;&nbsp;&nbsp;&nbsp; • Chief Executive Officer, from 2002 to 2006. <br>**Israeli Defense Forces** <br> &nbsp;&nbsp;&nbsp;&nbsp; • Variety of leadership roles over 32 years, retiring as a Major General. <br>&nbsp;&nbsp;&nbsp;&nbsp; • Received Israel's Medal of Valor in 1973.  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **Teva Pharmaceuticals Industries Ltd.**,a pharmaceutical company <br> &nbsp;&nbsp;&nbsp;&nbsp; • President and Chief Executive Officer, from 2007 to 2012. <br>**Adama Industries**, a global crop protection company <br> &nbsp;&nbsp;&nbsp;&nbsp; • Chief Executive Officer, from 2002 to 2006. <br>**Israeli Defense Forces** <br> &nbsp;&nbsp;&nbsp;&nbsp; • Variety of leadership roles over 32 years, retiring as a Major General. <br>&nbsp;&nbsp;&nbsp;&nbsp; • Received Israel's Medal of Valor in 1973.  |
| ![[MISSING IMAGE: ph_shlomoyanai-bwlr.jpg]](ph_shlomoyanai-bwlr.jpg) <br> **Occupation:** <br> Chairman of the Board, Lumenis Ltd. <br> **Committees:** <br> Nominating and Corporate Governance, and Product Innovation and Regulatory Affairs  | **Director Qualifications:** <br> Mr. Yanai's extensive experience in the pharmaceuticals industry brings a unique perspective to the Company's critical efforts to develop and commercialize RRPs, and to advocate for the development of science-based regulatory frameworks for the development and commercialization of such products. <br> **Other Directorships and Associations:** <br> Mr. Yanai currently also sits on the board of directors of Amneal Pharmaceuticals, Inc., a publicly held generics and specialty U.S. pharmaceutical company. Until October 2021, Mr. Yanai served on the board of directors of W.R. Grace and Company, a publicly held specialty chemicals U.S. company. <br> He has served as Chairman of the boards of directors of several private companies: Makhteshim Chemical Works Ltd., Agan Chemical Manufacturers Ltd, Milenia Agro Chemicals and Aroma Fine Chemicals Ltd. Mr. Yanai has also served as either Chairman or a member of boards of directors of the following publicly traded pharmaceutical companies: Cambrex Corp., Protalix Biotherapeutics, Inc., PDL BioPharm, Inc., Perrigo plc, and Sagent Pharmaceuticals, Inc. Mr. Yanai was also a member of the boards of directors of Elisra Group, a privately owned electronic device company, from 2002 to 2005, and Bank Leumi, Israel's second-largest publicly traded bank, from 2004 to 2007.  | **Director Qualifications:** <br> Mr. Yanai's extensive experience in the pharmaceuticals industry brings a unique perspective to the Company's critical efforts to develop and commercialize RRPs, and to advocate for the development of science-based regulatory frameworks for the development and commercialization of such products. <br> **Other Directorships and Associations:** <br> Mr. Yanai currently also sits on the board of directors of Amneal Pharmaceuticals, Inc., a publicly held generics and specialty U.S. pharmaceutical company. Until October 2021, Mr. Yanai served on the board of directors of W.R. Grace and Company, a publicly held specialty chemicals U.S. company. <br> He has served as Chairman of the boards of directors of several private companies: Makhteshim Chemical Works Ltd., Agan Chemical Manufacturers Ltd, Milenia Agro Chemicals and Aroma Fine Chemicals Ltd. Mr. Yanai has also served as either Chairman or a member of boards of directors of the following publicly traded pharmaceutical companies: Cambrex Corp., Protalix Biotherapeutics, Inc., PDL BioPharm, Inc., Perrigo plc, and Sagent Pharmaceuticals, Inc. Mr. Yanai was also a member of the boards of directors of Elisra Group, a privately owned electronic device company, from 2002 to 2005, and Bank Leumi, Israel's second-largest publicly traded bank, from 2004 to 2007.  | **Director Qualifications:** <br> Mr. Yanai's extensive experience in the pharmaceuticals industry brings a unique perspective to the Company's critical efforts to develop and commercialize RRPs, and to advocate for the development of science-based regulatory frameworks for the development and commercialization of such products. <br> **Other Directorships and Associations:** <br> Mr. Yanai currently also sits on the board of directors of Amneal Pharmaceuticals, Inc., a publicly held generics and specialty U.S. pharmaceutical company. Until October 2021, Mr. Yanai served on the board of directors of W.R. Grace and Company, a publicly held specialty chemicals U.S. company. <br> He has served as Chairman of the boards of directors of several private companies: Makhteshim Chemical Works Ltd., Agan Chemical Manufacturers Ltd, Milenia Agro Chemicals and Aroma Fine Chemicals Ltd. Mr. Yanai has also served as either Chairman or a member of boards of directors of the following publicly traded pharmaceutical companies: Cambrex Corp., Protalix Biotherapeutics, Inc., PDL BioPharm, Inc., Perrigo plc, and Sagent Pharmaceuticals, Inc. Mr. Yanai was also a member of the boards of directors of Elisra Group, a privately owned electronic device company, from 2002 to 2005, and Bank Leumi, Israel's second-largest publicly traded bank, from 2004 to 2007.  |

---

---

| | |
|:---|:---|
| P M I **2 0 2 3** P r o x y S t a t e m e n t  | **33**  |

---

------

[**TABLE OF CONTENTS**](#TOC)

C O M P E N S A T I O N O F D I R E C T O R S

![[MISSING IMAGE: tm2136562d1-icon_topbarpn.jpg]](tm2136562d1-icon_topbarpn.jpg)

## COMPENSATION OF DIRECTORS

## Compensation Philosophy
Directors who are full-time employees of the Company receive no additional compensation for services as a director. The Company's philosophy is to provide competitive compensation necessary to attract and retain high-quality non-employee directors. The Board believes that a substantial portion of director compensation should consist of equity-based compensation to assist in aligning directors' interests with the interests of shareholders.

#### C O M P E N S A T I O N
At his request, Dr. Paulsen served as a director without compensation in 2022. The compensation of all other non-employee directors is set forth in the accompanying chart.

PMI's non-employee directors' compensation for 2022 was set at the levels presented below. The Board has approved an increase in the Lead Independent Director cash retainer to $50,000, effective on Ms. Hook's appointment. All other director compensation continues in effect for 2023:

---

| | |
|:---|:---|
| Annual cash retainer | $125000  |
| Annual equity award | $175000  |
| Committee Chair cash retainer | $35000  |
| Lead Independent Director cash retainer | $35000  |
| Committee member cash retainer |  |
| Committee meeting fees |  |
| Stock Options |  |

---

 **S H A R E R E T E N T I O N R E Q U I R E M E N T** 

A non-employee director may not sell or otherwise dispose of PMI shares received pursuant to the annual share award (other than shares withheld from the grant to pay taxes) unless he or she continues after the disposition to own PMI shares having an aggregate value of at least five times the then-current annual cash retainer. The Company's anti-hedging and anti-pledging policies also apply to non-employee directors (see page 52).

---

| | |
|:---|:---|
| **34** | ***D e l i v e r i n g a S m o k e - F r e e F u t u r e***  |

---

------

[**TABLE OF CONTENTS**](#TOC)

C O M P E N S A T I O N O F D I R E C T O R S

#### E X E C U T I V E C H A I R M A N
Mr. Calantzopoulos is our former Chief Executive Officer and became our Executive Chairman in 2021. He is an employee of the Company and the Board believes that it is in the Company's best interest for Mr. Calantzopoulos to continue to serve as Executive Chairman, ensuring that the Company will continue to benefit from his substantial experience and industry knowledge. As a Company employee, he does not receive additional compensation for his role as a director.

For 2022, there was no change to his compensation as Executive Chairman from the levels established in 2021. His base salary is set at 1,000,000 CHF (or $1,112,290 based on the conversion rate at the time of the Compensation Committee's decision in 2021) with an equity award target equal to 300% of his base salary, split 60% PSUs and 40% RSUs. He is no longer eligible for annual Incentive Compensation Awards. His 2022 equity award was based on his 2021 individual performance and pro-rated to reflect the different positions he held during 2021.

The following table presents the compensation received by the non-employee directors and the Executive Chairman for fiscal year 2022 for their services as directors.

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Name**  | **Fees Earned or <br> Paid in Cash <br> ($)**  | **Stock <br> Awards<sup>(a)</sup> <br> ($)**  | **All Other <br> Compensation <br> ($)**  | **Total <br> ($)**  |
| **Bonin Bough**  | 125000 | 175000 |  | 300000 |
| **André Calantzopoulos<sup>(b)</sup>**  |  |  |  |  |
| **Michel Combes**  | 125000 | 175000 |  | 300000 |
| **Juan José Daboub**  | 125000 | 175000 |  | 300000 |
| **Werner Geissler**  | 160000 | 175000 |  | 335000 |
| **Lisa A. Hook**  | 160000 | 175000 |  | 335000 |
| **Jun Makihara**  | 160000 | 175000 |  | 335000 |
| **Kalpana Morparia**  | 160000 | 175000 |  | 335000 |
| **Lucio A. Noto**  | 195000 | 175000 |  | 370000 |
| **Frederik Paulsen**  |  |  |  |  |
| **Robert B. Polet**  | 125000 | 175000 |  | 300000 |
| **Dessi Temperley<sup>(</sup><sup>c</sup><sup>)</sup>**  | 125000 | 246438 |  | 371438 |
| **Shlomo Yanai**  | 125000 | 175000 |  | 300000 |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (a)

Represents the aggregate grant date fair value of the stock awards made in fiscal 2022 as determined in accordance with FASB ASC Topic 718. In May 2022, we granted 1,759 shares of common stock to each non-employee director then in office, except for Dr. Paulsen who has requested to receive no compensation for his role on the Board and Ms. Temperley, who joined the Board in December 2021 and received 2,477 shares, representing a pro-rated stock award through May 4, 2022, in addition to her full 2022 annual award. Non-employee directors may elect to defer the award of shares of common stock and all or part of the annual cash and committee chair retainers. Deferred fee amounts are "credited" to an unfunded account and may be "invested" in nine "investment choices," including a PMI common stock equivalent account. These "investment choices" parallel the investment options offered to employees under the PMI Deferred Profit-Sharing Plan and determine the "earnings" that are credited for bookkeeping purposes to a non-employee director's account. Mr. Bough, Mr. Combes, Ms. Hook, Mr. Makihara, Mr. Noto, Ms. Temperley, and Mr. Yanai elected to defer receipt of their shares.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (b)

Mr. Calantzopoulos, who is an employee but not an executive officer of the Company, receives no additional compensation for his services as a director. His 2022 compensation is allocated fully to his services as an employee in assisting our CEO with the Company's long-term strategy. His 2022 employee compensation was $8,269,240, which includes base salary of $1,050,455, stock awards with the aggregate grant date fair value of $7,212,844 and all other compensation of $5,941. Amounts that were paid or incurred in currency other than U.S. dollars are converted to U.S. dollars using an average conversion rate for 2022 of $1.00 = 0.9550 CHF. The 2022 change in the present value of Mr. Calantzopoulos' benefits under Swiss pension plans (such plans as described in more detail on pages 61 to 63 and based on the same assumptions as for our named executive officers, except that his retirement age is assumed to be 65) reflects a decrease of ($5,090,207). In accordance with the regulations of these plans, the payments for Mr. Calantzopoulos commenced as of January 1, 2023, the first day of the month following his 65<sup>th</sup> birthday, and he elected to receive the pension benefits in the form of a lump sum that was paid on January 3, 2023 in the total amount of $36,899,750. The benefits payable from the Supplemental Plan include the adjustment for the loss of favorable tax-qualified plan treatment under this plan as further described on page 63. He did not accrue any pension benefits for his services as a director during 2022. The pension benefits amounts are converted to U.S. dollars using the conversion rate on December 30, 2022, of $1.00 = 0.9218 CHF.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (c)

Ms. Temperley joined the Board in December 2021 and received a pro-rated stock award through May 4, 2022, in addition to her full 2022 annual award.

The Company reimburses non-employee directors (other than Dr. Paulsen) for their reasonable expenses incurred in attending Board of Directors, committee and shareholder meetings, and other corporate functions, including travel, meals and lodging. Non-employee directors (other than Dr. Paulsen) also are covered by business travel and accident insurance, which the Company maintains for their benefit when they travel on Company business, as well as group life insurance.

---

| | |
|:---|:---|
| P M I **2 0 2 3** P r o x y S t a t e m e n t  | **35**  |

---

------

[**TABLE OF CONTENTS**](#TOC)

STOCK OWNERSHIP INFORMATION

![[MISSING IMAGE: tm2136562d1-icon_topbarpn.jpg]](tm2136562d1-icon_topbarpn.jpg)

## STOCK OWNERSHIP INFORMATION

## Ownership of Equity Securities
The following table shows the number of shares of common stock beneficially owned as of March 10, 2023, by each director, nominee for director and named executive officer ("NEO"), and the directors, nominees for director and executive officers of the Company as a group. As of March 10, 2023, the number of shares of the Company's common stock outstanding was 1,552,147,867. Unless otherwise indicated, each of the named individuals has sole voting and investment power with respect to the shares shown. The beneficial ownership of each director, nominee for director and executive officer, and of the directors, nominees for director and executive officers as a group, is less than 1% of the outstanding shares.

---

| | |
|:---|:---|
| **Name**  | **Amount and Nature of <br> Beneficial Ownership<sup>(1)(2)</sup>**  |
| **Drago Azinovic**  | 171528  |
| **Emmanuel Babeau**  | 82820  |
| **Bonin Bough**  | 4496  |
| **André Calantzopoulos** | **1007048**  |
| **Michel Combes**  | 4929  |
| **Juan José Daboub** | **3893**  |
| **Frederic de Wilde**  | 184187  |
| **Werner Geissler**  | 81787  |
| **Lisa A. Hook**  | 12173  |
| **Jorge Insuasty**  | 15513  |
| **Martin G. King<sup>(3)</sup>**  | 128463  |
| **Jun Makihara**  | 25503  |
| **Kalpana Morparia**  | 22514  |
| **Lucio A. Noto**  | 131270  |
| **Jacek Olczak**  | 276373  |
| **Frederik Paulsen**  | 0  |
| **Robert B. Polet**  | 24043  |
| **Dessi Temperley**  | 2613  |
| **Stefano Volpetti**  | 40649  |
| **Shlomo Yanai**  | 3695  |
| **Group (25 persons)**  | 2257279  |

---

(1) Includes shares of deferred stock as follows: Mr. Bough, 4,438; Mr. Combes, 3,845; Ms. Hook, 11,978; Mr. Makihara, 21,861; Mr. Noto, 90,523; Ms. Temperley, 2,580; Mr. Yanai, 1,832. Also includes 17,085 shares as to which beneficial ownership is disclaimed by Mr. Noto (shares held by spouse) and 22,196 shares held in trust for Mr. Noto as to which he has not disclaimed beneficial ownership. Also includes 1,360 shares as to which beneficial ownership is disclaimed by Mr. Makihara (shares held by spouse).

(2) Includes shares of deferred stock to be issued on April 11, 2023, in connection with the Company's scheduled quarterly dividend. Estimated deferred share amounts are calculated using the closing price of $98.35 on March 10, 2023, and are as follows: Mr. Bough, 57; Mr. Combes, 50; Ms. Hook, 155; Mr. Makihara, 282; Mr. Noto, 1,169; Ms. Temperley, 33; Mr. Yanai, 24.

(3) Reported ownership of Mr. King reflects most recent Form 4 information as of July 27, 2021.

---

| | |
|:---|:---|
| **36** | ***D e l i v e r i n g a S m o k e - F r e e F u t u r e***  |

---

------

[**TABLE OF CONTENTS**](#TOC)

STOCK OWNERSHIP INFORMATION

In addition to the shares shown in the table above, as of March 10, 2023, those directors who participate in the Company's director deferred fee program had the following PMI share equivalents allocated to their accounts: Mr. Makihara, 18,639 and Mr. Noto, 132,745. See "Compensation of Directors" on pages [34](#tCOD)-[36](#tCOD2) for a description of the deferred fee program for directors.

The following table sets forth information regarding persons or groups known to the Company to be beneficial owners of more than 5% of the outstanding common stock as of December 31, 2022.

---

| | |
|:---|:---|
| **Name and Address of Beneficial Owner**  | **Percent of Class**  |
| **The Vanguard Group** <br> 100 Vanguard Blvd. <br> Malvern, PA 19355 <br> 134134252<sup>(1)</sup>  | 8.65%  |
| **BlackRock, Inc.** <br> 55 East 52nd Street <br> New York, NY 10055 <br> 102158305<sup>(2)</sup>  | 6.6%  |
| **Capital International Investors** <br> 333 South Hope Street <br> Los Angeles, CA 90071 <br> 103019220<sup>(3)</sup>  | 6.6%  |
| **Capital World Investors** <br> 333 South Hope Street <br> Los Angeles, CA 90071 <br> 100042888<sup>(4)</sup>  | 6.5%  |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (1)

According to a Schedule 13G/A, dated February 9, 2023, filed with the U.S. Securities and Exchange Commission on February 9, 2023, by The Vanguard Group presenting the number of shares as of December 31, 2022.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (2)

According to a Schedule 13G/A, dated February 7, 2023, filed with the U.S. Securities and Exchange Commission on February 7, 2023, by BlackRock, Inc., presenting the number of shares as of December 31, 2022.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (3)

According to a Schedule 13G, dated February 14, 2023, filed with the U.S. Securities and Exchange Commission on February 13, 2023, by Capital International Investors, presenting the number of shares as of December 31, 2022.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (4)

According to a Schedule 13G/A, dated February 14, 2023, filed with the U.S. Securities and Exchange Commission on February 13, 2023, by Capital World Investors, presenting the number of shares as of December 31, 2022.

---

| | |
|:---|:---|
| P M I **2 0 2 3** P r o x y S t a t e m e n t  | **37**  |

---

------

[**TABLE OF CONTENTS**](#TOC)

C O M P E N S A T I O N D I S C U S S I O N A N D A N A L Y S I S

![[MISSING IMAGE: tm2136562d1-icon_topbarpn.jpg]](tm2136562d1-icon_topbarpn.jpg)

## COMPENSATION DISCUSSION AND ANALYSIS

## Executive Summary
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Our Compensation Discussion and Analysis outlines: <br> &nbsp;&nbsp;&nbsp;&nbsp; 1. <br>The design of our executive compensation program, and the objectives and principles upon which they are based. (See Pages 39-41) <br>&nbsp;&nbsp;&nbsp;&nbsp; 2. <br>Our performance, and the resulting decisions of the Compensation and Leadership Development Committee to reflect that performance in setting compensation for our CEO and the other NEOs. (See Pages 42-49) <br>

#### C D & A T A B L E O F C O N T E N T S

---

| | |
|:---|:---|
| [Compensation and Leadership Development Committee](#sCALD)  | [38](#sCALD) |
| [Program Design, Philosophy and Objectives](#sPDPA)  | [39](#sPDPA) |
| [Target Compensation Mix and 2022 Compensation](#sTCMA)  | [42](#sTCMA) |

---

---

| | |
|:---|:---|
| [Company Performance and Targets](#sCPAT)  | [45](#sCPAT) |
| [Additional Compensation Policies and Processes](#sACPA)  | [51](#sACPA) |
| [Compensation and Leadership Development Committee Report](#sCALD1)  | [54](#sCALD1) |

---

## Compensation and Leadership Development Committee
The Compensation and Leadership Development Committee (hereinafter, the "Committee") consists entirely of non-management directors, all of whom our Board has determined are independent within the rules and regulations of the SEC, the meaning of independence under the listing standards of the New York Stock Exchange and our Corporate Governance Guidelines. Its responsibilities are described on page 10 above and set forth in the Compensation and Leadership Development Committee Charter, which is available on the Company's website at *www.pmi.com/corporate-governance/board-committees*.

The members of the Committee are Werner Geissler (Chair), Juan José Daboub, Lisa A. Hook, Jun Makihara, Lucio A. Noto, and Robert B. Polet. The Committee met 5 times in 2022. The Chair of the Committee, in consultation with the other members, sets meeting agendas. The Committee reports its actions and recommendations to the Board.

---

| | |
|:---|:---|
| **38** | ***D e l i v e r i n g a S m o k e - F r e e F u t u r e***  |

---

------

[**TABLE OF CONTENTS**](#TOC3)

C O M P E N S A T I O N D I S C U S S I O N A N D A N A L Y S I S

## Program Design, Philosophy and Objectives
Our compensation and benefits program supports our business, financial, and strategic objectives. Each component of our program is designed to achieve one or more of the following objectives:

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| 1  | To support our ability to attract, develop and retain world-class leaders in a controversial industry;<sub>2</sub> | To align the interests of executives and shareholders;<sub>3</sub> | To reward performance against pre- established objectives;<sub>4</sub> | To support long-term business growth, superior financial results, sustainability efforts, societal alignment and integrity of conduct;<sub>5</sub> | To promote internal fairness and a disciplined assessment of performance; and<sub>6</sub> | To align executive incentives with our risk management objectives.  |

---

These objectives provide the framework for the various components of compensation and benefits to our executives and take into account the specific nature of our business. Together, these elements form a total rewards package that is intended to be appropriately competitive.

The Committee reviews data from the local market and our Peer Group (see page [51](#sACPA)) but does not target total direct compensation at a specific percentile of the market. Instead, the Committee sets total direct compensation at levels that it believes necessary to attract and retain talented executives in a controversial industry and remain competitive with other consumer product companies.

---

| | |
|:---|:---|
| P M I **2 0 2 3** P r o x y S t a t e m e n t  | **39**  |

---

------

[**TABLE OF CONTENTS**](#TOC3)

C O M P E N S A T I O N D I S C U S S I O N A N D A N A L Y S I S

The design of the overall compensation package for our executive officers encompasses the following features:

---

| | |
|:---|:---|
| **1**  | **A MIX OF FIXED AND "AT-RISK" COMPENSATION** <br> The higher the organizational level of the executive, the lower the fixed component of the overall compensation and benefits package.  |
| **2**  | **A MIX OF ANNUAL AND LONG-TERM COMPENSATION AND BENEFITS** <br> To appropriately reward the achievement of both annual and long-term goals and objectives**.**  |
| **3**  | **A MIX OF CASH AND DEFERRED EQUITY COMPENSATION** <br> That seeks to discourage actions that are solely driven by the Company's share price at any given time to the detriment of PMI's long-term strategic goals**.**  |
| **4**  | **AN OPTIMAL BALANCE OF EQUITY COMPENSATION** <br> Comprising both performance-based and time-based awards, without using stock options, and with significant share ownership requirements, to align the interests of executives and shareholders, while remaining mindful of the potentially dilutive nature of equity compensation on shareholder value.  |

---

---

| | |
|:---|:---|
| Historically, our shareholders overwhelmingly supported our compensation program, with our say-on-pay proposal receiving more than 91% approval every year from 2016 to 2021. In 2022, our 2022 Performance Incentive Plan was approved by a vote of 95.78%, however our say-on-pay proposal was approved by a vote of 70.00%. <br> **Say-on-Pay Shareholder Engagement**: Following our 2022 say-on-pay vote, we conducted an engagement campaign with our shareholders to better understand investor concerns with our executive compensation program and the reasons for the lower vote in 2022. We reached out to shareholders representing approximately 40% of our total shares outstanding to invite them to participate in calls to discuss our executive compensation programs and shareholders representing over approximately 20% of our outstanding shares accepted our offer to provide feedback.  | ![[MISSING IMAGE: bc_historical-pn.jpg]](bc_historical-pn.jpg)  |

---

In general, our shareholders expressed their support for our senior management team and our executive compensation program and practices as a whole. Investors were also generally complimentary of our specific plan designs and expressed the view that the metrics used for our annual Incentive Compensation ("IC") awards and PSUs were both appropriately aggressive and well aligned with our long-term business plan. A number of shareholders singled out the incorporation of our Sustainability Index into our PSU performance metrics as a positive development.

Certain shareholders were interested in hearing about the severance payment made to a former executive upon his departure from the Company. In particular, the discussions related to the entry into a Separation Agreement and Release and the recommendations of a proxy advisory firm on our say-on-pay resolution due to this severance payment. While shareholders recognized the need for severance arrangements in appropriate situations, some shareholders also shared in the concerns raised by the proxy advisory firm. One investor questioned whether severance payments should be made in any situation, no matter whether the separation is consensual or involuntary.

A few shareholders also expressed preferences for other modest changes to specific elements of our compensation program. This included one investor who suggested that the proportion of PSUs in our long-term equity award program should be increased.

Generally, however, the investors with whom we spoke expressed the view that our compensation program has supported the creation of shareholder value over the long term.

The feedback we received from these meetings was reported to the Committee and the Committee considered and discussed this feedback with management. The Committee decided not to implement any substantial changes to the program at this time but will consider the feedback and concerns that were raised when making future compensation decisions, especially when it comes to separation arrangements with departing executives. The Committee expects to continue taking into account current and emerging trends, shareholder feedback, and its own judgment about what's best for PMI and its shareholders when considering changes to the design of our executive compensation program.

---

| | |
|:---|:---|
| **40** | ***D e l i v e r i n g a S m o k e - F r e e F u t u r e***  |

---

------

[**TABLE OF CONTENTS**](#TOC3)

C O M P E N S A T I O N D I S C U S S I O N A N D A N A L Y S I S

The three components of total direct compensation for our executive officers are: (i) base salary; (ii) annual performance- based variable cash awards; and (iii) variable equity awards. We also provide our executives retirement benefits and limited perquisites. Our total direct compensation program emphasizes a pay-for-performance culture, and the one component that is fixed for a given year, base salary, constitutes the smallest portion of executive compensation for salary grades 26 and above. See page [42](#sTCMA) for the target compensation mix of our NEOs in 2022. The key characteristics and key objectives of each component of our compensation program as it applies to our NEOs are as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Component**  | **Purpose**  | **Key Objectives**  | **How it is determined**  |
|  | **BASE <br> SALARY**  | Fixed component of cash compensation. | Intended to provide sufficient competitive base pay to attract, develop and retain world-class leaders. | Reflects the scope of the executive's role, his or her performance and market pay practices. |
| **◀ AT-RISK AND PERFORMANCE-BASED COMPENSATION ▶**  | **INCENTIVE COMPENSATION (IC) AWARDS**  | Annual performance-based variable cash award for meeting or exceeding performance goals pre- established by the Committee.  | Intended to motivate executives to meet or exceed our performance goals and strategic objectives in a given fiscal year.  | The Company's IC performance rating is determined by a fixed formula that measures Company results against performance targets pre-established and pre-weighted by the Committee (see pages [45](#sCPAT)-[46](#tTCAICP)). The final award is determined by multiplying the executive's base salary by the IC performance rating and by the IC target percentage for that salary grade and the executive's individual performance rating.  |
| **◀ AT-RISK AND PERFORMANCE-BASED COMPENSATION ▶**  | **EQUITY <br> AWARDS**  | Long-term variable equity awards contribute to all six of the Committee's program design objectives while minimizing share dilution and protecting against excessive risk taking. | Intended to motivate our executives to produce results that enhance sustainable shareholder value and strengthen the Company over the long term. | &nbsp;&nbsp;&nbsp; Amount of each award is determined by multiplying the executive's base salary by the target percentage for that salary grade, and then by the executive's individual performance rating for the most recently completed year, plus or minus ten percentage points. <br> • 60% of the February 2022 award was in the form of PSUs that vest at the end of the 2022-2024 performance cycle in amounts that depend on the degree to which pre-established and pre-weighted performance goals are achieved or exceeded (see pages [47](#tLTEAWARDS)-[49](#tfolio49)). <br>• 40% of the February 2022 award was in the form of RSUs that cliff vest at the end of the three-year cycle (assuming continued employment). <br>|

---

---

| | |
|:---|:---|
| P M I **2 0 2 3** P r o x y S t a t e m e n t  | **41**  |

---

------

[**TABLE OF CONTENTS**](#TOC3)

C O M P E N S A T I O N D I S C U S S I O N A N D A N A L Y S I S

## Target Compensation Mix and 2022 Compensation
We set target compensation mix by salary grade. In 2022, all of our NEOs (except our CEO) were in salary grades 25 and 26. Our CEO is the only employee in salary grade 28, and we do not have any employees in salary grade 27. The target compensation mix for 2022 and for 2023 is shown in the following charts.

![[MISSING IMAGE: pc_grade-pn.jpg]](pc_grade-pn.jpg)

#### 2022 Executive Compensation Determinations
**2022 Base Salaries:** The table below presents the 2022 base salary levels for our NEOs.

---

| | |
|:---|:---|
| | **2022 Base Salary ($)<sup>(1)</sup>**  |
| **Jacek Olczak** | **1517204**  |
| **Emmanuel Babeau** | **1300465**  |
| **Drago Azinovic** | **915741**  |
| **Frederic de Wilde** | **915741**  |
| **Stefano Volpetti** | **975349**  |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (1)

Amount converted to U.S. dollars using conversion rate on the date of Committee's decision in 2022. Year-to-year variations in the salaries and other amounts reported for our NEOs result in part from the year-to-year variations in exchange rates between U.S. dollar and CHF. Base salary amounts reported in our Summary Compensation Table on page [55](#tSCT) are calculated using an average conversion rate of CHF to U.S. dollars for fiscal year 2022, which resulted in lower U.S. dollar values than the amounts reported above.

At its February 2022 meeting, the Committee reviewed the base salaries for our NEOs and determined that, with the exception of Mr. Olczak, the base salaries of our NEOs remained appropriate. Regarding Mr. Olczak, the Committee assessed the competitiveness of his compensation based on the reference market data and relative positioning of Mr. Olczak's compensation versus other CEOs in our Peer Group. As a result of this review, the Committee determined to increase his base salary by 3.7% to CHF 1,400,000 (or $1,517,204) effective March 1, 2022.

In connection with his promotion to salary grade 26, Mr. de Wilde's base salary was increased to CHF 1,000,008 (or $1,062,313) effective January 31, 2023, as determined by the Committee at its December 2022 meeting. The promotion is in connection with his appointment as President, South and South-East Asia, Commonwealth of Independent States, & Middle East and Africa Region as of the same date.

---

| | |
|:---|:---|
| **42** | ***D e l i v e r i n g a S m o k e - F r e e F u t u r e***  |

---

------

[**TABLE OF CONTENTS**](#TOC3)

C O M P E N S A T I O N D I S C U S S I O N A N D A N A L Y S I S

**2022 Annual Incentive Compensation Awards:** In March 2022, the Committee established performance targets for the 2022 annual incentive compensation awards that were paid in February 2023. Award targets and actual payouts as a percentage of base salary for our NEOs were as follows:

---

| | | |
|:---|:---|:---|
| | **2022 Cash Incentive <br> Target as % of Base <br> Salary<sup>(1)</sup>**  | **2022 Actual Cash <br> Incentive Payout <br> as % of Base Salary**  |
| **Jacek Olczak**  | 200%  | 300%  |
| **Emmanuel Babeau**  | 125%  | 173%  |
| **Drago Azinovic**  | 100%  | 150%  |
| **Frederic de Wilde**  | 100%  | 150%  |
| **Stefano Volpetti**  | 100%  | 138%  |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (1)

Possible award range is between 0% and 225% of target.

At its February 2022 meeting, the Committee reviewed the IC target percentages for each of the NEOs and determined that the target percentages remained appropriate. At its February 2023 meeting, the Committee approved the actual IC award payments based on the individual performance of our NEOs in 2022 and company performance against the IC performance targets established at the beginning of 2022. For further details on 2022 company performance refer to pages [45](#sCPAT) to [46](#tTCAICP).

In determining the individual component of Mr. Olczak's 2022 IC award, the Committee assessed his performance against the CEO objectives defined at the beginning of the year and took into account additional achievements, namely the agreement to regain full control of *IQOS* in the U.S. from 2024, successful completion of the acquisition of Swedish Match, and performance on sustainability priorities. Following a similar process, for other NEOs, the CEO recommended, and the Committee approved above target individual performance ratings based on an assessment of their achievements against individual objectives as well as additional achievements in 2022. In particular, the Committee based their decisions on the following factors:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; • Emmanuel Babeau led the Company to exceed the financial performance targets provided to him in 2022, including with respect to various cost productivity initiatives and working capital management efforts. In addition, Mr. Babeau was instrumental to the Company's successful completion of our agreement with Altria Group, Inc. and our acquisition of Swedish Match.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; • Frederic de Wilde significantly exceeded targeted performance for the European Union (the "EU") Region in terms of net operating revenue, Heat-not-Burn ("HnB") volume and adjusted operating income ("OI") growth, in addition to achieving significant progress in the pursuit of the Company's Tobacco Harm Reduction strategy in that Region.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; • Drago Azinovic significantly exceeded targeted performance for the Middle East & Africa (the "MEA") Region and Duty Free business in terms of net operating revenue, increased share of market, and adjusted OI growth, in addition to achieving significant progress in the pursuit of the Company's Tobacco Harm Reduction strategy in the MEA Region.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; • Stefano Volpetti exceeded his targets with regards to HnB volume, user acquisition, and extending the smoke-free product portfolio despite challenging supply chain constrains. Mr. Volpetti also provided significant contributions to the development of the Company's future product pipeline in 2022, which will be evidenced in future years. Mr. Volpetti's leadership is also instrumental in promoting and implementing responsible marketing practices aiming at continuing to protect youth access to our products while offering adult smokers our better alternatives.

The 2023 award targets for our NEOs are unchanged versus 2022 levels, with the exception of Mr. de Wilde. His target will increase to 125% of his base salary as a result of his promotion. Mr. Azinovic will not be eligible for this award due to his previously disclosed departure, see page [65](#tSEVAGREE) for additional discussion.

---

| | |
|:---|:---|
| P M I **2 0 2 3** P r o x y S t a t e m e n t  | **43**  |

---

------

[**TABLE OF CONTENTS**](#TOC3)

C O M P E N S A T I O N D I S C U S S I O N A N D A N A L Y S I S

**2022 Equity Awards:** The table below presents the long-term equity awards granted to our NEOs in February 2022:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **2022-24 <br> PSUs Target <br> as % of Base Salary <br> (60% of total Equity <br> Award)<sup>(1)</sup>**  | **2022 RSUs <br> Target <br> as % of Base Salary <br> (40% of total Equity <br> Award)<sup>(2)</sup>**  | **2022-24 PSUs <br> Actual Award <br> as % of Base Salary <br> (60% of total Equity <br> Award)**  | **2022 RSUs <br> Actual Award <br> as % of Base Salary <br> (40% of total Equity <br> Award)**  |
| **Jacek Olczak COO / CEO<sup>(3)</sup>**  | 165% / 360%  | 110% / 240%  | 206% / 450%  | 138% / 300%  |
| **Emmanuel Babeau**  | 165%  | 110%  | 190%  | 127%  |
| **Drago Azinovic**  | 105%  | 70%  | 116%  | 77%  |
| **Frederic de Wilde**  | 105%  | 70%  | 121%  | 81%  |
| **Stefano Volpetti**  | 105%  | 70%  | 126%  | 84%  |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (1)

Possible award grant range is between 0% and 150% of target; between 0% and 200% of PSUs granted may vest, depending on performance versus criteria established at the time of grant.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (2)

Possible award grant range is between 0% and 150% of target.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (3)

2022 PSUs and RSUs granted to Mr. Olczak were pro-rated to reflect the different positions he held during 2021.

In February 2022, the Committee granted PSUs for the 2022-2024 performance cycle and RSUs with a three-year cliff vesting schedule. The grants of these awards were determined in reference to the target PSU and RSU percentages applicable to the salary grade held by each NEO, as set forth in the table above. The Committee based the actual award granted after an evaluation of the 2021 individual performance of our NEOs.

The Committee approved above target equity awards for each NEO, as set forth in the table above, as the Committee determined they each exceeded their individual performance ratings for 2021 and recognized their individual contributions to progress in pursuing the Company's strategic priorities with regards to capability building, product pipeline development, sustainability programs and the challenging regulatory environment.

In February 2023, the Committee granted PSUs for the 2023-2025 performance cycle and RSUs with a three-year cliff vesting schedule. The grants of these awards were based on the 2022 individual performance of our NEOs. There were no changes in the award targets versus 2022, with the exception of Mr. Olczak, for whom the entire award was based on targets for his role as CEO. Consistent with our practice applicable to all eligible employees, considering the timing of Mr. Azinovic's departure, he remained eligible for 2023 equity award, which was granted based on his 2022 individual performance.

---

| | |
|:---|:---|
| **44** | ***D e l i v e r i n g a S m o k e - F r e e F u t u r e***  |

---

------

[**TABLE OF CONTENTS**](#TOC4)

C O M P E N S A T I O N D I S C U S S I O N A N D A N A L Y S I S

## Company Performance and Targets

#### INCENTIVE COMPENSATION AWARDS
**Quantitative Performance Targets:** The Committee determined the 2022 IC Award performance rating based on 2022 results versus performance metrics pre-established by the Committee. When setting the targets in March 2022, the Committee excluded results from Russia and Ukraine due to the uncertainty and volatility related to our business in those countries resulting from the impact of the war in Ukraine. For terms not otherwise defined in this section, see the Glossary of Terms in Exhibit C.

---

| |
|:---|
| **2022 Results excluding Russia and Ukraine:** We exceeded our targets for number of stable or growing top 28 OI markets, organic growth of adjusted net revenues, and currency-neutral growth of our operating cash flow. Smoke-Free (HTU) shipment volume was on target and organic growth of adjusted OI was below target. |
| *Share of Top 28 OI Markets:* We registered a growing or stable market share in 20 of our Top 28 OI markets, which was above our target of 13-15 markets. |
| *Smoke-Free (HTU) Shipment Volume: Shipments of 89.3 billion units were on target of 89.2 to 91.2 billion.* |
| *Adjusted Net Revenues*\**: Adjusted* Net revenues of $29.2 billion grew by 7.7% compared to 2021, on an organic basis, above our target of 4.3% to 5.1%. |
| *Adjusted OI*\**:* Adjusted OI of $11.7 billion grew by 6.2% on an organic basis, below our target of 6.7% to 8.2%. |
| &nbsp;&nbsp; *Operating Cash Flow*\**:* Operating cash flow of $10.0 billion increased by 5.1% on a currency-neutral basis, above our target of (1.5) to (0.3)%. <br> \* <br>For a reconciliation of non-GAAP to the most directly comparable U.S. GAAP financial measures, see Exhibit B to this proxy statement. All amounts exclude Russia and Ukraine. <br>|

---

*2022 Quantitative Performance Targets Achievement:* The Committee employed the following pre-established matrix that assigned a rating of 100 correlating to attaining the targeted performance. Ratings for each factor could range from 0 to 150. The percentages indicated for adjusted net revenues, adjusted OI, and operating cash flow represent growth versus 2021 results. Actual results are shown in the blue boxes. All amounts exclude Russia and Ukraine.

#### 2022 IC Performance Versus Target

---

| | | | | | | | | | | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **Target**  | **Target**  | **Target**  | **Target**  | **Target**  | **Target**  | **Target**  | **Target**  | **Target**  | **Target**  | **Target**  | **Target**  | **Target**  | **Target**  | **Target**  | **Target**  | **Target**  | **Target**  | **Target**  |
| **Rating:** | **0…**  | **30**  | **40**  | **50**  | **60**  | **70**  | **80**  | **88**  | **90**  | **100**  | **110**  | **120**  | **125**  | **130**  | **133**  | **140**  | **150**  |  |
| **Growth <br> Measure<sup>(a)</sup>** |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
| Market Share <br> (Top 28 OI<sup>(b)</sup> Markets) | <4  | 4  | 5  | 6  | 7  | 8  | 9  | 11  | 11  | 13-15  | 17  | 19  | **20**  | 21  | 22  | 23  | 24  |  |
| Smoke-Free (HTU) Shipment Volume | <74.3  | 74.3  | 76.2  | 78.2  | 80.6  | 82.9  | 85.3  | 87.4  | 87.9  | 89.2 - <br> 91.2  | 92.9  | 94.2  | 94.8  | 95.4  | 95.8  | 96.8  | 98.3  |  |
| Adjusted Net Revenues<sup>(c)</sup> | <1.5%  | 1.5%  | 1.9%  | 2.2%  | 2.7%  | 3.3%  | 3.5%  | 4.0%  | 4.1%  | 4.3 - <br> 5.1%  | 5.5%  | 5.7%  | 5.8%  | 6.0%  | 6.0%  | 6.2%  | 6.7  | **7.7%**  |
| Adjusted OI<sup>(c)</sup> | <2.7%  | 2.7%  | 3.1%  | 3.7%  | 4.5%  | 5.1%  | 5.6%  | **6.2%**  | 6.3%  | 6.7 - <br> 8.2%  | 8.5%  | 8.9%  | 9.1%  | 9.3%  | 9.4%  | 9.6%  | 10.2%  |  |
| Operating Cash Flow<sup>(d)</sup> | <(12.6)%  | (12.6)%  | (10.0)%  | (8.4)%  | (6.9)%  | (5.3)%  | (3.7)%  | (2.5)%  | (2.2)%  | (1.5) - <br> (0.3)%  | 1.2%  | 2.7%  | 3.4%  | 4.2%  | **5.1%**  | 7.4%  | 10.8%  |  |
| Strategic Initiatives | Key Initiatives missed <br> 0 - 79  | Key Initiatives missed <br> 0 - 79  | Key Initiatives missed <br> 0 - 79  | Key Initiatives missed <br> 0 - 79  | Key Initiatives missed <br> 0 - 79  | Key Initiatives missed <br> 0 - 79  | Key Initiatives missed <br> 0 - 79  | Mostly/ all accomplished <br> 80 - 120  | Mostly/ all accomplished <br> 80 - 120  | Mostly/ all accomplished <br> 80 - 120  | Mostly/ all accomplished <br> 80 - 120  | Majority/ all exceeded <br> 121 - 150  | Majority/ all exceeded <br> 121 - 150  | Majority/ all exceeded <br> 121 - 150  | Majority/ all exceeded <br> 121 - 150  | Majority/ all exceeded <br> 121 - 150  | Majority/ all exceeded <br> 121 - 150  |  |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (a)

For a reconciliation of non-GAAP to the most directly comparable U.S. GAAP financial measures, see Exhibit B to this proxy statement.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (b)

Number of Top 28 OI markets (reflecting the deconsolidation of RBH and removal of Russia and Ukraine) in which total share of the heated tobacco units and cigarettes was growing or stable.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (c)

Organic growth.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (d)

Net cash provided by operating activities, excluding currency.

**Qualitative Performance Targets and Analysis:** The Committee also rated our performance on the following five key strategic initiatives that the Committee pre-set in February 2022, based on a ratings range of 0-79 if they were missed, 80-120 if they were mostly or all accomplished, and 121-150 if the majority or all of them were exceeded:

---

| | |
|:---|:---|
| P M I **2 0 2 3** P r o x y S t a t e m e n t  | **45**  |

---

------

[**TABLE OF CONTENTS**](#TOC4)

C O M P E N S A T I O N D I S C U S S I O N A N D A N A L Y S I S

---

| | |
|:---|:---|
| **Strategic Initiatives**  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; • Shaping Tobacco Harm Reduction and championing Sustainability to create a positive social and environmental impact; <br>• Accelerating conversion through superior Smoke-Free Products; <br>• Leveraging our leadership in Combustibles to build Smoke-Free Products; <br>| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; • Rapidly scaling differentiated Wellness & Healthcare solutions; and <br>• Building a purpose-driven organization with distinctive capabilities and a winning team culture. <br>|

---

As a result of this evaluation, the Committee concluded that the Company had exceeded its strategic objectives and assigned a strategic initiatives rating of 130.

**2022 IC Award Certification:** Our performance rating for each quantitative and qualitative factor was weighted in accordance with the pre-established formula shown below to produce an overall IC performance rating of 121. The Committee used its discretion to round down the final rating to 120 to remove the positive impact on the Operating Cash Flow driven by the acquisition of Swedish Match during the fourth quarter of 2022, as the acquisition was not contemplated at the time the performance criteria were determined at the beginning of 2022. As explained on page [51](#sACPA), this rating applies to our management employees worldwide.

#### 2022 IC Performance Rating

---

| | | | |
|:---|:---|:---|:---|
| **Growth <br> Measure** | **Performance <br> Rating, %**  | **Weight**  | **Weighted Performance <br> Rating, %**  |
| Market Share (Top 28 OI Markets) | 125  | 15%  | 19  |
| Smoke-Free (HTU) Shipment Volume | 100  | 20%  | 20  |
| Adjusted Net Revenues | 150  | 15%  | 23  |
| Adjusted OI | 88  | 15%  | 13  |
| Operating Cash Flow | 133  | 20%  | 27  |
| Strategic Initiatives | 130  | 15%  | 20  |
|  |  |  | 121\*  |

---

\* Column does not total due to rounding

All results exclude Russia and Ukraine.

The Committee approved an IC performance rating for 2022 of:

![[MISSING IMAGE: fc_rating-pn.jpg]](fc_rating-pn.jpg)

In addition to certifying the IC performance rating, the Committee rated each executive officer's individual performance during 2022. Individual ratings can range from 0% to 150%. To assure a disciplined, fair and equitable assessment, individual performance ratings were calibrated to reflect each executive's contribution to the overall results of the Company. Application of the following formula then determined the cash incentive award for each NEO in 2022:

![[MISSING IMAGE: tm2136562d1-tbl_incentivepn.jpg]](tm2136562d1-tbl_incentivepn.jpg)

**2023 IC Awards:** For 2023, the Committee determined that the performance metrics used in 2022 continued to reflect the Company's strategic priorities.

---

| | |
|:---|:---|
| **46** | ***D e l i v e r i n g a S m o k e - F r e e F u t u r e***  |

---

------

[**TABLE OF CONTENTS**](#TOC4)

C O M P E N S A T I O N D I S C U S S I O N A N D A N A L Y S I S

The Committee also set performance targets for those metrics. Each of the 2023 financial performance targets reflects the Company's 2023 budget approved by the Board, with a performance factor of 100 equating to achieving budgeted results in a pre-determined range. To measure the Company's 2023 performance, the Committee has also established five key strategic levers, which are at the core of the Company's corporate strategy. The full range of potential results is reflected in a pre-established matrix that will generate an overall IC performance rating for 2023. In addition to pre-establishing a formula for grading our results against the performance factors, the Committee pre-established the weights for each factor. The Committee also added a modifier increasing the performance rating by 10 percentage points if Swedish Match achieved a certain share of segment and shipment volume goals in the U.S. for 2023.

Additionally, the Committee put in place a second set of performance targets for adjusted net revenues, adjusted OI, and operating cash flow that would apply only in the event of a favorable ruling from German courts regarding an excise tax surcharge currently being accrued. If the ruling is favorable and occurs in fiscal year 2023, it could significantly and positively impact the three performance metrics. The second set of performance targets incorporates this positive impact.

#### LONG-TERM EQUITY AWARDS
The Committee establishes the equity award target opportunity for our CEO and each other NEO based on Company targets by salary grade and the individual's performance rating for this award. The Committee grants the individual 60% of the award opportunity in the form of performance-based PSUs, and 40% in the form of time-based RSUs.

![[MISSING IMAGE: tm2136562d1-tbl_equitypn.jpg]](tm2136562d1-tbl_equitypn.jpg)

**Use of PSUs and RSUs Versus Stock Options**: We grant equity awards in the form of RSUs and PSUs, rather than stock options, because these forms of awards:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; • establish a relationship between our cost and the value ultimately delivered to our executives that is more direct and more visible than is the case with stock options; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; • require the use of substantially fewer shares than stock options to deliver equivalent value, resulting in an annual Company run rate in 2022 of 0.15% (the sum of all equity awards to non-employee Directors and RSUs granted to employees during the period, plus the number of all PSUs vested during the period, divided by the weighted average number of shares outstanding during the period), and a total 2022 year-end overhang of 0.39% (number of unvested RSUs plus unvested PSUs at target as a percentage of all shares outstanding at year-end).

Our run rate and overhang each compares favorably to those of our Peer Group.

**2020 — 2022 PSU Performance Metrics Achievement**: In February 2020, the Committee established three metrics for determining the aggregate number of PSUs that would vest at the end of the 2020-2022 performance cycle: relative Total Shareholder Return ("TSR"), subject to a cap if absolute TSR is less than zero – 40%, currency neutral compound annual growth rate of adjusted diluted EPS – 30%, and performance against its transformation metric, defined as net revenues from PMI's RRPs and any other non-combustible products as a percentage of PMI's total net revenues in the last year of the performance cycle – 30%.

The aggregate of the weighted performance metrics for the three metrics determined the percentage of PSUs that vested at the end of the three-year performance cycle. Each vested PSU entitles the participant to one share of common stock. An aggregate weighted PSU performance factor of 100 would result in the targeted number of PSUs being vested. The minimum percentage of PSUs that could vest was zero, while the maximum was twice the targeted number.

*TSR Performance Metric (40% Weighting).* The TSR performance metric was calculated based on the Company's three-year rolling TSR versus the Company's Peer Group (see page [51](#sACPA)) using the average of the 20 trading days immediately before the start of the performance cycle and the last 20 trading days of the performance cycle. To reflect that several members of the Peer Group are primarily listed on foreign stock exchanges and report their financial results in different currencies, the Company measures the TSRs for those companies by using the price performance of their publicly traded American Depository Receipts. In addition to evaluating our relative TSR, if the Company's absolute TSR for a performance cycle is less than zero, the Committee will cap the TSR performance metric at target. This approach would limit rewards for a performance cycle in which we performed in line with, or better than, the Peer Group, but shareholders did not realize a positive return. The TSR performance factor for the 2020-2022 performance cycle was calculated relative to the Peer Group in accordance with the following schedule:

---

| | |
|:---|:---|
| P M I **2 0 2 3** P r o x y S t a t e m e n t  | **47**  |

---

------

[**TABLE OF CONTENTS**](#TOC4)

C O M P E N S A T I O N D I S C U S S I O N A N D A N A L Y S I S

#### PMI TSR as a Percentile of Peer Group

---

| | | | |
|:---|:---|:---|:---|
| | **Performance Factor**  | **Actual**  | **Rating**  |
| Below Threshold <br> Below 25<sup>th</sup> percentile  | 0%  | **85th <br> percentile**  | **200%**  |
| Threshold 25<sup>th</sup> percentile  | 50%  | **85th <br> percentile**  | **200%**  |
| Target 50<sup>th</sup> percentile  | 100%  | **85th <br> percentile**  | **200%**  |
| Maximum 80<sup>th</sup> percentile and above  | 200%  | **85th <br> percentile**  | **200%**  |

---

*Adjusted Diluted EPS Currency Neutral Growth Performance Metric (30% Weighting).* The adjusted diluted EPS currency neutral growth performance metric for the 2020-2022 performance cycle was the currency neutral compound annual growth rate of adjusted diluted EPS as shown below:

#### Three-Year Adjusted Diluted EPS CAGR, excluding Currency\*

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Result**  | **Performance Factor**  | **Actual**  | **Rating**  |
| Below Threshold  | <5.0%  | 0%  | **10.8%**  | **200%**  |
| Threshold | 5.0%  | 50%  | **10.8%**  | **200%**  |
| Target | 8.0%  | 100%  | **10.8%**  | **200%**  |
| Maximum | ≥10.5%  | 200%  | **10.8%**  | **200%**  |

---

\*

For a reconciliation of non-GAAP to the most directly comparable U.S. GAAP financial measures, see Exhibit B of this proxy statement.

*Transformation Performance Metric (30% Weighting).* The transformation performance metric was defined as net revenues from RRPs and any other non-combustible products as a percentage of total net revenues during 2022, as shown below:

#### RRP and Other Non-Combustible Products\* Net Revenue Percentage

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Result**  | **Performance Factor**  | **Actual**  | **Rating**  |
| Below Threshold  | <25.5%  | 0%  | **32.1%**  | **132%**  |
| Threshold | 25.5%  | 50%  | **32.1%**  | **132%**  |
| Target | 30.5%  | 100%  | **32.1%**  | **132%**  |
| Maximum | ≥35.5%  | 200%  | **32.1%**  | **132%**  |

---

\*

Smoke-Free Products ("SFPs") is the term we primarily use to refer to all of our products that are non-combustible tobacco products, including RRPs. In addition, SFPs include wellness and healthcare products as well as consumer accessories such as lighters and matches. Please refer to Exhibit B Reconciliations and Exhibit C Glossary of Terms for additional information.

**Performance Rating for 2020-2022 PSU Cycle.** The overall performance rating for the 2020-2022 PSU award cycle was 180%.

 **2022-2024 PSU Performance Metrics: For the PSUs granted in February 2022, which will vest in 2025, the Committee revised the performance metrics to align with the Company's changing transformation goals more closely.** 

The Committee set performance metrics at what it believes are appropriately ambitious levels that also reflect the Board-approved three-year plan. The Committee determined that the TSR performance metric and currency neutral compound annual growth rate of adjusted diluted EPS remained important measures of the Company's performance and so it retained those metrics for the 2022 PSUs. For the TSR metric, the threshold (50% performance factor) and target (100% performance factor) performance metrics remained at the 25<sup>th</sup> and 50<sup>th</sup> percentile relative to the Peer Group, respectively. The maximum performance factor of 200% would be achieved at the 80<sup>th</sup> percentile relative to the Peer Group. Regarding the currency neutral compound annual growth rate of adjusted diluted EPS over the 2022-2024 PSU performance cycle, the performance factors were set at 0% for growth below 5%, 50% for growth at the threshold level of 5%, 100% for growth at the target level of 8%, and 200% for growth at or above 11%.

However, the Committee replaced the RRP and other non-combustible products net revenue metric with a new performance metric using the Company's Sustainability Index, which consists of two components:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; • **Product Sustainability:** is defined as an aggregation of key performance indicators pertaining to social and environmental impacts generated by the Company's products; measuring progress on the Company's efforts to maximize the benefits of smoke-free products, purposefully phase out cigarettes, seek net positive impact in wellness and healthcare, and reduce post-consumer waste; and

---

| | |
|:---|:---|
| **48** | ***D e l i v e r i n g a S m o k e - F r e e F u t u r e***  |

---

------

[**TABLE OF CONTENTS**](#TOC4)

C O M P E N S A T I O N D I S C U S S I O N A N D A N A L Y S I S

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; • **Operational Sustainability:** is defined as an aggregation of key performance indicators pertaining to social and environmental impacts generated by the Company's business activities; it measures progress on the Company's efforts to tackle climate change, preserve nature, improve the quality of life of people in its supply chain, and foster an empowered, and inclusive workplace.

The Company's 2022 Integrated Report includes more granular information about the Company's Sustainability Index and its product and operational sustainability components.

The Committee weighted the 2022-2024 performance metrics as follows: TSR, 40%; currency neutral compound annual growth of adjusted diluted EPS, 30%; and the Sustainability Index, 30%. In line with the Company's sustainability materiality assessment and their relative priority level in the context of the Company's corporate strategy, Product Sustainability is weighted at 20% and Operational Sustainability is weighted at 10%, together amounting to 30% of the total PSU award. The Committee measures performance on these metrics consistent with the way the Company communicates its results, which may include adjustments.

For the 2022 PSU grant, the Committee preserved its discretion to use the following modifier in its certification of the TSR performance metric:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; • The Company's TSR during the three-year cycle relative to the share performance of certain other tobacco companies may have positive or negative 15 percentage point impact on TSR performance factor.

*PSU Vesting Mechanics*. At the end of the three-year performance cycle, the Company's performance factor for each of the three metrics will be calculated and then weighted, resulting in an overall PSU performance factor from 0% to 200%. This percentage will be applied to the executive's target PSU award to determine the number of shares of common stock to be issued to the executive.

The Committee may adjust the PSU performance metrics if appropriate to reflect significant unplanned acquisitions or dispositions. The Committee may also adjust the PSU performance metrics in appropriate situations for unusual, impactful events, such as the COVID-19 pandemic or disruptions to operations caused by significant geopolitical events.

The 2022 equity awards granted for each NEO reflect their individual performance for 2021.

**2023-2025 PSU Performance Metrics**: For the PSUs granted in February 2023, which will vest in 2026, the Committee maintained the performance metrics approved for the PSUs granted in February 2022. The targets for the TSR performance metric were unchanged from the 2022-2024 PSU performance cycle. For the currency neutral compound annual growth rate of adjusted diluted EPS, the performance factors were set at 0% for growth below 4.5%, 50% for growth at the threshold level of 4.5%, 100% for growth at the target level of 8%, and 200% for growth at or above 10.5%. The Committee also continued the use of the Company's Sustainability Index as performance metric.

The Committee weighted the 2023-2025 performance metrics as follows: TSR, 40%; currency neutral compound annual growth rate of adjusted diluted EPS, 30%; and the Sustainability Index, 30%. In line with the Company's sustainability materiality assessment and their relative priority level in the context of the Company's corporate strategy, Product Sustainability is weighted at 20% and Operational Sustainability is weighted at 10%, together amounting to 30% of the total PSU award. The Committee measures performance on these metrics consistent with the way the Company communicates its results, which may include adjustments.

However, the Committee removed the TSR performance modifier tied to PMI's relative share performance against certain other tobacco companies because the Committee determined that it no longer represents a useful performance measure in light of the maturity of PMI's business transformation relative to certain other tobacco competitors.

---

| | |
|:---|:---|
| P M I **2 0 2 3** P r o x y S t a t e m e n t  | **49**  |

---

------

[**TABLE OF CONTENTS**](#TOC4)

C O M P E N S A T I O N D I S C U S S I O N A N D A N A L Y S I S

#### ADDITIONAL ELEMENTS OF COMPENSATION
We provide our executive officers the benefits available to Company employees generally. We also provide the limited perquisites described below. These benefits and perquisites are intended to be part of a competitive compensation package.

**Pension Benefits**: All Swiss payroll-based employees participate in pension plans. Our NEOs participate in the Pension Fund of Philip Morris in Switzerland, the IC Pension Plan of Philip Morris in Switzerland, and the Supplemental Plan of Philip Morris in Switzerland. Descriptions of these plans can be found in the narrative discussion following the Pension Benefits table on pages [61](#tPEBE)-[63](#tECTO).

**Employment and Severance Agreements**: We have employment agreements with our NEOs. With the exception of Mr. Babeau, and the agreement with Mr. Azinovic discussed below, these agreements do not contain severance or change-in-control provisions. The Committee determined the terms of the agreement with Mr. Babeau were appropriate as part of a competitive compensation package in connection with his recruitment to the Company. We have also entered into a Separation Agreement and Release with Mr. Azinovic in connection with the termination of his employment effective March 31, 2023. Descriptions of these agreements can be found in the Employment Contracts, Termination of Employment and Change in Control Arrangements section on pages [63](#tECTO)-[65](#tSEVAGREE).

**International Relocation Benefits**: We provide relocation benefits for new employees relocating from other countries and for existing employees relocating between countries. Mr. Babeau received benefits under PMI's New Hire from Abroad Guidelines, which cover temporary housing benefits, relocation support, tax and social security equalization on relocation benefits and other program allowances.

**Transportation Benefits**: We provide each of our NEOs with the use of a Company owned vehicle. Mr. Olczak also receives personal driver services, which are provided for reasons of security, personal safety, and operational efficiency.

**Tax Preparation**: Tax preparation services are provided to each of our NEOs pursuant to PMI policies that apply to all Swiss payroll-based management employees.

---

| | |
|:---|:---|
| **50** | ***D e l i v e r i n g a S m o k e - F r e e F u t u r e***  |

---

------

[**TABLE OF CONTENTS**](#TOC)

C O M P E N S A T I O N D I S C U S S I O N A N D A N A L Y S I S

## Additional Compensation Policies and Processes
**Peer Group:** The Committee uses a single customized peer group both to benchmark its compensation programs and to compare the Company's TSR when calculating the Company's PSU performance factor. The Committee reviews the Company's peer group annually and updates as needed to better align our business with relevant comparator companies. After conducting its annual review, the Committee decided to retain the same peer group for 2022 as for 2021. The following 19 companies, selected on the basis of their global presence, focus on consumer products, and similarity to the Company in terms of net revenues and market capitalization, constitute our Peer Group:

---

| | |
|:---|:---|
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; • Altria Group, Inc. <br>• Anheuser-Busch InBev SA/NV <br>• British American Tobacco p.l.c. <br>• The Coca-Cola Company <br>• Colgate-Palmolive Co. <br>• Diageo plc <br>• Heineken N.V. <br>• Imperial Brands PLC <br>• Japan Tobacco Inc. <br>• Johnson & Johnson <br>| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; • Kimberly-Clark Corporation <br>• The Kraft Heinz Company <br>• McDonald's Corp. <br>• Mondelēz International, Inc. <br>• Nestlé S.A. <br>• PepsiCo, Inc. <br>• The Procter & Gamble Company <br>• Roche Holding AG <br>• Unilever NV and PLC <br>|

---

**Factors Mitigating Against Possible Adverse Consequences of Our Compensation Program:** Our Committee, with assistance from its independent compensation consultant, as needed, and with input from management, annually reviews our compensation programs, policies and practices to determine whether they encourage risk-taking that would have a material adverse effect on the Company. As part of this review, the Company evaluated the primary components of its compensation plans to identify whether those components properly balanced compensation opportunities and risk. Our Committee considered various factors, including the factors described below.

Several elements of our compensation program protect against the possibility that compensation incentives might cause employees to take risks that could materially adversely affect the Company. First, our annual incentive compensation and equity awards apply to management employees worldwide, and the award pools for each of those programs are based on company-wide performance measures that cannot be unduly influenced by a particular business unit or group. Second, all employees are rated on the same scale within general guidelines set by the Committee. These ratings are based on individual performance criteria so that no particular group of employees will all receive the same rating. Third, both the Company-wide and the individual performance measures are subject to maximum levels that limit the amount of awards.

Furthermore, with respect to the long-term equity component of our compensation program, RSUs generally vest only after three years from the date of grant, and PSUs generally vest to the extent pre-established targets are achieved over a three-year performance cycle. In addition, our executives are subject to share ownership requirements and comprehensive anti-hedging, anti-pledging and clawback policies described in the following four sections.

Based on this review, both for our executive officers and all other employees, the Company and our Committee concluded that the risks arising from the Company's compensation policies and practices are not reasonably likely to have a material adverse effect on the Company.

---

| | |
|:---|:---|
| P M I **2 0 2 3** P r o x y S t a t e m e n t  | **51**  |

---

------

[**TABLE OF CONTENTS**](#TOC)

C O M P E N S A T I O N D I S C U S S I O N A N D A N A L Y S I S

**Share Ownership Requirements:** The Company sets share ownership requirements for executives at levels that are among the highest for publicly traded companies. The required ownership levels are as follows:

---

| | |
|:---|:---|
| **NEOs**  | **Required Salary Multiple**  |
| **Salary Grade 28** | **10 times**  |
| **Salary Grade 27** | **6 times**  |
| **Salary Grade 26** | **5 times**  |
| **Salary Grade 25** | **3 times**  |

---

Unvested PSUs, which comprise 60% of our NEOs' equity award, do not count towards the share ownership requirement. Executives are required to meet their ownership levels within five years of joining PMI or within three years of a promotion. The Committee reviews each executive officer's compliance with the requirements on an annual basis. As of December 31, 2022, all of our NEOs complied with the share ownership requirements.

**Post-Termination Share Holding Period:** In addition to these longstanding and rigorous share ownership requirements, the Committee has determined that if any equity award held by an executive officer under the 2017 and 2022 Performance Incentive Plans vests on an accelerated basis upon such officer's termination of employment for any reason other than death or disability, the shares acquired must be held for at least one year following such termination.

**Anti-Hedging and Anti-Pledging Policies:** The Company's anti-hedging policy prohibits directors, executive officers and other designated employees from purchasing any financial instrument or otherwise engaging in any transaction that is designed to hedge or offset any decrease in the market value of the Company's shares held by them directly or indirectly, including prepaid variable forward contracts, equity swaps, collars and exchange funds, and other transactions with comparable economic consequences. The foregoing does not prohibit trading in broad-based index funds.

Directors, executive officers and designated employees are also prohibited from engaging in short sales related to the Company's shares.

The Company's anti-pledging policy prohibits directors and executive officers from pledging the Company's shares, including holding shares in a margin account.

**Clawback Policy Regarding the Adjustment or Recovery of Compensation:** Under our Board-approved policy and as set forth in each NEO's equity award agreement, if the Board or an appropriate committee of the Board determines that, as a result of fraud, misconduct, a restatement of our financial statements, or a significant write-off not in the ordinary course affecting our financial statements, an executive has received more compensation than would have otherwise been paid, the Board or the assigned committee shall take action as it deems necessary or appropriate to address the events that gave rise to the fraud, misconduct, write-off or restatement, and to prevent its recurrence. Such action may include, to the extent permitted by applicable law, requiring partial or full reimbursement of any incentive compensation paid to the executive, causing the partial or full cancellation of equity awards, adjusting the future compensation of such executive, and dismissing or taking legal action against the executive, in each case as the Board or such committee determines to be in the best interests of the Company.

On October 26, 2022, the SEC adopted long-awaited final rules implementing the incentive-based compensation recovery provisions of the Dodd-Frank Act. The final rules direct the stock exchanges to establish listing standards requiring listed companies to develop and implement a policy providing for the recovery of erroneously awarded incentive-based compensation received by current or former executive officers and to satisfy related disclosure obligations. We intend to timely amend and restate our clawback policy to reflect these new requirements when they become effective.

**Role of the Committee in Executive Compensation:** The role of the Committee is to discharge the Board's responsibilities relating to executive compensation matters. In this regard, the Committee is responsible for the development and administration of our executive compensation and benefits program, in furtherance of which the Committee has the authority and responsibility:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; • to review and approve the Company's overall compensation philosophy and design;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; • to review and recommend to the Board for approval corporate goals and objectives relevant to the compensation of the CEO, to evaluate the performance of the CEO in light of these goals and objectives (including an evaluation of performance against the goals and objectives related to the Company's Sustainability Index), and determine and recommend to the Board for approval the compensation of the CEO based on this evaluation;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; • to review and recommend to the Board for approval all compensation for executive officers, except that any compensation decisions for the CEO will be presented to the non-management members of the Board for approval;

---

| | |
|:---|:---|
| **52** | ***D e l i v e r i n g a S m o k e - F r e e F u t u r e***  |

---

------

[**TABLE OF CONTENTS**](#TOC)

C O M P E N S A T I O N D I S C U S S I O N A N D A N A L Y S I S

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; • to make recommendations to the Board with respect to incentive compensation plans and equity-based plans that are subject to Board approval, to administer and make awards under such plans and to review the cumulative effect of its actions;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; • to monitor risks relating to the Company's compensation policies and practices;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; • to monitor compliance by executives with the Company's share ownership requirements; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; • to review and assist with the development of executive succession plans, to evaluate and make recommendations to the Board regarding potential candidates to become chief executive officer, and to evaluate candidates to fill other corporate officer positions.

In fulfilling these duties, the Committee is supported by our Global Head of People & Culture and his department, the Committee's executive compensation consultant and other outside legal, financial and compensation advisors, where appropriate.

**Role of the CEO in Executive Compensation:** Our CEO makes recommendations to the Committee with respect to the compensation of executive officers other than himself. The Committee reviews and discusses the compensation of these officers with the CEO, and the Committee makes the final compensation decisions with respect to these executive officers. The CEO makes no recommendation and has no role in setting any aspect of his own compensation; he does not attend any Committee meetings when any element of his compensation is discussed.

**Role of the Executive Chairman in Executive Compensation:** The Committee reviews and discusses the compensation of the CEO with the Executive Chairman, and the Committee makes the final compensation decision with respect to the CEO. In addition, the Executive Chairman makes no recommendation and has no role in setting any aspect of his own compensation; he does not attend any Committee meetings when any element of his compensation is being discussed.

**Role of Compensation Consultants:** During 2022, the Committee retained the services of Frederic W. Cook & Co., an independent compensation consulting firm ("FW Cook"), to advise the Committee with respect to the compensation of the CEO and other executives. In addition, FW Cook provided input into the design of our compensation and benefit programs and evolving regulatory and executive compensation market trends.

Consistent with the requirements of its charter to assess the independence of the compensation consultant, the Committee has reviewed and considered:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; • the services the senior advisor of the FW Cook consulting team performed for the Committee during 2022;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; • the fees paid by the Company as a percentage of FW Cook's total revenue;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; • the senior advisor's ownership of the Company's stock, of which he has none;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; • the conflicts of interest policies and procedures of FW Cook;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; • the relationships among the Company, its executive officers and the Committee members, and FW Cook; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; • the quality and objectivity of the services provided to the Committee.

Other than obtaining advice on executive and director compensation, the Company has no relationship with the senior advisor from FW Cook or his firm, and the Committee regards them as independent.

**Compensation and Leadership Development Committee Interlocks and Insider Participation:** No member of the Committee at any time during 2022 had any relationship with the Company that would be required to be disclosed as a related person transaction or as a compensation committee interlock.

---

| | |
|:---|:---|
| P M I **2 0 2 3** P r o x y S t a t e m e n t  | **53**  |

---

------

[**TABLE OF CONTENTS**](#TOC)

C O M P E N S A T I O N D I S C U S S I O N A N D A N A L Y S I S

## Compensation and Leadership Development Committee Report
The Compensation and Leadership Development Committee has reviewed and discussed the Compensation Discussion and Analysis included in this proxy statement with management. Based on its review and discussions with management, the Committee recommended to the Board of Directors that the Compensation Discussion and Analysis be included in this proxy statement.

#### Compensation and Leadership Development Committee:
Werner Geissler, Chair

Juan José Daboub

Lisa A. Hook

Jun Makihara

Lucio A. Noto

Robert B. Polet

*The information contained in the report above shall not be deemed to be "soliciting material" or to be "filed" with the Securities and Exchange Commission or subject to Regulation 14A or 14C or the liabilities of Section 18 of the Securities Exchange Act of 1934, as amended, nor shall such information be incorporated by reference into any future filing under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended, except to the extent specifically incorporated by reference therein.* 

---

| | |
|:---|:---|
| **54** | ***D e l i v e r i n g a S m o k e - F r e e F u t u r e***  |

---

------

[**TABLE OF CONTENTS**](#TOC2)

C O M P E N S A T I O N T A B L E S

## Summary Compensation Table
The following table sets forth information concerning the cash and non-cash compensation awarded by PMI to our NEOs: the Chief Executive Officer, the Chief Financial Officer, and the three most highly compensated officers serving as executive officers on December 31, 2022. These amounts are based on the compensation earned by these officers while employed by PMI for each year. The compensation for Mr. Azinovic for 2020 is not shown because he was not an NEO for that year. All of our NEOs are Swiss payroll-based executive officers paid in CHF.

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **Name and <br> Principal Position** | **Year**  | **Salary <sup>(1)</sup> <br> ($)**  | **Bonus <br> ($)**  | **Stock <br> Awards <sup>(2)</sup> <br> ($)**  | **Non-Equity <br> Incentive Plan <br> Compensation <sup>(3)</sup> <br> ($)**  | **Change in <br> Pension <br> Value <sup>(4)</sup> <br> ($)**  | **All Other <br> Compensation <sup>(5)</sup> <br> ($)**  | **Total <br> Compensation <br> ($)**  |
| **Jacek Olczak, <br> Chief Executive Officer**  | 2022  | 1461248  |  | 9751292  | 4556303  | —  | 6265  | 15775108  |
| **Jacek Olczak, <br> Chief Executive Officer**  | 2021  | 1427758  |  | 4713468  | 3617484  | 781194  | 17664  | 10557568  |
| **Jacek Olczak, <br> Chief Executive Officer**  | 2020  | 1281619  |  | 4371767  | 1838611  | 3456211  | 14341  | 10962549  |
| **Emmanuel Babeau, <br> Chief Financial Officer**  | 2022  | 1256882  |  | 4575952  | 2245614  | 403940  | 37078  | 8519466  |
| **Emmanuel Babeau, <br> Chief Financial Officer**  | 2021  | 1312514  |  | 4320696  | 2169871  | 1141868  | 49413  | 8994362  |
| **Emmanuel Babeau, <br> Chief Financial Officer**  | 2020  | 852155  |  | 8814207  | 1129213  | 1015118  | 69748  | 11880441  |
| **Drago Azinovic,** <br> President, Middle East & Africa Region and PMI Duty Free  | 2022  | 886984  |  | 1961939  | 1375027  | —  | 33215  | 4257165  |
| **Drago Azinovic,** <br> President, Middle East & Africa Region and PMI Duty Free  | 2021  | 926193  |  | 2104727  | 1222356  | —  | 31555  | 4284831  |
| **Frederic de Wilde,** <br> President, South and South-East Asia, Commonwealth of Independent States, & Middle East and Africa Region  | 2022  | 890375  |  | 2051202  | 1375027  | —  | 16727  | 4333331  |
| **Frederic de Wilde,** <br> President, South and South-East Asia, Commonwealth of Independent States, & Middle East and Africa Region  | 2021  | 927586  |  | 2418278  | 1277918  | —  | 16787  | 4640569  |
| **Frederic de Wilde,** <br> President, South and South-East Asia, Commonwealth of Independent States, & Middle East and Africa Region  | 2020  | 903477  |  | 2216885  | 992600  | 2479770  | 27511  | 6620243  |
| **Stefano Volpetti,** <br> President, Smoke-Free Inhalable Products & Chief Consumer Officer  | 2022  | 942912  |  | 2279999  | 1347369  | —  | 24483  | 4594763  |
| **Stefano Volpetti,** <br> President, Smoke-Free Inhalable Products & Chief Consumer Officer  | 2021  | 984604  |  | 2249550  | 1301922  | —  | 31877  | 4567953  |
| **Stefano Volpetti,** <br> President, Smoke-Free Inhalable Products & Chief Consumer Officer  | 2020  | 958843  | 213038  | 2003297  | 1057201  | 2233857  | 24002  | 6490238  |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (1)

The 2022 base salaries are converted to U.S. dollars using an average conversion rate for 2022 of $1.00 = 0.9550 CHF. Average conversion rates for 2021 and 2020 were $1.00 = 0.9144 CHF and 0.9388 CHF, respectively. Year-to-year variations in the salaries and other amounts reported for our NEOs result in part from year-to-year variations in exchange rates.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (2)

The amounts shown in this column represent the aggregate grant date fair value of stock awards computed in accordance with FASB ASC Topic 718. The number of shares awarded in 2022, together with the grant date fair values of each award, is disclosed in the Grants of Plan-Based Awards During 2022 table on page [57](#tGOPA).

The assumptions used in the calculation of the grant date fair value of PSUs awarded in 2022 are described in Item 8, Note 10. Stock Plans, to the consolidated financial statements contained in our Annual Report on Form 10-K for the fiscal year ended December 31, 2022. The table below provides the grant date fair value of PSUs awarded in 2022 for each of our NEOs, assuming the maximum level performance is achieved.

---

| | |
|:---|:---|
| **Name**  | **2022 PSUs Maximum <br> Value at 200% <br> ($)**  |
| Jacek Olczak | 12336810  |
| Emmanuel Babeau | 5789664  |
| Drago Azinovic | 2482318  |
| Frederic de Wilde | 2595700  |
| Stefano Volpetti | 2885182  |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (3)

The 2022, 2021 and 2020 annual incentive compensation awards are converted to U.S. dollars using year-end conversion rates of $1.00 = 0.9218, 0.9125 CHF and 0.8811 CHF, respectively.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (4)

The amounts shown reflect the change in the present value of benefits under the pension plans listed in the Pension Benefits table. The 2022 amounts for all of our NEOs with the exception of Mr. Babeau are shown as $0 due to a decrease in present value of pension benefits in 2022. The decrease was significantly driven by the mandated use of higher interest rates to discount projected future benefits and the impact of exchange rates between U.S. dollars and CHF. Such decreases would reverse in the event lower interest rates are used in future periods. The aggregated amount of decrease is as follows: Mr. Olczak, ($3,765,945); Mr. Azinovic, ($3,666,736); Mr. de Wilde, ($3,929,012); and Mr. Volpetti, ($3,647,436). The increase in the present value of pension benefits for Mr. Babeau is attributable to his purchase of additional service credit of 1.08 years in the amount of $183,705, funded fully by him with no Company contribution; as described on page [62](#tPFPMSWITZ), Swiss law permits participants in a pension plan to make additional voluntary contributions to the pension plan to compensate for missing years of credited service.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (5)

Details of All Other Compensation for each of the NEOs appear on the following page.

---

| | |
|:---|:---|
| P M I **2 0 2 3** P r o x y S t a t e m e n t  | **55**  |

---

------

[**TABLE OF CONTENTS**](#TOC2)

C O M P E N S A T I O N T A B L E S

## All Other Compensation

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Name and Principal Position**  | **Year**  | **International <br> Assignments <sup>(a)</sup> <br> ($)**  | **Car <br> Expenses <sup>(b)</sup> <br> ($)**  | **Tax Preparation <br> Services <sup>(c)</sup> <br> ($)**  | **Totals <br> ($)**  |
| **Jacek Olczak,** <br> Chief Executive Officer  | 2022  | —  | 6265  | —  | 6265  |
| **Jacek Olczak,** <br> Chief Executive Officer  | 2021  | —  | 17664  | —  | 17664  |
| **Jacek Olczak,** <br> Chief Executive Officer  | 2020  | —  | 14341  | —  | 14341  |
| **Emmanuel Babeau,** <br> Chief Financial Officer  | 2022  | 16282  | 20796  | —  | 37078  |
| **Emmanuel Babeau,** <br> Chief Financial Officer  | 2021  | 14883  | 34530  | —  | 49413  |
| **Emmanuel Babeau,** <br> Chief Financial Officer  | 2020  | 50889  | 18859  | —  | 69748  |
| **Drago Azinovic,** <br> President, Middle East & Africa Region and PMI Duty Free  | 2022  | —  | 24314  | 8901  | 33215  |
| **Drago Azinovic,** <br> President, Middle East & Africa Region and PMI Duty Free  | 2021  | —  | 27727  | 3828  | 31555  |
| **Frederic de Wilde,** <br> President, South and South-East Asia, Commonwealth of Independent States, & Middle East and Africa Region  | 2022  | —  | 15156  | 1571  | 16727  |
| **Frederic de Wilde,** <br> President, South and South-East Asia, Commonwealth of Independent States, & Middle East and Africa Region  | 2021  | —  | 15147  | 1640  | 16787  |
| **Frederic de Wilde,** <br> President, South and South-East Asia, Commonwealth of Independent States, & Middle East and Africa Region  | 2020  | —  | 25913  | 1598  | 27511  |
| **Stefano Volpetti,** <br> President Smoke-Free Inhalable Products & Chief Consumer Officer  | 2022  | —  | 22912  | 1571  | 24483  |
| **Stefano Volpetti,** <br> President Smoke-Free Inhalable Products & Chief Consumer Officer  | 2021  | —  | 30237  | 1640  | 31877  |
| **Stefano Volpetti,** <br> President Smoke-Free Inhalable Products & Chief Consumer Officer  | 2020  | —  | 22404  | 1598  | 24002  |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (a)

The amounts shown for Mr. Babeau include payments and reimbursements made pursuant to PMI's New Hire from Abroad Guidelines, which are designed to facilitate the relocation of our new hires, when they are hired from a different country than their work location. New Hire from Abroad Guidelines cover temporary housing benefits, relocation support, tax and social security equalization on relocation benefits and other program allowances.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (b)

Amounts shown for Mr. Olczak include the incremental cost of personal use of driver services that PMI provided for reasons of security and personal safety. The amounts for all our NEOs include the cost, amortized over a five-year period in 2022 and 2021, and a six-year period in 2020, respectively, of a vehicle, including insurance, maintenance, repairs and taxes. Executives are responsible for their own taxes on any imputed taxable income resulting from car expenses. Amounts that were paid or incurred in currency other than U.S. dollars are converted to U.S. dollars using an average conversion rate for 2022 of $1.00 = 0.9550 CHF.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (c)

The tax preparation services are pursuant to PMI policies that apply to all Swiss payroll-based management employees. For Mr. Azinovic the amount also includes tax advisory services related to his termination. The amounts shown are converted to U.S. dollars using an average conversion rate for 2022 of $1.00 = 0.9550 CHF.

The following are the specific amounts paid by the Company under the International Assignments:

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Name and Principal Position**  | **Year**  | **Relocation <br> ($)**  | **Tax and Social <br> Security <br> Equalization <sup>(a)</sup> <br> ($)**  | **Other Program <br> Allowances <sup>(b)</sup> <br> ($)**  | **Totals <br> ($)**  |
| **Emmanuel Babeau,** <br> Chief Financial Officer  | 2022  | 4969  | 1289  | 10024  | 16282  |
| **Emmanuel Babeau,** <br> Chief Financial Officer  | 2021  | 648  | 4529  | 9706  | 14883  |
| **Emmanuel Babeau,** <br> Chief Financial Officer  | 2020  | 43049  | —  | 7840  | 50889  |

---

Amounts that were paid or incurred in currency other than U.S. dollars are converted to U.S. dollars using an average conversion rate for 2022 of $1.00 = 0.9550 CHF.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (a)

The tax and social security equalization payments made pursuant to PMI's New Hire from Abroad Guidelines aim to offset the incremental tax and social security liability resulting from temporary relocation benefits. Payments for tax equalization often occur in years following the actual tax year. The Company has covered the excess taxes and social security on behalf of Mr. Babeau pursuant to our assignment tax principle.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (b)

Other Program Allowances include tax preparation services paid by the Company under the New Hire from Abroad Guidelines.

---

| | |
|:---|:---|
| **56** | ***D e l i v e r i n g a S m o k e - F r e e F u t u r e***  |

---

------

[**TABLE OF CONTENTS**](#TOC2)

C O M P E N S A T I O N T A B L E S

Grants of Plan-Based Awards During 2022

---

| | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | | **Estimated Possible Payouts <br> Under Non-Equity <br> Annual Incentive Plan <sup>(1)</sup>**  | **Estimated Possible Payouts <br> Under Non-Equity <br> Annual Incentive Plan <sup>(1)</sup>**  | **Estimated Possible Payouts <br> Under Non-Equity <br> Annual Incentive Plan <sup>(1)</sup>**  | **Estimated Future <br> Payouts Under Equity <br> Incentive Plan <sup>(2)</sup>**  | **Estimated Future <br> Payouts Under Equity <br> Incentive Plan <sup>(2)</sup>**  | **Estimated Future <br> Payouts Under Equity <br> Incentive Plan <sup>(2)</sup>**  | **All Other <br> Stock <br> Awards: <br> Number of Shares <br> of Stock or Units <sup>(3)</sup> <br> (#)**  | **Grant Date <br> Fair Value of <br> Stock Awards <br> ($)**  |
| **Name and Principal <br> Position** | **Grant Date**  | **Threshold <br> ($)**  | **Target <br> ($)**  | **Maximum <br> ($)**  | **Threshold <br> (#)**  | **Target <br> (#)**  | **Maximum <br> (#)**  | **All Other <br> Stock <br> Awards: <br> Number of Shares <br> of Stock or Units <sup>(3)</sup> <br> (#)**  | **Grant Date <br> Fair Value of <br> Stock Awards <br> ($)**  |
| **Jacek Olczak, <br> Chief Executive Officer**  | 2022  | —  | 3037535  | 6834454  |  |  |  |  |  |
| **Jacek Olczak, <br> Chief Executive Officer**  | 2/10/2022  |  |  |  | 25570  | 51140  | 102280  |  | 6168405  |
| **Jacek Olczak, <br> Chief Executive Officer**  | 2/10/2022  |  |  |  |  |  |  | 34100  | 3582887  |
| **Emmanuel Babeau, <br> Chief Financial Officer**  | 2022  | —  | 1627256  | 3661326  |  |  |  |  |  |
| **Emmanuel Babeau, <br> Chief Financial Officer**  | 2/10/2022  |  |  |  | 12000  | 24000  | 48000  |  | 2894832  |
| **Emmanuel Babeau, <br> Chief Financial Officer**  | 2/10/2022  |  |  |  |  |  |  | 16000  | 1681120  |
| **Drago Azinovic,** <br> President, Middle East & Africa Region and PMI Duty Free  | 2022  | —  | 916685  | 2062541  |  |  |  |  |  |
| **Drago Azinovic,** <br> President, Middle East & Africa Region and PMI Duty Free  | 2/10/2022  |  |  |  | 5145  | 10290  | 20580  |  | 1241159  |
| **Drago Azinovic,** <br> President, Middle East & Africa Region and PMI Duty Free  | 2/10/2022  |  |  |  |  |  |  | 6860  | 720780  |
| **Frederic de Wilde,** <br> President, South and South-East Asia, Commonwealth of Independent States, & Middle East and Africa Region  | 2022  | —  | 916685  | 2062541  |  |  |  |  |  |
| **Frederic de Wilde,** <br> President, South and South-East Asia, Commonwealth of Independent States, & Middle East and Africa Region  | 2/10/2022  |  |  |  | 5380  | 10760  | 21520  |  | 1297850  |
| **Frederic de Wilde,** <br> President, South and South-East Asia, Commonwealth of Independent States, & Middle East and Africa Region  | 2/10/2022  |  |  |  |  |  |  | 7170  | 753352  |
| **Stefano Volpetti,** <br> President, Smoke-Free Inhalable Products & Chief Consumer Officer  | 2022  | —  | 976354  | 2196797  |  |  |  |  |  |
| **Stefano Volpetti,** <br> President, Smoke-Free Inhalable Products & Chief Consumer Officer  | 2/10/2022  |  |  |  | 5980  | 11960  | 23920  |  | 1442591  |
| **Stefano Volpetti,** <br> President, Smoke-Free Inhalable Products & Chief Consumer Officer  | 2/10/2022  |  |  |  |  |  |  | 7970  | 837408  |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (1)

The estimated possible payouts are converted to U.S. dollars using the conversion rate on December 30, 2022, of $1.00 = 0.9218 CHF. The numbers in these columns represent the range of potential cash awards as of the time of the grant. Actual awards paid under these plans for 2022 are found in the Non-Equity Incentive Plan Compensation column of the Summary Compensation Table.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (2)

On February 10, 2022, each of our NEOs, received 60% of his targeted equity award in the form of PSUs. The target number of PSUs awarded was determined by using the average closing price of PMI stock over the 20 trading days period preceding the grant date of $102.694. The closing price of PMI stock on that date was $105.07. These equity awards are scheduled to vest on February 19, 2025, to the extent performance goals pre-established and pre-weighted by the Committee are achieved. For the 2022-2024 performance cycle the performance goals are based on TSR (including modifier on TSR performance against certain other tobacco companies), currency neutral adjusted compound annual diluted EPS growth rate and sustainability index. Dividend equivalents will be payable at vesting only on the earned shares.

The numbers in these columns represent the potential number of PSUs that can vest at three different levels of performance. Threshold assumes achievement of a threshold performance level for each of the three pre-established performance goals and no adjustment for the modifier resulting in the vesting of 50% of the target number of PSUs. The vesting percentage can be zero if none of the threshold levels is achieved.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (3)

On February 10, 2022, each of our NEOs received 40% of his targeted equity award in the form of RSUs. The number of RSUs awarded was determined by using the average closing price of PMI stock over the 20 trading days period preceding the grant date of $102.694. The closing price of PMI stock on that date was $105.07. These equity awards are scheduled to vest on February 19, 2025. Dividend equivalents are payable on a quarterly basis throughout the vesting restriction period.

On February 9, 2023, the following NEOs received equity awards that will vest (subject to the conditions of the awards) on February 18, 2026, as follows: Mr. Olczak, 48,280 RSUs, 72,410 PSUs; Mr. Babeau, 17,560 RSUs, 26,340 PSUs; Mr. Azinovic, 7,870 RSUs, 11,810 PSUs; Mr. de Wilde, 7,870 RSUs, 11,810 PSUs; and Mr. Volpetti, 8,390 RSUs, 12,580 PSUs. The amount of these awards was determined based on 2022 individual performance and targeted award levels by salary grade and then split between PSUs (60%) and RSUs (40%).

---

| | |
|:---|:---|
| P M I **2 0 2 3** P r o x y S t a t e m e n t  | **57**  |

---

------

[**TABLE OF CONTENTS**](#TOC2)

C O M P E N S A T I O N T A B L E S

## Outstanding Equity Awards as of December 31, 2022

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | | **Stock Awards**  | **Stock Awards**  | **Stock Awards**  | **Stock Awards**  |
| **Name and Principal Position**  | **Stock Award <br> Grant Date <sup>(1)</sup>**  | **Number of <br> Units that <br> Have not <br> Vested <sup>(1)(2)(3)</sup> <br> (#)**  | **Market Value <br> of Units that <br> Have not <br> Vested <sup>(4)</sup> <br> ($)**  | **Equity <br> Incentive <br> Plan Awards: <br> Number of <br> Unearned <br> Units that <br> Have not <br> Vested <sup>(1)(5)</sup> <br> (#)**  | **Equity <br> Incentive <br> Plan Awards: <br> Market or <br> Payout Value <br> of Unearned <br> Units that <br> Have not <br> Vested <sup>(4)</sup> <br> ($)**  |
| **Jacek Olczak, <br> Chief Executive Officer**  | 2/10/2022  |  |  | 102280  | 10351759  |
| **Jacek Olczak, <br> Chief Executive Officer**  | 2/10/2022  | 34100  | 3451261  |  |  |
| **Jacek Olczak, <br> Chief Executive Officer**  | 2/4/2021  |  |  | 64360  | 6513876  |
| **Jacek Olczak, <br> Chief Executive Officer**  | 2/4/2021  | 21460  | 2171967  |  |  |
| **Jacek Olczak, <br> Chief Executive Officer**  | 2/6/2020<sup>(6)</sup>  | 52740  | 5337815  |  |  |
| **Jacek Olczak, <br> Chief Executive Officer**  | 2/6/2020  | 19540  | 1977643  |  |  |
| **Emmanuel Babeau, <br> Chief Financial Officer**  | 2/10/2022  |  |  | 48000  | 4858080  |
| **Emmanuel Babeau, <br> Chief Financial Officer**  | 2/10/2022  | 16000  | 1619360  |  |  |
| **Emmanuel Babeau, <br> Chief Financial Officer**  | 2/4/2021  |  |  | 59000  | 5971390  |
| **Emmanuel Babeau, <br> Chief Financial Officer**  | 2/4/2021  | 19670  | 1990801  |  |  |
| **Emmanuel Babeau, <br> Chief Financial Officer**  | 5/1/2020<sup>(6)</sup>  | 49644  | 5024469  |  |  |
| **Emmanuel Babeau, <br> Chief Financial Officer**  | 5/1/2020  | 18390  | 1861252  |  |  |
| **Drago Azinovic,** <br> President, Middle East & Africa Region and PMI Duty Free  | 2/10/2022  |  |  | 20580  | 2082902  |
| **Drago Azinovic,** <br> President, Middle East & Africa Region and PMI Duty Free  | 2/10/2022  | 6860  | 694301  |  |  |
| **Drago Azinovic,** <br> President, Middle East & Africa Region and PMI Duty Free  | 2/4/2021  |  |  | 24040  | 2433088  |
| **Drago Azinovic,** <br> President, Middle East & Africa Region and PMI Duty Free  | 2/4/2021  | 8010  | 810692  |  |  |
| **Drago Azinovic,** <br> President, Middle East & Africa Region and PMI Duty Free  | 2/6/2020<sup>(6)</sup>  | 19854  | 2009423  |  |  |
| **Drago Azinovic,** <br> President, Middle East & Africa Region and PMI Duty Free  | 2/6/2020  | 7360  | 744906  |  |  |
| **Frederic de Wilde,** <br> President, South and South-East Asia, Commonwealth of Independent States, & Middle East and Africa Region  | 2/10/2022  |  |  | 21520  | 2178039  |
| **Frederic de Wilde,** <br> President, South and South-East Asia, Commonwealth of Independent States, & Middle East and Africa Region  | 2/10/2022  | 7170  | 725676  |  |  |
| **Frederic de Wilde,** <br> President, South and South-East Asia, Commonwealth of Independent States, & Middle East and Africa Region  | 2/4/2021  |  |  | 27640  | 2797444  |
| **Frederic de Wilde,** <br> President, South and South-East Asia, Commonwealth of Independent States, & Middle East and Africa Region  | 2/4/2021  | 9220  | 933156  |  |  |
| **Frederic de Wilde,** <br> President, South and South-East Asia, Commonwealth of Independent States, & Middle East and Africa Region  | 2/6/2020<sup>(6)</sup>  | 23634  | 2391997  |  |  |
| **Frederic de Wilde,** <br> President, South and South-East Asia, Commonwealth of Independent States, & Middle East and Africa Region  | 2/6/2020  | 8760  | 886600  |  |  |
| **Stefano Volpetti,** <br> President, Smoke-Free Inhalable Products & Chief Consumer Officer  | 2/10/2022  |  |  | 23920  | 2402943  |
| **Stefano Volpetti,** <br> President, Smoke-Free Inhalable Products & Chief Consumer Officer  | 2/10/2022  | 7970  | 806644  |  |  |
| **Stefano Volpetti,** <br> President, Smoke-Free Inhalable Products & Chief Consumer Officer  | 2/4/2021  |  |  | 30720  | 3109171  |
| **Stefano Volpetti,** <br> President, Smoke-Free Inhalable Products & Chief Consumer Officer  | 2/4/2021  | 10240  | 1036390  |  |  |
| **Stefano Volpetti,** <br> President, Smoke-Free Inhalable Products & Chief Consumer Officer  | 2/6/2020<sup>(6)</sup>  | 24174  | 2446651  |  |  |
| **Stefano Volpetti,** <br> President, Smoke-Free Inhalable Products & Chief Consumer Officer  | 2/6/2020  | 8950  | 905830  |  |  |

---

---

| | |
|:---|:---|
| **58** | ***D e l i v e r i n g a S m o k e - F r e e F u t u r e***  |

---

------

[**TABLE OF CONTENTS**](#TOC2)

C O M P E N S A T I O N T A B L E S

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (1)

These awards vest according to the following schedule (subject to continuous employment):

---

| | | |
|:---|:---|:---|
| **Grant Date**  | **Grant Type**  | **Vesting Schedule**  |
| 2/10/2022 | PSU  | Award vests between 0-200% on 2/19/2025 upon certification of the achievement of performance goals pre-established by the Committee.  |
| 2/10/2022 | RSU  | 100% of award vests on 2/19/2025.  |
| 2/4/2021 | PSU  | Award vests between 0-200% on 2/21/2024 upon certification of the achievement of performance goals pre-established by the Committee.  |
| 2/4/2021 | RSU  | 100% of award vests on 2/21/2024.  |
| 5/1/2020 | PSU  | Award vested at 180% on 2/15/2023 based upon certification of the achievement of performance goals pre-established by the Committee.  |
| 5/1/2020 | RSU  | 100% of award vested on 2/15/2023.  |
| 2/6/2020 | PSU  | Award vested at 180% on 2/15/2023 based upon certification of the achievement of performance goals pre-established by the Committee.  |
| 2/6/2020 | RSU  | 100% of award vested on 2/15/2023.  |

---

Upon normal retirement or upon separation from employment by mutual agreement after reaching age 58, outstanding RSUs will vest immediately, while outstanding PSUs will vest at the end of the relevant three-year performance cycle to the extent performance goals are met. Upon death or disability, all outstanding RSUs will vest and all outstanding PSUs will vest at 100% of target. In all other cases, the extent of vesting or forfeiture will be subject to the Committee's discretion.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (2)

Amounts reflect unvested RSUs and earned PSUs for 2020-2022 performance cycle, described further in footnote (6).

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (3)

Dividend equivalents paid in 2022 on outstanding RSUs for each of our NEOs were as follows: Mr. Olczak, $353,422; Mr. Babeau, $292,776; Mr. Azinovic, $118,025; Mr. de Wilde, $131,125; and Mr. Volpetti, $148,686. Dividend equivalents paid in 2022 on vested PSUs for our NEOs were as follows:

Mr. Olczak, $495,911; Mr. Azinovic, $261,420; and Mr. de Wilde, $213,983. Any variations in the amounts reported previously result from the impact of the exchange rate between U.S. dollar and CHF.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (4)

Based on the closing market price of PMI common stock on December 30, 2022, of $101.21.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (5)

Amounts reflect unearned PSUs and assume 200% (maximum) performance goals are achieved for 2021 and 2022 PSUs. The actual number of units that vest will range between 0% and 200%, depending on actual performance during the performance cycle.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (6)

2020 PSUs that were earned at 180% upon certification of the achievement of performance goals by the Committee.

---

| | |
|:---|:---|
| P M I **2 0 2 3** P r o x y S t a t e m e n t  | **59**  |

---

------

[**TABLE OF CONTENTS**](#TOC2)

C O M P E N S A T I O N T A B L E S

## Stock Option Exercises and Stock Vested During 2022

---

| | | |
|:---|:---|:---|
| | **Stock Awards**  | **Stock Awards**  |
| **Name and Principal Position**  | **Number of <br> Shares <br> Acquired on <br> Vesting <br> (#)**  | **Value <br> Realized on <br> Vesting <br> ($)**  |
| **Jacek Olczak, <br> Chief Executive Officer**  | 51870  | 5738637  |
| **Emmanuel Babeau, <br> Chief Financial Officer**  | 34820  | 3852311  |
| **Drago Azinovic, <br> President, Middle East & Africa Region and PMI Duty Free**  | 31560  | 3491641  |
| **Frederic de Wilde,** <br> President, South and South-East Asia, Commonwealth of Independent States, & Middle East and Africa Region | 27195  | 3008719  |
| **Stefano Volpetti, <br> President, Smoke-Free Inhalable Products & Chief Consumer Officer**  | 9310  | 982968  |

---

On February 15, 2023, vesting restrictions lapsed for the following RSUs granted in 2020: Mr. Olczak, 19,540 shares; Mr. Babeau, 18,390 shares; Mr. Azinovic, 7,360 shares; Mr. de Wilde, 8,760 shares and Mr. Volpetti, 8,950 shares.

On February 15, 2023, the PSUs granted in 2020 vested at an overall performance factor of 180% (as certified by the Committee) as follows: Mr. Olczak, 52,740 shares; Mr. Babeau, 49,644; Mr. Azinovic, 19,854 shares; Mr. de Wilde, 23,634 shares; and Mr. Volpetti, 24,174 shares.

Dividend equivalents paid in 2023 on vested PSUs for our NEOs were as follows: Mr. Olczak, $774,223; Mr. Babeau, $670,690; Mr. Azinovic, $291,457; Mr. de Wilde, $346,947; and Mr. Volpetti, $354,874.

---

| | |
|:---|:---|
| **60** | ***D e l i v e r i n g a S m o k e - F r e e F u t u r e***  |

---

------

[**TABLE OF CONTENTS**](#TOC2)

C O M P E N S A T I O N T A B L E S

## Pension Benefits
The Pension Benefits table below generally reflects amounts accumulated as a result of the NEOs' service over their full careers with us, our prior parent company and affiliates. The increments related to 2022 are reflected in the Change in Pension Value column of the Summary Compensation Table on page [55](#tSCT). Our plans providing pension benefits are described below the Pension Benefits table. None of our NEOs participates in the nonqualified defined contribution or deferred compensation plans.

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Name and Principal <br> Position** | **Plan Name**  | **Number of <br> Years of <br> Credited <br> Service <sup>(1)</sup> <br> (#)**  | **Present Value <br> of Accumulated <br> Benefits <sup>(2)</sup> <br> ($)**  | **Payments <br> During Last <br> Fiscal Year <br> ($)**  |
| **Jacek Olczak, <br> Chief Executive Officer**  | Pension Fund of Philip Morris in Switzerland  | 33.00  | 10716967  | —  |
| **Jacek Olczak, <br> Chief Executive Officer**  | IC Pension Plan of Philip Morris in Switzerland | 16.92  | 891412  | —  |
| **Jacek Olczak, <br> Chief Executive Officer**  | Supplemental Plan of Philip Morris in Switzerland  | 14.00  | 7596794  | —  |
| **Emmanuel Babeau, <br> Chief Financial Officer**  | Pension Fund of Philip Morris in Switzerland  | 5.92  | 1809726  | —  |
| **Emmanuel Babeau, <br> Chief Financial Officer**  | IC Pension Plan of Philip Morris in Switzerland | 1.92  | 68263  | —  |
| **Emmanuel Babeau, <br> Chief Financial Officer**  | Supplemental Plan of Philip Morris in Switzerland  | 2.67  | 682937  | —  |
| **Drago Azinovic,** <br> President, Middle East & Africa Region and PMI Duty Free  | Pension Fund of Philip Morris in Switzerland  | 36.00  | 12074726  | —  |
| **Drago Azinovic,** <br> President, Middle East & Africa Region and PMI Duty Free  | IC Pension Plan of Philip Morris in Switzerland | 12.92  | 1168979  | —  |
| **Drago Azinovic,** <br> President, Middle East & Africa Region and PMI Duty Free  | Supplemental Plan of Philip Morris in Switzerland  | 11.00  | 973227  | —  |
| **Frederic de Wilde,** <br> President, South and South-East Asia, Commonwealth of Independent States, & Middle East and Africa Region  | Pension Fund of Philip Morris in Switzerland  | 31.00  | 8986870  | —  |
| **Frederic de Wilde,** <br> President, South and South-East Asia, Commonwealth of Independent States, & Middle East and Africa Region  | IC Pension Plan of Philip Morris in Switzerland | 17.92  | 1274410  | —  |
| **Frederic de Wilde,** <br> President, South and South-East Asia, Commonwealth of Independent States, & Middle East and Africa Region  | Supplemental Plan of Philip Morris in Switzerland  | 14.00  | 1455042  | —  |
| **Stefano Volpetti,** <br> President, Smoke-Free Inhalable Products & Chief Consumer Officer  | Pension Fund of Philip Morris in Switzerland  | 27.00  | 7579112  | —  |
| **Stefano Volpetti,** <br> President, Smoke-Free Inhalable Products & Chief Consumer Officer  | IC Pension Plan of Philip Morris in Switzerland | 2.92  | 249653  | —  |
| **Stefano Volpetti,** <br> President, Smoke-Free Inhalable Products & Chief Consumer Officer  | Supplemental Plan of Philip Morris in Switzerland  | 3.58  | 341721  | —  |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (1)

As of December 31, 2022, each NEO's total years of service with PMI or its affiliates were as follows: Mr. Olczak, 29.79 years; Mr. Babeau, 2.67 years; Mr. Azinovic, 13.83 years; Mr. de Wilde, 30.41 years; and Mr. Volpetti, 3.58 years.

The years shown in this column are the years credited under the named plan for purposes of benefit accrual. Additional years may count for purposes of vesting or early retirement eligibility. Differences between each NEO's total service and the credited service shown for each plan result from transfers between entities sponsoring various plans and from voluntary contributions to such plans. The Pension Fund of Philip Morris in Switzerland allows employees to purchase additional service credit with contributions from their own funds, and Messrs. Olczak, Babeau, Azinovic, de Wilde, and Volpetti have purchased 15.67, 3.25, 22.17, 11.75, and 23.42 years, respectively, without any Company contribution. Mr. de Wilde's credited service includes his service at our Belgian affiliate. Mr. Volpetti's service credit includes 4.25 years transferred from his previous pension plan.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (2)

The amounts shown in this column are based on a 60% joint and survivor annuity commencing at age 62 (the earliest date on which, assuming continued employment, the individual would be eligible for benefits that are not reduced for early commencement) and the following actuarial assumptions: discount rate 2.13%, mortality table LPP 2020 (fully generational) for expected improvements in mortality and interest rate on account balances of 3.0%. Present value amounts in Swiss francs are converted to U.S. dollars using the conversion rate on December 30, 2022, of $1.00 = 0.9218 CHF.

Like all present value amounts, the amounts shown in this column change as the interest rate used to discount projected future benefits is adjusted, with lower interest rates producing higher present values and higher interest rates producing lower present values.

#### Retirement Plans for Swiss Payroll-Based Employees
Pensions for our Swiss payroll-based employees are payable from a funded defined benefit pension plan and incentive compensation (IC) pension plan qualifying for favorable treatment under Swiss law. To the extent that Swiss tax or other limitations do not allow paying the full pension under the qualified plans, the balance is expected to be payable under a supplemental pension plan. In accordance with the regulations of the plans, the benefits must commence at the latest on the first day of the month following the employee's 65<sup>th</sup> birthday.

---

| | |
|:---|:---|
| P M I **2 0 2 3** P r o x y S t a t e m e n t  | **61**  |

---

------

[**TABLE OF CONTENTS**](#TOC2)

C O M P E N S A T I O N T A B L E S

#### Pension Fund of Philip Morris in Switzerland
With limited exceptions, all Swiss payroll-based employees over 25 years of age become immediately covered by the Pension Fund of Philip Morris in Switzerland, a broad-based contributory-funded plan providing defined retirement, disability and death benefits up to limits prescribed under Swiss law. Retirement benefits are expressed as an annuity at normal retirement age equal to 1.8% of the participant's five-year average pensionable salary (base salary minus two-thirds of the maximum social security benefits of CHF 28,680 in 2022) multiplied by years of credited service (to a maximum of 40 to 41 years, depending on the employee's date of birth).

![[MISSING IMAGE: tb_pension1-pn.jpg]](tb_pension1-pn.jpg)

Employees between the ages of 25 and 34 contribute 6% of their pensionable salary to the fund, and the contribution increases to 7% for employees between the ages of 35 and 54 and 8% for employees between the ages of 55 and 65. Subject to certain conditions, participants may elect to receive pension benefits entirely or partially in a lump sum. For determining lump sum values, a discount rate of 3.5% and the LPP 2020 mortality table are used. The LPP mortality table is a commonly used mortality table in Switzerland. For an employee who completes 30 years of service and retires at age 62, this translates into payments equivalent to a pension of 54% of five years' annual average pensionable salary. For an employee with 40 years of credited service at age 65, this "replacement ratio" is approximately 72% of average salary. Participants may retire and commence benefits as early as age 58; however, for each year that retirement precedes age 62, the 1.8% multiplier used to calculate the amount of the retirement pension is reduced by 0.06% (at age 58 the multiplier is 1.56%). Swiss law permits participants in a pension plan to make additional voluntary contributions to the pension plan to compensate for missing years of credited service.

If an employee terminates employment with us before age 58, the lump sum value of the pension calculated using the termination lump sum factors is transferred either to a new pension fund or to a blocked bank account until early retirement age is reached. An employee who is age 50 or over upon termination of employment can elect, under certain conditions, to remain in the plan as an external member. In this case, neither the employee nor the employer can contribute any further funds. At the age of 58, the former employee must then elect to take retirement in the form of an annuity, a lump sum or a mix of both.

#### IC Pension Plan of Philip Morris in Switzerland
Swiss payroll-based employees in salary grades 14 and above who are eligible to participate in the annual incentive compensation award program described above are also eligible to participate in the IC Pension Plan of Philip Morris in Switzerland, a funded cash balance plan which, for the NEOs, provides for participant contributions of up to 1.5% of pensionable salary (as defined above), subject to maximum Swiss pension law limits, and an equal matching contribution from the employer. As with the pension plan, participants may make additional voluntary contributions subject to certain terms and conditions.

Benefits ultimately received depend on interest rates set by the Pension Board of the plan (which consists of members appointed by the employer and an equal number selected by participants in the plan) and are payable in a lump sum or as an annuity. The plan guarantees that there is no loss of principal on either the employee contributions or the Company match. In 2022, the assets of the funds had a negative performance of 12.8%, and no interest was credited on plan balances.

If an employee terminates employment with the Company before age 58, the employee's account value is transferred to either a new pension fund or to a blocked bank account until early retirement age is reached. An employee who is age 50 or over upon termination of employment can elect under certain conditions to remain in the plan as an external member. In this case, neither the employee nor the employer can contribute any further funds to the plan although interest does accrue on the account balance. At the age of 58, the former employee must then elect to take retirement in the form of an annuity, a lump sum or a mix of both.

---

| | |
|:---|:---|
| **62** | ***D e l i v e r i n g a S m o k e - F r e e F u t u r e***  |

---

------

[**TABLE OF CONTENTS**](#TOC2)

C O M P E N S A T I O N T A B L E S

#### Supplemental Plan of Philip Morris in Switzerland
For some Swiss payroll-based employees, including our NEOs, the laws and regulations applicable to the Pension Fund of Philip Morris in Switzerland and the IC Pension Plan of Philip Morris in Switzerland limit the benefits that can be provided under those plans. For these employees, we maintain a Supplemental Plan under which an amount is calculated and deposited annually in a Swiss foundation to make up for the difference between the full pension an employee would have received had these plans not been subject to such limitations (assuming the employee becomes entitled to benefits from the Supplemental Plan). However, the annual deposits do not serve to increase the amount that an individual would have received absent such limits. In determining the amount of the annual deposit, the actuarial assumptions used are the same as those described above for the Pension Fund of Philip Morris in Switzerland.

In the event of a Supplemental Plan participant's termination of employment from the Company, if the Foundation Board determines in its sole discretion that he or she is entitled to a benefit, the Supplemental Plan benefit is paid in a lump sum at the time that benefits first become payable to the participant under the Pension Fund of Philip Morris in Switzerland and the IC Pension Plan of Philip Morris in Switzerland. As the Supplemental Plan is not a tax-qualified plan, the benefits from this plan, when paid, are adjusted for the loss of favorable tax-qualified plan treatment.

#### EMPLOYMENT CONTRACTS, TERMINATION OF EMPLOYMENT AND CHANGE IN CONTROL ARRANGEMENTS
All of our NEOs are Swiss payroll-based executive officers covered by contracts, which do not include change in control provisions. Messrs. Olczak and de Wilde do not have special employment contracts. The employment contract with Mr. Babeau, our Chief Financial Officer, provides for severance if his employment is terminated without cause. If such termination occurs after two years upon commencement of his employment, Mr. Babeau would be entitled to a lump sum cash payment of one time his annual base salary and incentive compensation award (which would be pro-rated based on the period of his employment during the year of termination). His RSUs will vest fully and PSUs will vest on a pro-rated basis as scheduled and certified by the Committee. Any severance under the contract is conditioned on a 24-month non-compete obligation. The severance provisions in the employment contract of Mr. Volpetti were valid for two years upon commencement of his employment and are no longer applicable.

The amounts in the accompanying table are estimates of the severance benefits that would be payable to Mr. Babeau in case of involuntary separation without cause assuming end of employment date of December 31, 2022.

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Name**  | **Severance<sup>(1)</sup> <br> ($)**  | **Estimated <br> Value of <br> Stock Awards<sup>(2)</sup> <br> ($)**  | **Incentive <br> Compensation <br> Award<sup>(3)</sup> <br> ($)**  | **Total <br> ($)**  |
| **Emmanuel Babeau**  | 1301805  | 10827851  | 2245614  | 14375270  |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (1)

The amount for Mr. Babeau assumes a severance payment equivalent to one time his annual base salary. Amount is converted to U.S. dollars using the conversion rate on December 30, 2022, of $1.00 = 0.9218 CHF.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (2)

Assumes the value of the stock awards that would vest as a result of termination without cause assuming the closing price of PMI common stock on December 30, 2022, of $101.21. The value of unvested PSUs granted under the 2017 Performance Incentive Plan assumes target number of shares would vest, pro-rated to reflect the period between the grant date and December 31, 2022.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (3)

Assumes incentive compensation award based on actual individual and company performance ratings for 2022. Amount is converted to U.S. dollars using the conversion rate on December 30, 2022, of $1.00 = 0.9218 CHF.

Additionally, Mr. Azinovic's initial employment contract from 2008 provided that in the event his employment is terminated by the Company he would receive a severance package with a value of at least EUR 1.32 million (or $1.41 million using the conversion rate on December 30, 2022 of $1 = 0.9372 EUR) net of taxes. See below under "Severance Agreements" for more information about Mr. Azinovic's severance arrangements in connection with his involuntary separation from the Company.

Our 2020, 2021 and 2022 equity awards were granted under the 2017 Performance Incentive Plan. That plan and also the 2022 Performance Incentive Plan include a double-trigger feature. Under both plans, outstanding equity awards will not accelerate or vest if the entity acquiring PMI agrees to replace the award with a time-based equity award of equivalent value. For this purpose, the value of outstanding PSUs would be determined based on actual performance through the date of the change in control if more than one-half of the performance cycle has elapsed and such performance is determinable. Otherwise, the value of the outstanding PSUs will be based on the assumption that target performance had been achieved. If outstanding equity awards are not replaced, the outstanding RSUs would fully vest, and the value of outstanding PSUs would be determined as set forth above and both would be payable immediately in cash. Fully earned but unpaid annual incentive compensation awards would become payable.

---

| | |
|:---|:---|
| P M I **2 0 2 3** P r o x y S t a t e m e n t  | **63**  |

---

------

[**TABLE OF CONTENTS**](#TOC2)

C O M P E N S A T I O N T A B L E S

If outstanding equity awards are replaced as described above, but within two years after the change in control, the employee's employment is terminated involuntarily and other than for cause or the employee terminates employment for good reason, the replacement awards would fully vest.

Under PMI's 2017 and 2022 Performance Incentive Plans, a change in control occurs: (i) upon an acquisition of 20% or more of either PMI's common stock or the voting power of PMI's voting securities, excluding certain acquisitions involving PMI or its affiliates or where PMI's beneficial owners continue to meet certain ownership thresholds; (ii) when members of the PMI Board as of the effective date of each Plan, or thereafter nominated or elected by such members, cease to constitute a majority of the PMI Board; (iii) upon certain reorganizations, mergers, share exchanges and consolidations involving PMI; or (iv) upon the liquidation or dissolution, or sale of substantially all of the assets of PMI, with limited exceptions.

The amounts in the accompanying table are estimates of the amounts that would have become payable on a change in control of PMI, calculated as if a change in control occurred on December 31, 2022, applying certain assumptions. For outstanding equity awards granted under the 2017 Performance Incentive Plan and annual cash incentive awards, we have assumed that the outstanding awards became vested and payable as of December 31, 2022, because they were not replaced by the acquirer or employment was involuntarily terminated.

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Name**  | **Unvested <br> PSUs<sup>(1)</sup> <br> ($)**  | **Unvested <br> RSUs<sup>(1)</sup> <br> ($)**  | **Completed <br> 2022 <br> Annual <br> Incentive <br> Compensation <br> Award <br> Cycle <sup>(2)</sup> <br> ($)**  | **Total <br> ($)**  |
| **Jacek Olczak**  | 11398270  | 7600871  | 3037535  | 22036676  |
| **Emmanuel Babeau**  | 8206107  | 5471413  | 1627256  | 15304776  |
| **Drago Azinovic**  | 3374341  | 2249899  | 916685  | 6540925  |
| **Frederic de Wilde**  | 3816629  | 2545432  | 916685  | 7278746  |
| **Stefano Volpetti**  | 4124308  | 2748864  | 976354  | 7849526  |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (1)

Assumes the change in control price is equal to the closing market price of PMI on December 30, 2022, of $101.21. The value of unvested PSUs granted under the 2017 Performance Incentive Plan assumes target number of shares awarded (because less than half of the performance cycle had lapsed or actual performance was not determinable).

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (2)

Assumes target award payable under our annual incentive compensation award program for a full year. Amounts are converted to U.S. dollars using the conversion rate on December 30, 2022, of $1.00 = 0.9218 CHF.

Benefits payable under PMI's qualified pension plans and supplemental plans are discussed above. None of those plans provides PMI's executive officers with an additional enhancement, early vesting or other benefit in the event of a change in control or termination of employment. Similarly, no enhanced provisions apply to the above-NEOs with respect to continued medical, life insurance or other insurance coverage following termination of employment, whether or not in connection with a change in control.

#### Involuntary Separation Without Cause
In the event of involuntary separation without cause, a severance payment is typically determined as a multiple of monthly base salary. The amount of severance paid varies based on a number of factors, including the circumstances of the termination and the executive's years of service. The separation benefits that would be offered to our NEOs are consistent with those that would apply to any other Swiss payroll-based employees who are involuntarily terminated without cause under similar circumstances. Conditions to accelerated vesting of equity awards are set out in the applicable award agreements and summarized on page [59](#AWARDAGREE).

---

| | |
|:---|:---|
| **64** | ***D e l i v e r i n g a S m o k e - F r e e F u t u r e***  |

---

------

[**TABLE OF CONTENTS**](#TOC2)

C O M P E N S A T I O N T A B L E S

#### Severance Agreements
Mr. Azinovic, our President, Middle East and Africa and PMI Duty Free Region, will leave the organization effective March 31, 2023, in connection with the Company's new regional structure and related senior management changes and after a transition period. On February 27, 2023, in connection with Mr. Azinovic's departure, he and Philip Morris Products S.A. entered into a Separation Agreement and Release with the following terms:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; • Mr. Azinovic's separation is a severance-qualifying event due to Philip Morris Products S.A. giving notice of termination of employment, and he will therefore receive a severance payment of CHF 2,401,909 (or $2,553,728 based upon the conversion rate on February 27, 2023), which is equal to EUR 1.32 million net of taxes as required by the terms of the 2008 letter described above;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; • Due to the severance payment, Mr. Azinovic will not be eligible to receive any pro-rated incentive compensation award payment for the portion of 2023 during which he remains employed;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; • Mr. Azinovic's restricted share units will fully vest in accordance with the terms thereof, and his performance share units will vest as scheduled and certified by the Committee; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; • Mr. Azinovic will receive a cash payment of CHF 1,267,500 (or $1,347,616 based upon the conversion rate on February 27, 2023) subject to his compliance with a 24-month non-compete obligation. This payment will be made after 24 months from his March 31, 2023 separation date, and only subject to certification of compliance with the non-compete obligations.

Under the Separation Agreement, Mr. Azinovic provided the Company with a general release, and is subject to confidentiality, non-disparagement and other provisions customary for separations at this level.

---

| | |
|:---|:---|
| P M I **2 0 2 3** P r o x y S t a t e m e n t  | **65**  |

---

------

[**TABLE OF CONTENTS**](#TOC2)

PAY RATIO <br>

![[MISSING IMAGE: tm2136562d1-icon_topbarpn.jpg]](tm2136562d1-icon_topbarpn.jpg)

## PAY RATIO

#### ABOUT OUR WORKFORCE
At December 31, 2022, we employed approximately 79,800 people worldwide. As the majority of our manufacturing and sales activities are outside of the U.S., 97.8% of our employees (or approximately 78,045) are located outside of the U.S. Approximately 59% of our employees are located in non-OECD countries, which tend to be lesser developed countries with lower wages than OECD countries. Approximately 28% of our workforce is in Indonesia. The national average annual net salary is approximately $2,500 in that country.<sup>1</sup> Over 60%<sup>2</sup> of our workforce is covered by collective labor agreements, and approximately 68%<sup>2</sup> of our workforce in non-OECD countries is covered by collective labor agreements.

#### OUR PAY RATIO
Given our global footprint, and in accordance with regulatory guidance, we have determined that the cost-of-living adjusted ratio based on the purchasing power parity index (or "PPP") reflects the differences in the living and economic conditions of approximately 90 countries where our employees reside.<sup>3</sup> The PPP conversion factor represents the number of units of local currency that can buy a basket of goods that 1 CHF would buy in Switzerland, where our CEO resides. The total PPP- adjusted compensation for our median employee residing in Turkey is approximately CHF 92,262.<sup>4</sup> Comparing this employee's total PPP-adjusted compensation to the 2022 total compensation of our CEO in CHF, our adjusted pay ratio is 158:1.<sup>5</sup>

Had we not used the PPP adjustment, our median employee's total 2022 compensation would have been approximately $19,411. Comparing this employee's total compensation to the total compensation of our CEO as set forth in the Summary Compensation Table on page [55](#tSCT), the ratio would be 813:1. For reference, the ratio of the CEO's total compensation to that of our median employee in Switzerland is 80:1. As of December 31, 2022, we employed approximately 3,310 people in Switzerland, including approximately 310 in our factory and 640 in our R&D facility in Neuchâtel. In addition, the ratio of our CEO's total compensation to the average total compensation of our other NEOs for 2022, was 2.9:1.

Because the SEC rules for identifying the median employee and calculating the pay ratio based on that employee's annual total compensation allow companies to adopt a variety of methodologies, to apply certain exclusions, and to make reasonable estimates and assumptions that reflect their compensation practices, the pay ratio reported by other companies — including companies in our Peer Group — may not be comparable to the pay ratio reported above. Other companies may have different employment & compensation practices, different geographic breadth, perform different types of work, and may utilize different methodologies, exclusions, estimates and assumptions in calculating their own pay ratios.

This information is being provided for compliance purposes. Neither the Committee nor management of the Company used the pay ratio measure in making compensation decisions.

<sup>1</sup>

https://www.bi.go.id/id/statistik/sdds/Default.aspx#real-sector-section.

<sup>2</sup>

These figures exclude the workforce of Swedish Match that became part of PMI at the end of November 2022. At December 31, 2022 there were approximately 7,500 employees in Swedish Match.

<sup>3</sup>

The PPP conversion factor is described at https://data.worldbank.org. The PPP indices are publicly available in the jurisdictions where our employees reside, with limited exceptions. At the determination date of October 1, 2020, we have excluded from the cost-of-living adjusted ratio calculation approximately 0.4% of our total workforce at that time in Curaçao (13 employees), Aruba (6 employees), La Reunion (43 employees), Taiwan (126 employees) and Venezuela (102 employees) due to unavailability of the PPP factors in these countries.

<sup>4</sup>

This represents the median of the total compensation of all employees. As there was no significant change in our employee population before October 1, 2022 (October 1 being our determination date), or compensation arrangements that would significantly impact the pay ratio disclosure, this median employee (selected in October 2020) is the same as the one described in our 2021 proxy statement, filed with the U.S. Securities and Exchange Commission on March 25, 2021. As the most recently available PPP conversion factor covers 2021, the impact of hyperinflation in Turkey in 2022 may not be fully reflected. This being the case also for other jurisdictions with significant inflation in the previous year, selecting a different median employee would not show a more accurate picture until the 2022 data are published. For this reason, the adjusted pay ratio may fluctuate in those years affected by significant economic changes.

<sup>5</sup>

To identify a median employee in the above calculations, we analyzed base salary information because that is the only pay element applied consistently throughout our global workforce. This compensation measure was annualized for permanent employees who were employed on the determination date but who did not work for the full year.

---

| | |
|:---|:---|
| **66** | ***D e l i v e r i n g a S m o k e - F r e e F u t u r e***  |

---

------

[**TABLE OF CONTENTS**](#TOC2)

PAY RATIO <br>

#### PMI AS AN EMPLOYER
We are the first multinational company to receive a global EQUAL-SALARY certification from the EQUAL-SALARY Foundation.

This year, the Top Employer Institute recognized us as a Global Top Employer for the seventh consecutive year. The Top Employer Institute also granted us a Top Employer certification in a number of countries worldwide, including Indonesia and Turkey.

---

| | |
|:---|:---|
| P M I **2 0 2 3** P r o x y S t a t e m e n t  | **67**  |

---

------

**[**TABLE OF CONTENTS**](#TOC2)

PAY VERSUS PERFORMANCE

![[MISSING IMAGE: tm2136562d1-icon_topbarpn.jpg]](tm2136562d1-icon_topbarpn.jpg)

## PAY VERSUS PERFORMANCE
The following table illustrates certain information about executive compensation for our CEO and other NEOs as well as certain performance measures against which compensation information can be compared. This disclosure has been prepared in accordance with Item 402(v) of Regulation S-K of the Exchange Act and does not necessarily reflect value actually realized by our NEOs or how our Compensation and Leadership Development Committee (the "Committee") evaluates compensation decisions in light of Company or individual performance. In particular, our Committee has not used compensation actually paid as a basis for making compensation decisions, nor does it use GAAP Net Income for purposes of determining incentive compensation. Please refer to our Compensation Discussion and Analysis on pages [38](#tCDAA) to [54](#tCDAA2) for a discussion of our executive compensation program, its objectives, and the ways in which we align executive compensation with Company performance.

---

| | | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| Year  | Summary Compensation Table Total for CEO — Mr. Calantzopoulos ($)<sup>(1)(2)</sup>  | Summary Compensation Table Total for CEO — Mr. Olczak ($)<sup>(1)(2)</sup> | Compensation Actually Paid to CEO — Mr. Calantzopoulos ($)<sup>(2)(4)</sup> | Compensation Actually Paid to CEO — Mr. Olczak ($)<sup>(2)(4)</sup> | Average Summary Compensation Table Total for Other NEOs ($)<sup>(1)(3)</sup>  | Average Compensation Actually Paid to Other NEOs ($)<sup>(3)(4)</sup>  | Value of Initial Fixed $100 Investment Based On:  | Value of Initial Fixed $100 Investment Based On:  | Net Income (in millions $)<sup>(6)</sup>  | Adjusted Diluted EPS, 1-year Growth<sup>(7)</sup>  |
| Year  | Summary Compensation Table Total for CEO — Mr. Calantzopoulos ($)<sup>(1)(2)</sup>  | Summary Compensation Table Total for CEO — Mr. Olczak ($)<sup>(1)(2)</sup> | Compensation Actually Paid to CEO — Mr. Calantzopoulos ($)<sup>(2)(4)</sup> | Compensation Actually Paid to CEO — Mr. Olczak ($)<sup>(2)(4)</sup> | Average Summary Compensation Table Total for Other NEOs ($)<sup>(1)(3)</sup>  | Average Compensation Actually Paid to Other NEOs ($)<sup>(3)(4)</sup>  | Total Shareholder Return<sup>(5)</sup>  | Peer Group Total Shareholder Return<sup>(5)</sup>  | Net Income (in millions $)<sup>(6)</sup>  | Adjusted Diluted EPS, 1-year Growth<sup>(7)</sup>  |
| 2022 | n/a  | 15775108  | n/a  | 24410701  | 5426181  | 7848730  | $141.0  | $119.9  | 9048  | 10.1%  |
| 2021 | 15349110  | 10557568  | 30404029  | 15485410  | 5433435  | 7491440  | $125.5  | $123.7  | 9109  | 15.4%  |
| 2020 | 21936798  | n/a  | 19391601  | n/a  | 10447764  | 7470429  | $103.9  | $107.0  | 8056  | 7.2%  |

---

(1) The Summary Compensation Table Total amounts can be found on page [55](#tSCT). For those NEOs in previous years who were no longer NEOs for 2022, the respective amounts can be found in our 2022 and 2021 proxy statements.

(2) Mr. Calantzopoulos served as the Company's CEO during the covered period until May 2021 when Mr. Olczak was appointed as our CEO.

(3) Our NEOs other than the CEO for each of the covered fiscal years are as follows:

<u> 2022 </u> <u> E. Babeau, D. Azinovic, F. de Wilde, S. Volpetti </u> <br> <u> 2021 </u> <u> E. Babeau, D. Azinovic, F. de Wilde, S. Volpetti, J. Insuasty, M. King </u> <br> <u> 2020 </u> <u> J. Olczak, E. Babeau, M. King, F. de Wilde, S. Volpetti, M. Firestone, M. Zielinski </u>

68 *D e l i v e r i n g a S m o k e - F r e e F u t u r e*

------**

[**TABLE OF CONTENTS**](#TOC2)

PAY VERSUS PERFORMANCE

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

(4) The amounts deducted and added to the Summary Compensation Table Total for each of the covered fiscal years are as shown in the table below. No awards were modified or forfeited during the covered years:

---

| | | | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **Year**  | **Name**  | **Summary <br> Compensation <br> Table <br> Total <br> ($)**  | **Amount <br> deducted <br> for Change <br> in Pension <br> Value <br> ($)**  | **Amount <br> added for <br> Pension <br> Cost <br> ($)<sup>(a)</sup>**  | **Amount <br> deducted <br> for Stock <br> Awards <br> ($)**  | **Amount <br> added for <br> EOY Fair <br> Value of <br> Stock <br> Awards <br> Granted <br> During <br> Fiscal Year <br> that are <br> Outstanding <br> and <br> Unvested <br> at EOY <br> ($)<sup>(b)</sup>**  | **Amount <br> added <br> (deducted) <br> for change <br> in value <br> from EOPY <br> to EOY <br> in Fair <br> Value of <br> Stock <br> Awards <br> Granted in <br> Any Prior <br> Fiscal Year <br> that are <br> Outstanding <br> and <br> Unvested <br> at EOY <br> ($)<sup>(b)</sup>**  | **Amount <br> added for <br> Fair Value <br> at Vesting <br> Date of <br> Stock <br> Awards <br> Granted <br> and Vested <br> During the <br> Fiscal Year <br> ($)<sup>(b)</sup>**  | **Amount <br> added <br> (deducted) <br> for change <br> in Fair <br> Value <br> from <br> EOPY to <br> Vesting <br> Date of <br> Stock <br> Awards <br> Granted <br> in Any <br> Prior <br> Fiscal <br> Year that <br> Vested <br> (or Failed <br> to Vest) <br> During the <br> Fiscal Year <br> ($)<sup>(b)</sup>**  | **Amount <br> added for <br> Dividend <br> Equivalents <br> Paid During <br> the Fiscal <br> Year <br> ($)**  | **Compensation <br> Actually <br> Paid <br> ($)**  |
| 2022  | Mr. Olczak  | 15775108  | 0  | 4458977  | 9751292  | 10300776  | 1864468  | 0  | 913331  | 849333  | 24410701  |
| 2022  | Average other NEOs  | 5426181  | 100985  | 630261  | 2717273  | 2870426  | 1033698  | 0  | 414918  | 291504  | 7848730  |
| 2021  | Mr. Calantzopoulos  | 15349110  | 0  | 1669036  | 12331239  | 17286561  | 6755580  | 0  | 423089  | 1251892  | 30404029  |
| 2021  | Mr. Olczak | 10557568  | 781194  | 1008654  | 4713468  | 6607423  | 2269335  | 0  | 124847  | 412245  | 15485410  |
| 2021  | Average other NEOs  | 5433435  | 236975  | 439187  | 2544006  | 3357205  | 735550  | 24478  | 95123  | 187443  | 7491440  |
| 2020  | Mr. Calantzopoulos  | 21936798  | 4857081  | 2651169  | 12024210  | 13872491  | (3220211)  | 0  | (188212)  | 1220857  | 19391601  |
| 2020  | Average other NEOs  | 10447764  | 3966343  | 894828  | 3579539  | 3810785  | (513023)  | 276341  | (141487)  | 241103  | 7470429  |

---

*"EOY" = End of Year, "EOPY" = End of Previous Year* 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (a)

Current year pension service cost including adjustments for prior year service cost, as applicable. For assumptions used in the calculation refer to Item 8, Note 13 to the consolidated financial statements contained in our Annual Report on Form 10-K for the fiscal years ended December 31, 2020 and December 31, 2021 and to Item 8, Note 14 for the fiscal year ended December 31, 2022.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (b)

The methodology used to calculate the fair values for stock awards at each fiscal year end is consistent with that disclosed at the time of grant. The fair value of the RSU awards is determined based on the closing price of PMI stock at the respective fiscal year end date and based on the average of the high and the low trading prices of PMI stock at the vesting date. The fair value for the portion of the PSU awards subject to the TSR performance factor was determined by using a Monte Carlo simulation model for the fiscal year end calculations and the average of the high and the low trading prices of PMI stock and actual performance at the vesting date. The fair value for the portion of the PSU awards subject to other performance factors was determined based on the closing price of PMI stock at the respective fiscal year end and estimated performance and based on the average of the high and the low trading prices of PMI stock and actual performance at the vesting date.

(5) The Peer Group is described on page [51](#sACPA), which is the same PMI Peer Group reported in the performance graph found in Part II, Item 5 of our Annual Report on Form 10-K for the fiscal year ending December 31, 2022. There have been no changes to the PMI Peer Group during the covered period. The amounts compare the cumulative total shareholder return of PMI's common stock with the cumulative total shareholder return for the same period of PMI's Peer Group. The calculation assumes the investment of $100 as of December 31, 2019, in PMI common stock and the PMI Peer Group index as of the market close and reinvestment of dividends on a quarterly basis.

(6) PMI's Net Income is reported as "net earnings attributable to PMI" in Item 8 of the Company's Annual Report on Form 10-K for the fiscal years ended December 31, 2020, December 31, 2021 and December 31, 2022.

(7) Currency neutral adjusted diluted EPS growth rate has been chosen as our Company Selected Measure, out of the performance measures in the tabular list set forth below, because of its weight and impact on PSUs. Adjusted diluted EPS growth over 3-year period is one of the metrics used in our long-term Equity Award program, under performance-based PSUs. In accordance with regulatory guidance, the measure presented in the table covers 1-year growth. For the definition of adjusted diluted EPS see the Glossary of Terms in Exhibit C.

---

| | |
|:---|:---|
| P M I **2 0 2 3** P r o x y S t a t e m e n t  | **69**  |

---

------

[**TABLE OF CONTENTS**](#TOC2)

PAY VERSUS PERFORMANCE

#### RELATIONSHIP BETWEEN COMPENSATION ACTUALLY PAID AND COMPANY FINANCIAL PERFORMANCE REPRESENTED BY THE MEASURES DETAILED IN THE ABOVE TABLE
The below graphical illustrations of compensation actually paid and the change in the performance measures selected demonstrates the alignment between the compensation actually paid to our CEO and other NEOs and company performance. The increase in the 2022 compensation for Mr. Olczak is partially driven by his 2022 equity awards that were based on increased targets in connection with his appointment as CEO for the portion of 2021 in which he served in this role. The last graph illustrates the relationship between compensation actually paid and the 3-year adjusted diluted EPS growth measure, which we believe is a more accurate representation of how the compensation actually paid relates to this measure, since this is the actual measure used in our long-term incentive program.

![[MISSING IMAGE: bc_tsr-pn.jpg]](bc_tsr-pn.jpg)

![[MISSING IMAGE: bc_growth1year-pn.jpg]](bc_growth1year-pn.jpg)

![[MISSING IMAGE: bc_netincome-pn.jpg]](bc_netincome-pn.jpg)

![[MISSING IMAGE: bc_growth3year-pn.jpg]](bc_growth3year-pn.jpg)

#### Tabular list of measures
As required by SEC rules, we have listed below the financial and non-financial performance measures that we consider to be the most important performance measures used to link compensation actually paid to our CEO and other NEOs for the most recently completed fiscal year to company performance. In selecting the below measures we considered the metrics used under our Incentive Compensation and Equity Awards Programs and prioritized those with highest weight and impact on compensation actually paid for 2022. Further information on the use of the below measures in our performance-based compensation programs can be found in Compensation Discussion and Analysis section on pages [45](#sCPAT)-[49](#tfolio49).

• Adjusted Diluted EPS (CAGR, ex-currency growth)

• Smoke-Free (HTU) Shipment Volume

• Adjusted Net Revenues, % Growth on organic basis

• Operating Cash Flow, % Growth ex-currency

• RRP & Other Non-Combustible Products Net Revenues / Total Adjusted Net Revenues

• TSR Performance (relative to peer group)

• Absolute TSR

---

| | |
|:---|:---|
| **70** | ***D e l i v e r i n g a S m o k e - F r e e F u t u r e***  |

---

------

[**TABLE OF CONTENTS**](#TOC2)

ADVISORY VOTE APPROVING EXECUTIVE COMPENSATION <br>

![[MISSING IMAGE: tm2136562d1-icon_topbarpn.jpg]](tm2136562d1-icon_topbarpn.jpg)

## ADVISORY VOTE APPROVING EXECUTIVE COMPENSATION
The Compensation Discussion and Analysis section discusses in detail how our compensation programs support our business and financial objectives, how they work and are administered under the direction of our independent Compensation and Leadership Development Committee, and how its decisions concerning the 2022 compensation of our executive officers were directly tied to our performance.

Pursuant to Section 14A of the Exchange Act, we are asking our shareholders to indicate their support for our named executive officer compensation as described in this proxy statement. This annual say-on-pay vote gives our shareholders the opportunity to express their views on the compensation of our named executive officers at each Annual Meeting of Shareholders. This vote is not intended to address any specific item of compensation, but rather the overall compensation of our named executive officers and the philosophy, policies and practices described in this proxy statement. Accordingly, we will ask our shareholders to vote "FOR" the following resolution at the Annual Meeting:

RESOLVED, that the Company's shareholders approve, on an advisory basis, the compensation of the named executive officers, as disclosed in the Company's Proxy Statement for the 2023 Annual Meeting of Shareholders pursuant to the compensation disclosure rules of the Securities and Exchange Commission, including the Compensation Discussion and Analysis, the Summary Compensation Table and the other related tables and disclosure.

This say-on-pay vote is advisory and, therefore, not binding on the Company, the Compensation and Leadership Development Committee or the Board of Directors. The Board and the Compensation and Leadership Development Committee value the opinions of our shareholders and will review the voting results when making future decisions regarding executive compensation.

---

| | |
|:---|:---|
| **PROPOSAL 2: ADVISORY VOTE APPROVING EXECUTIVE COMPENSATION <br> The Board recommends a vote FOR Proposal Two. <br>**  | **"FOR" <br> ![[MISSING IMAGE: tm2136562d1-icon_chkmarkpn.gif]](tm2136562d1-icon_chkmarkpn.gif)**  |

---

---

| | |
|:---|:---|
| P M I **2 0 2 3** P r o x y S t a t e m e n t  | **71**  |

---

------

[**TABLE OF CONTENTS**](#TOC2)

ADVISORY VOTE ON THE FREQUENCY OF FUTURE SAY-ON-PAY VOTES <br>

![[MISSING IMAGE: tm2136562d1-icon_topbarpn.jpg]](tm2136562d1-icon_topbarpn.jpg)

## ADVISORY VOTE ON THE FREQUENCY OF FUTURE SAY-ON-PAY VOTES
Pursuant to Section 14A of the Exchange Act, we are seeking your input with regard to the frequency of future shareholder advisory votes on our executive compensation programs. We are asking whether the advisory vote should occur every year, every two years or every three years.

After careful consideration, the Board has determined that an advisory vote on executive compensation that occurs every year continues to be the most appropriate alternative for our Company and, therefore, the Board recommends that you vote for a one-year interval for the say-on-pay advisory vote.

In formulating its recommendation, the Board considered that an annual advisory vote on executive compensation will allow our shareholders to provide us with their direct input on our compensation philosophy, policies and practices every year. Additionally, an annual advisory vote on executive compensation is consistent with our policy of seeking input from, and engaging in discussions with, our shareholders on corporate governance matters and our executive compensation philosophy, policies and practices.

You may cast your vote on your preferred voting frequency by choosing the option of every one year, two years or three years or you may abstain from voting on the resolution set forth below:

RESOLVED, that the option of once every one year, two years, or three years that receives the highest number of votes cast in response to this resolution will be determined, on an advisory basis, to be the preferred frequency with which the Company is to hold a shareholder vote to approve the compensation of the named executive officers.

We will regard the option that receives the highest number of votes cast by shareholders to be the frequency that has been selected by shareholders. Although this vote is advisory and not binding on the Board or PMI, the Board will carefully consider the outcome.

---

| | |
|:---|:---|
| **PROPOSAL 3: ADVISORY VOTE ON THE FREQUENCY OF SAY-ON-PAY VOTES <br> The Board recommends a vote of ONE YEAR on Proposal Three. <br>**  | **"ONE YEAR" <br> ![[MISSING IMAGE: tm2136562d1-icon_chkmarkpn.gif]](tm2136562d1-icon_chkmarkpn.gif)**  |

---

---

| | |
|:---|:---|
| **72** | ***D e l i v e r i n g a S m o k e - F r e e F u t u r e***  |

---

------

[**TABLE OF CONTENTS**](#TOC2)

AUDIT COMMITTEE MATTERS

![[MISSING IMAGE: tm2136562d1-icon_topbarpn.jpg]](tm2136562d1-icon_topbarpn.jpg)

## AUDIT COMMITTEE MATTERS

## Audit Committee Report for the Year Ended

#### December 31, 2022

#### To Our Shareholders:
Management has the primary responsibility for the financial statements and the reporting process, including the systems of internal accounting control. The Audit Committee monitors the Company's financial reporting processes and systems of internal accounting control, the independence and the performance of the independent auditors, and the performance of the internal auditors. The Audit Committee has the sole authority for appointing, compensating and overseeing the work of the independent auditors. The Audit Committee also, among other things, reviews and oversees the Company's policies and practices with respect to risk assessment and risk management, including major financial risk exposures. It receives regular updates from management on cybersecurity trends, risks, policies, and practices, including the results of risk advisories, reviews and other assurance activities as deployed by the Company's information security and risk control functions. It also receives regular updates from management regarding business continuity risks; excessive or discriminatory taxation; illicit trade; risks associated with device reliability; and the dilution of the rule of law.

The Audit Committee has received representations from management that the Company's consolidated financial statements were prepared in accordance with accounting principles generally accepted in the United States of America, and the Audit Committee has reviewed and discussed the consolidated financial statements with management and the independent auditors. The Audit Committee has discussed with the independent auditors, including in executive sessions without the presence of management, the independent auditors' evaluation of the accounting principles, practices and judgments applied by management, the adequacy of the Company's financial reporting processes, controls and procedures, and the Audit Committee has discussed any items required to be communicated to it by the independent auditors in accordance with regulations promulgated by the U.S. Securities and Exchange Commission, the Public Company Accounting Oversight Board and the Independence Standards Board.

The Audit Committee has received from the independent auditors written disclosures and a letter required by applicable requirements of the Public Company Accounting Oversight Board regarding the independent accountant's communications with the Audit Committee concerning their independence, and has discussed with the independent auditors the auditors' independence from the Company and its management. The Audit Committee has pre-approved all audit and permissible non-audit services provided by the independent auditors and the fees for those services. As part of this process, the Audit Committee has reviewed the audit fees of the independent auditors. It has also reviewed non-audit services and fees to assure compliance with regulations prohibiting the independent auditors from performing specified services that might impair their independence, as well as compliance with the Company's and the Audit Committee's policies.

The Audit Committee discussed with the Company's internal auditors and independent auditors the overall scope of and plans for their respective audits. The Audit Committee has met with the internal auditors and the independent auditors, separately and together, with and without management present, to discuss the Company's financial reporting processes and internal control over financial reporting and overall control environment. The Audit Committee has reviewed significant audit findings prepared by the independent auditors and those prepared by the internal auditors, together with management's responses.

In reliance on the reviews and discussions referred to above, the Audit Committee recommended to the Board the inclusion of the audited consolidated financial statements in the Company's Annual Report on Form 10-K for the year ended December 31, 2022.

#### Audit Committee:
Lucio A. Noto, Chair

Michel Combes

Werner Geissler

Lisa A. Hook

Jun Makihara

Dessi Temperley

---

| | |
|:---|:---|
| P M I **2 0 2 3** P r o x y S t a t e m e n t  | **73**  |

---

------

[**TABLE OF CONTENTS**](#TOC2)

AUDIT COMMITTEE MATTERS

*The information contained in the report above shall not be deemed to be "soliciting material" or to be "filed" with the Securities and Exchange Commission or subject to Regulation 14A or 14C or the liabilities of Section 18 of the Securities Exchange Act of 1934, as amended, nor shall such information be incorporated by reference into any future filing under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended, except to the extent specifically incorporated by reference therein.* 

#### Independent Auditors' Fees
Aggregate fees, including out-of-pocket expenses, paid to our independent auditors, PricewaterhouseCoopers SA, consisted of the following (in millions):

---

| | | |
|:---|:---|:---|
| | **2021**  | **2022**  |
| Audit Fees<sup>(1)</sup> | $20.60  | $22.01  |
| Audit-Related Fees<sup>(2)</sup> | 1.44  | 1.42  |
| Tax Fees<sup>(3)</sup> | 2.49  | 2.71  |
| All Other Fees<sup>(4)</sup> | 1.28  | 0.84  |
| **TOTAL** | **$25.81**  | **$26.98**  |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (1)

Fees and expenses associated with professional services in connection with (i) the audit of the Company's consolidated financial statements and internal control over financial reporting, including statutory audits of the financial statements of the Company's affiliates; (ii) reviews of the Company's unaudited condensed consolidated interim financial statements; (iii) reviews of documents filed with the Securities and Exchange Commission; and (iv) audit procedures in connection with transactions, financings and system implementations.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (2)

Fees and expenses for professional services for audit-related services, which include due diligence related to acquisitions and divestitures, employee benefit plan audits, and procedures relating to various other audit and special reports.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (3)

Fees and expenses for professional services in connection with U.S. and foreign tax compliance assistance, consultation and advice on various foreign tax matters, transfer pricing documentation for compliance purposes and advice relating to customs and duties compliance matters.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (4)

Fees and expenses for professional services relating to certain human resources matters, market analysis and other professional services including in connection with sustainability reporting and equal salary certification.

#### Pre-Approval Policy
The Audit Committee's policy is to pre-approve all audit and permissible non-audit services provided by the independent auditors. These services may include audit services, audit-related services, tax services and other services. Pre-approval is detailed as to the particular service or category of service and is subject to a specific budget. The Audit Committee requires the independent auditors to report on the actual fees charged for each category of service at Audit Committee meetings throughout the year.

During the year, circumstances may arise when it may become necessary to engage the independent auditors for additional services not contemplated in the original pre-approval. In those instances, the Audit Committee requires specific pre-approval before engaging the independent auditors.

In 2021, the Audit Committee adopted and approved a revised pre-approval policy, titled the Philip Morris International Inc. Policy for Pre-Approval of Audit and Non-Audit Services Provided by Independent Audit Firm (the "Revised Policy"). Under the Revised Policy, any fees and services that arise that were not included in the annual budget presented to the Audit Committee at the beginning of the fiscal year will receive pre-approval by the Audit Committee chair if they meet the following criteria:

• Individual services up to $250,000; and

• Adjustments to any estimated pre-approval fee for any individual service up to $100,000.

The Audit Chair must report on such approvals at the next scheduled meeting of the Audit Committee. Any services that are greater than $250,000 or for which no specific approval was provided when the independent auditors' annual budget was approved by the Audit Committee will require pre-approval by the full Audit Committee.

---

| | |
|:---|:---|
| **74** | ***D e l i v e r i n g a S m o k e - F r e e F u t u r e***  |

---

------

[**TABLE OF CONTENTS**](#TOC2)

RATIFICATION OF THE SELECTION OF INDEPENDENT AUDITORS

![[MISSING IMAGE: tm2136562d1-icon_topbarpn.jpg]](tm2136562d1-icon_topbarpn.jpg)

## RATIFICATION OF THE SELECTION OF INDEPENDENT AUDITORS
The Audit Committee has selected PricewaterhouseCoopers SA ("PwC") as the Company's independent auditors for the fiscal year ending December 31, 2023, and has directed that management submit the selection of independent auditors to shareholders for ratification at the Annual Meeting. Representatives of PwC are expected to attend the Virtual Annual Meeting of Shareholders, will have an opportunity to make a statement if they so desire and will be available to respond to appropriate questions.

In determining to reappoint PwC, the Audit Committee considered a number of factors, including the following:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; • PwC has served as the Company's independent auditors since we became an independent company in 2008;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; • The results of the Audit Committee's evaluation of PwC's qualifications, performance, independence and quality control procedures;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; • The Audit Committee's belief that PwC's deep knowledge of the Company and the Company's information technology and systems platforms better equips it to focus the audit work where it is most needed, enhances the quality of risk-based reviews, and enables it to design and implement a superior audit plan and to effectively test for control weaknesses;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; • The Audit Committee's belief that PwC has the capability and expertise and professionals in the many countries that are necessary to conduct a quality audit of our worldwide business;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; • External data relating to audit quality and performance, including the Public Company Accounting Oversight Board's reports on PwC and its peer firms; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; • The appropriateness of PwC's fees.

Shareholder ratification of the selection of PwC as the Company's independent auditors is not required by the Company's by-laws or otherwise. However, we are submitting the selection of PwC to the shareholders for ratification as a matter of good corporate practice. If the shareholders fail to ratify the selection, the Audit Committee will reconsider whether or not to retain PwC. Even if the selection is ratified, the Audit Committee in its discretion may direct the appointment of a different independent audit firm at any time during the year if it is determined that such a change would be in the best interests of the Company and its shareholders.

---

| | |
|:---|:---|
| **PROPOSAL 4: RATIFICATION OF APPOINTMENT OF PRICEWATERHOUSECOOPERS SA AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM <br> The Board recommends a vote FOR Proposal Four. <br>**  | **"FOR" <br> ![[MISSING IMAGE: tm2136562d1-icon_chkmarkpn.gif]](tm2136562d1-icon_chkmarkpn.gif)**  |

---

---

| | |
|:---|:---|
| P M I **2 0 2 3** P r o x y S t a t e m e n t  | **75**  |

---

------

[**TABLE OF CONTENTS**](#TOC2)

SHAREHOLDER PROPOSAL

![[MISSING IMAGE: tm2136562d1-icon_topbarpn.jpg]](tm2136562d1-icon_topbarpn.jpg)

## SHAREHOLDER PROPOSAL
Trinity Health, together with co-filers Providence St. Joseph Health and Sisters of Charity of Saint Elizabeth, each claiming beneficial ownership of at least $2,000 worth of shares, submitted the proposal set forth below. The address and shareholdings of the proponents will be furnished upon request made to the Corporate Secretary. The Company is not responsible for the content of the shareholder proposal, which is printed below exactly as it was submitted.

RESOLVED: Shareholders request the Board take steps to preserve the health of its customers by making available to them information on the nicotine levels for each of our brands, including heated tobacco products, how those levels are determined, and begin reducing nicotine levels in our brands to a less addictive level.

WHEREAS: According to the World Health Organization, an estimated 1.3 billion people worldwide use tobacco products, 80% of whom are in low- and middle-income countries;

Philip Morris International ("PMI") states on its website: "Nicotine is a naturally occurring chemical in the tobacco plant, and is one of the reasons why people smoke cigarettes. Nicotine is addictive and is not risk free;"<sup>1</sup>

According to the United States Food and Drug Administration ("FDA"): "All tobacco products contain nicotine including cigarettes, non-combusted cigarettes, cigars, smokeless tobacco, hookah tobacco and most e-cigarettes. Using any tobacco product can lead to nicotine addiction. This is because nicotine can change the way the brain works, causing cravings for more of it. Some tobacco products are designed to deliver nicotine to the brain within seconds, making it easier to become dependent on nicotine and more difficult to quit. Nicotine is what keeps people using tobacco products. However, it's the thousands of chemicals contained in tobacco and tobacco smoke that make tobacco use so deadly. Some of these chemicals, known to cause lung damage, are also found in some e-cigarette aerosols;"<sup>2</sup>

PMl's "Marlboro's volume outside the United States and China was 233 billion cigarettes, reinforcing its leadership position as the number-one cigarette brand worldwide."<sup>3</sup> The company announced that its non-combusted, heated tobacco product *IQOS* volume growth increased 22% year over year in Q3 2022 and that it is paying the Altria Group $2.7 billion (pre-tax) in exchange for the ability to market *IQOS* in the U.S., effective April 30, 2024;<sup>4</sup>

The European Commission wants to ban sales of all flavored heated tobacco products<sup>5</sup> and the FDA has proposed a rule "that would establish a maximum nicotine level in cigarettes and certain finished tobacco products;"<sup>6</sup>

A report by the Bureau of Investigative Journalism<sup>7</sup> found that PMI "is drastically misleading consumers about the amount of nicotine in its range of *IQOS* heated tobacco products … in some promotional material, and to Bureau staff posing as consumers, PMI has claimed there is 0.5mg of nicotine in each tobacco stick, but new research conducted by the Bureau has revealed the actual figure is more than eight times higher;"

PMI disputed the Bureau's claim, saying that the Bureau conflated the measure of nicotine emission (what a person breathes in) and nicotine content. The Bureau recognized that without any clear universal regulation as to which figure should be used and how it should be described, consumers will continue to be misled;

In its Q3 2022 presentation to investors, PMI said 'there was no notable difference in the nicotine absorption between cigarettes and *IQOS*."<sup>8</sup>

<sup>1</sup>

https://www.pmi.com/glossary-section/glossary/nicotine

<sup>2</sup>

https://www.pmi.com/glossary-section/glossary/nicotine

<sup>3</sup>

https://www.pmi.com/investor-relations/overview/building-leading-brands

<sup>4</sup>

https://philipmorrisintemational.gcs-web.com/static-files/88d67ac2-85a8-4509-bbec-e061490b43ac

<sup>5</sup>

https://www.politico.eu/article/european-commission-want-ban-heated-tobacco-product/

<sup>6</sup>

https://www.reginfo.gov/public/do/eAgendaViewRule?publd=202204&RIN=09l 0-A176

<sup>7</sup>

https://www.thebureau investigates.com/stories/2022-08-28/philip-morris-misleading-public-about-nicotine-in-heated-tobacco

<sup>8</sup>

https://philipmorrisintemational.gcs-web.com/static-files/88d67ac2-85a8-4509-bbec-e061490b43ac

---

| | |
|:---|:---|
| **76** | ***D e l i v e r i n g a S m o k e - F r e e F u t u r e***  |

---

------

[**TABLE OF CONTENTS**](#TOC2)

SHAREHOLDER PROPOSAL

#### FOR THE REASONS EXPLAINED BELOW, THE BOARD UNANIMOUSLY RECOMMENDS A VOTE "AGAINST" THIS PROPOSAL.
Cigarette smoking is the most harmful form of nicotine consumption which is why we have set a course to replace cigarettes with scientifically substantiated, smoke-free alternatives. People who do not smoke should not start. Those who do smoke should quit tobacco and nicotine altogether. And those adults who would otherwise continue to smoke, should switch to better, smoke-free alternatives to cigarettes, which are now available.

Consumers are at the center of our efforts to deliver a smoke-free future by converting all adults who would otherwise continue to smoke to better, less harmful alternatives to cigarettes. Nicotine has an essential part to play in order for these alternatives to be an acceptable substitute for adult smokers. While nicotine is addictive and not risk-free, it is not the primary cause of smoking-related diseases such as lung cancer and heart disease. There is indeed a consensus that these diseases are primarily associated with chronic exposure to the high level of toxic substances emitted in the smoke when tobacco is burned. In fact, nicotine is a key ingredient in nicotine replacement therapies designed to help smokers quit smoking.

When speaking of nicotine levels, it is important to distinguish (i) the nicotine content, i.e., the nicotine that is naturally present in the tobacco of a cigarette or tobacco stick, from (ii) the actual nicotine "yield" or level that comes out of it in the smoke / aerosol during use, and (iii) what is eventually absorbed by the body. As is true with all tobacco and nicotine products, not all nicotine that is present in tobacco will be delivered to or absorbed by the body. Therefore, what we generally measure is what comes out in the aerosol during normal use, as this is the most relevant information for consumers.

To be acceptable, smoke-free alternatives should provide nicotine in levels and in a way that are comparable to those adult smokers find in cigarette smoke. If they don't, smokers are less likely to fully switch and more likely to continue smoking instead of leaving cigarettes behind. This is one of the reasons why *IQOS* represents an acceptable alternative that millions of adult smokers across the world have completely switched to, which our data shows as well.

There are two widely recognized machine testing methods for conducting this measurement: (i) the ISO testing regime; and (ii) a more intense puffing regime developed by Health Canada. We routinely measure nicotine levels using both.

Alone, machine generated measurements, including those related to nicotine, are not necessarily representative of the amounts generated and absorbed into the body during actual use as variances will occur due to human puffing behavior. This is why our comprehensive scientific approach also includes further toxicological and clinical assessments, perception and behavioral studies and long-term assessments. The level of nicotine absorbed in the body can only be measured in a clinical setting. We have conducted several clinical studies with *IQOS*, our flagship smoke-free, tobacco heating system, and found that after an adaptation period, adults who completely switch to *IQOS* have a level of nicotine absorption that is similar to the level measured when smoking cigarettes. These findings have also been subjected to independent scientific reviews. For example, in July 2020, the US FDA granted exposure modification orders for the *IQOS* tobacco heating system after an independent scientific review and found that "the issuance of exposure modifications orders is appropriate to promote the public health and expected to benefit the health of the population as a whole…". The US FDA also found that nicotine exposure in *IQOS* aerosol was similar to combusted cigarettes and went on to say that this nicotine exposure level appeared to be sufficient to provide user satisfaction which "supports the potential for *IQOS* to be a viable replacement product for current smokers who stand to gain the benefits of reduced exposure by completely switching."<sup>1</sup>

Regarding the shareholder proposal's requirement to make information available on the nicotine levels for our brands, numerous public health agencies and government entities have prohibited the publication of nicotine (and other emissions) information on product packaging. For example, both the World Health Organization and the European Union have stated that printed emissions information could be misleading if used by consumers to compare exposure and risk between tobacco brands. In a reversal of its previous packaging requirements, the European Union banned communication of this information on product packaging beginning in 2014. PMI complies with all applicable laws, including those relating to product standards, packaging and consumer labelling. But, for the reasons outlined above, we do not print nicotine information on packs unless we are required to do so by law. Otherwise, and where permitted by local regulations, the information outlined above is available to consumers upon request.

We also note the reference in the proposal to the article published by The Bureau of Investigative Journalism (the "BIJ") on August 28, 2022 (the "Article"). For the record, the Article contains a series of false, inaccurate, and misleading statements about the science and the facts of their investigation. We also note that the Article was directly sponsored by anti-tobacco organizations and as such the Article should be viewed in the context of a heavily conflicted piece, rather than genuine independent journalism. Prior to publication of the Article, we provided a detailed scientific briefing to the authors which explained the position on nicotine information we have outlined above. We have sought through correspondence to

<sup>1</sup>

FDA MR0000133 dated 7/7/2020: Scientific Review of Modified Risk Tobacco Product Application (MRTPA) Under Section 911(d) of the FD&C Act -Technical Project Lead (Pages 54-55) (https://www.fda.gov/media/139796/download)

---

| | |
|:---|:---|
| P M I **2 0 2 3** P r o x y S t a t e m e n t  | **77**  |

---

------

[**TABLE OF CONTENTS**](#TOC2)

SHAREHOLDER PROPOSAL

request the BIJ to correct the false and misleading statements and headline of the Article and explain to us (amongst other things) why they have chosen to ignore the facts and mislead the public. To date, they have refused to do so.

In particular, we are extremely concerned that by conflating nicotine content and nicotine yield, the Article misleads and confuses adult nicotine users and members of the public on an important matter of public health. Moreover, the very serious allegation made against PMI—that it understates the amount of nicotine in *IQOS* products by a factor of 8, which is cited in the proposal—is entirely wrong and baseless. In particular, the Article misleadingly compared the ISO nicotine yield (in the aerosol) of *IQOS* of 0.5mg<sup>2</sup> (which was the level PMI consistently provided verbally to the BIJ's researchers who requested it from our call center agents) to the nicotine content in the tobacco (which is in the range of 4.3-6mg) when falsely stating that PMI is understating the nicotine by a factor of 8.

Finally, the proposal includes a request to start reducing nicotine levels. As we explained above, to deliver a smoke-free future we need to provide alternatives to cigarettes that adults who do not quit smoking, find acceptable and switch to completely. This will ultimately enable us to cease selling cigarettes and combustible tobacco products. Our nicotine-containing smoke-free products are intended for current adult smokers and nicotine users, and we cannot selectively and unilaterally reduce nicotine levels without taking the risk that these adults would not find them acceptable and thus they may choose to simply renounce better alternatives and continue or return to smoking cigarettes. Similarly, we cannot selectively and unilaterally reduce the nicotine in our cigarettes without taking the risk that current adult smokers of our cigarettes would switch to competitor brands. We believe that nicotine levels should be looked at wholistically by policy makers at a country level and across the entire portfolio of existing combustible and non-combustible products currently available in the marketplace. We note that several authorities, including the US FDA and New Zealand, have initiated efforts to reduce the nicotine content in combustible tobacco products to minimally addictive levels but it remains to be seen what the long-term impact on smoking prevalence will be as result. We will continue to monitor these regulatory developments and comply with applicable laws.

For the reasons discussed above, we believe that this proposal is neither necessary nor in the best interest of shareholders.

#### Therefore, the Board recommends a vote AGAINST the proposal.

---

| | |
|:---|:---|
| **PROPOSAL 5: Shareholder Proposal <br> The Board recommends a vote AGAINST Proposal Five.**  | **"Against" <br> ![[MISSING IMAGE: tm2136562d3-icon_againstbw.gif]](tm2136562d3-icon_againstbw.gif)**  |

---

<sup>2</sup>

This measurement is typically used when information is requested by consumers because the ISO testing regime has been more traditionally used by regulatory authorities (such as the European Union) to measure cigarette emissions and enables a direct, and more familiar, comparison between *IQOS* aerosol and cigarette smoke emissions.

---

| | |
|:---|:---|
| **78** | ***D e l i v e r i n g a S m o k e - F r e e F u t u r e***  |

---

------

[**TABLE OF CONTENTS**](#TOC2)

RELATED PERSON TRANSACTIONS AND CODE OF CONDUCT

![[MISSING IMAGE: tm2136562d1-icon_topbarpn.jpg]](tm2136562d1-icon_topbarpn.jpg)

## RELATED PERSON TRANSACTIONS AND CODE OF CONDUCT
The Board has adopted a policy, which is available on the Company's website, at *www.pmi.com/corporate-governance/overview*, that requires our executive officers, directors and nominees for director to promptly notify the Vice President, Associate General Counsel and Corporate Secretary in writing of any transaction in which: (i) the amount exceeds $120,000; (ii) the Company is, was or is proposed to be a participant; and (iii) such person or such person's immediate family members ("Related Persons") has, had or may have a direct or indirect material interest (a "Related Person Transaction"). The Vice President, Associate General Counsel and Corporate Secretary, in consultation with outside counsel, to the extent appropriate, shall determine whether a potential transaction with a Related Person constitutes a Related Person Transaction requiring review under the policy (including whether the Company or the Related Person has a material interest, based on a review of all facts and circumstances). If the Vice President, Associate General Counsel and Corporate Secretary determines that the proposed transaction constitutes a Related Person Transaction or it would be beneficial to further review the transaction, then, in either case, the transaction will be referred to the CEO or the Nominating and Corporate Governance Committee of the Board. In practice, we expect the Nominating and Corporate Governance Committee to conduct a reasonable prior review and oversight of all Related Person Transactions for potential conflicts of interest. The Nominating and Corporate Governance Committee may ratify Related Person Transactions in limited situations. In deciding whether to approve, ratify or prohibit the Related Person Transaction, the Nominating and Corporate Governance Committee is required to consider all relevant facts and circumstances. The Nominating and Corporate Governance Committee will approve or ratify a Related Person Transaction only if it determines that the transaction is not opposed to the best interests of the Company, and the Nominating and Corporate Governance Committee must prohibit the transaction if it determines the transaction is inconsistent with the Company and its shareholders. All determinations by the CEO and the Vice President, Associate General Counsel and Corporate Secretary must be reported to the Nominating and Corporate Governance Committee at its next meeting.

Cristina Oka Dobrowolski, the wife of PMI's Vice President & Controller, Reginaldo Dobrowolski, is a longstanding employee of PMI, and her total compensation for the fiscal year ended December 31, 2022 was approximately $615,000. This Related Person Transaction has been ratified by the CEO and the Nominating and Corporate Governance Committee.

The Board has also adopted the Code of Business Conduct and Ethics for Directors (the "Director Code"), which is available on our website at *www.pmi.com/corporate-governance/overview*, has specific provisions addressing actual and potential conflicts of interest. The Director Code specifies: "Our directors have an obligation to act in the best interest of the Company. All directors should endeavor to avoid situations that present a potential or actual conflict between their interest and the interest of the Company." The Director Code defines conflict of interest to include any instance in which (i) a person's private interest interferes in any way, or even appears to interfere, with the interest of the Company, including its subsidiaries and affiliates; (ii) a director or a director's family member takes an action or has an interest that may make it difficult for that director to perform his or her work objectively and effectively; and (iii) a director (or his or her family member) receives improper personal benefits as a result of the director's position in the Company.

Similarly, our policies require all officers and employees of the Company to avoid situations where the officer's or employee's personal, financial or political activities have the potential of interfering with his or her loyalty and objectivity to the Company.

---

| | |
|:---|:---|
| P M I **2 0 2 3** P r o x y S t a t e m e n t  | **79**  |

---

------

[**TABLE OF CONTENTS**](#TOC2)

AVAILABILITY OF REPORTS, OTHER MATTERS AND 2023 ANNUAL ME ETING

![[MISSING IMAGE: tm2136562d1-icon_topbarpn.jpg]](tm2136562d1-icon_topbarpn.jpg)

## AVAILABILITY OF REPORTS, OTHER MATTERS AND 2024 ANNUAL MEETING

#### AVAILABILITY OF FORM 10-K AND ANNUAL REPORT TO SHAREHOLDERS
We are required to provide an Annual Report to shareholders who receive this proxy statement. We will also provide copies of the Annual Report to brokers, dealers, banks, voting trustees and their nominees for the benefit of their beneficial owners of record. Additional copies of the Annual Report, along with copies of our Annual Report on Form 10-K for the fiscal year ended December 31, 2022, are available without charge to shareholders upon written request to the Company's Corporate Secretary at Avenue de Rhodanie 50, 1007 Lausanne, Switzerland. You may review the Company's filings with the U.S. Securities and Exchange Commission ("SEC") by visiting our website at *www.pmi.com/investor-relations/overview*. The information on our websites, including our Integrated Report as referenced in this proxy statement, is not, and shall not be deemed to be, a part of this report or incorporated into any other filings we make with the SEC.

#### OTHER MATTERS
Management knows of no other business that will be presented to the meeting for a vote. If other matters properly come before the meeting, the persons named as proxies will vote on them in accordance with their best judgment.

The cost of this solicitation of proxies will be paid by us. In addition to the use of the mail, some of the officers and regular employees of the Company may solicit proxies by telephone and will request brokerage houses, banks and other custodians, nominees and fiduciaries to forward soliciting material to the beneficial owners of common stock held of record by such persons. We will reimburse such persons for expenses incurred in forwarding such soliciting material. It is contemplated that additional solicitation of proxies will be made in the same manner under the engagement and direction of D.F. King & Co., Inc., 48 Wall Street, New York, NY 10005, at an anticipated cost of $24,000, plus reimbursement of out-of-pocket expenses.

#### 2024 ANNUAL MEETING
Shareholders wishing to suggest candidates to the Nominating and Corporate Governance Committee for consideration as directors must submit a written notice to the Vice President, Associate General Counsel and Corporate Secretary of the Company. Our by-laws set forth the procedures a shareholder must follow to nominate directors or to bring other business before shareholder meetings. For a shareholder to nominate a candidate for director at the 2024 Annual Meeting of Shareholders, presently anticipated to be held on May 8, 2024, notice of the nomination must be received by the Company between October 25 and November 24, 2023. The notice must describe various matters regarding the nominee, including name, address, occupation and shares held. The Nominating and Corporate Governance Committee will consider any nominee properly presented by a shareholder and will make a recommendation to the Board. After full consideration by the Board, the shareholder presenting the nomination will be notified of the Board's conclusion. For a shareholder to bring other matters before the 2024 Annual Meeting and to include a matter in the Company's proxy statement and proxy for that meeting, notice must be received by the Company between October 25 and November 24, 2023. The notice must include a description of the proposed business, the reasons therefor and other specified matters. In each case, the notice must be timely given to the Vice President, Associate General Counsel and Corporate Secretary of the Company, whose address is Avenue de Rhodanie 50, 1007 Lausanne, Switzerland. Any shareholder desiring a copy of the Company's by-laws (which are posted on our website at *www.pmi.com/corporate-governance/overview*) will be furnished one without charge upon written request to the Vice President, Associate General Counsel and Corporate Secretary.

In addition, to comply with Rule 14a-19 under the Exchange Act, the SEC's universal proxy rule, if a stockholder intends to solicit proxies in support of director nominees submitted under the advance notice provisions of our By-laws for next year's 2024 Annual Meeting of Shareholders, then such stockholder must provide proper written notice that sets forth all the information required by Rule 14a-19 under the Exchange Act to the Corporate Secretary at the address above by March 4, 2024 (or, if the 2024 Annual Meeting of Shareholders is called for a date that is more than 30 days before or more than 30 days after the first anniversary of this year's Annual Meeting of Shareholders, then notice must be provided not

---

| | |
|:---|:---|
| **80** | ***D e l i v e r i n g a S m o k e - F r e e F u t u r e***  |

---

------

[**TABLE OF CONTENTS**](#TOC2)

AVAILABILITY OF REPORTS, OTHER MATTERS AND 2023 ANNUAL ME ETING

later than the close of business on the later of the 60th day prior to the date of the 2024 Annual Meeting of Shareholders or the 10th day following the day on which public announcement of the date of such meeting is first made by PMI). The notice requirements under Rule 14a-19 are in addition to the applicable advance notice requirements under our By-laws as described above.

Darlene Quashie Henry

Vice President,

Associate General Counsel and Corporate Secretary

March 23, 2023

---

| | |
|:---|:---|
| P M I **2 0 2 3** P r o x y S t a t e m e n t  | **81**  |

---

------

[**TABLE OF CONTENTS**](#TOC2)

EXHIBIT A: QUESTIONS & ANSWERS

![[MISSING IMAGE: tm2136562d1-icon_topbarpn.jpg]](tm2136562d1-icon_topbarpn.jpg)

## EXHIBIT A: QUESTIONS & ANSWERS
1. #### WHAT IS A PROXY?
It is your legal designation of another person to vote the stock you own. That other person is called a proxy. If you designate someone as your proxy in a written document, that document also is called a proxy or a proxy card. André Calantzopoulos and Darlene Quashie Henry have each been designated as proxies for the 2023 Annual Meeting of Shareholders.

2. #### WHAT IS THE RECORD DATE AND WHAT DOES IT MEAN?
The Record Date for the 2023 Annual Meeting of Shareholders is March 10, 2023. The Record Date is established by the Board of Directors as required by Virginia law. Shareholders of record (registered shareholders and street name holders) at the close of business on the Record Date are entitled to:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; a)

receive notice of the meeting; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; b)

vote at the meeting and any adjournments or postponements of the meeting.

3. #### WHAT IS THE DIFFERENCE BETWEEN A REGISTERED SHAREHOLDER AND A SHAREHOLDER WHO HOLDS STOCK IN STREET NAME?
If your shares of stock are registered in your name on the books and records of our transfer agent, Computershare Trust Company, N.A., you are a registered shareholder.

If your shares of stock are held for you in the name of a broker or bank, then your shares are held in street name. The organization holding your shares of stock is considered the shareholder of record for purposes of voting at the Annual Meeting. The answer to Question 19 describes brokers' discretionary voting authority, and when your broker or bank is permitted to vote your shares of stock without instruction from you.

4. #### HOW CAN I PARTICIPATE IN THE VIRTUAL ANNUAL MEETING OF SHAREHOLDERS?
The Virtual Annual Meeting of Shareholders will be held online via a live webcast at 9:00 a.m. EDT, on Wednesday, May 3, 2023. **There will be no physical location for shareholders to attend.** Instead, shareholders may participate online at *www.virtualshareholdermeeting.com/PM2023*. We encourage you to access the Virtual Annual Meeting of Shareholders prior to the start time. Online access will be available starting at 8:30 a.m. EDT, on May 3, 2023.

 **To participate in the Virtual Annual Meeting of Shareholders, including to vote your shares electronically and ask questions live during the Meeting, you will need to enter the 16-digit control number included on your proxy card, notice of Internet availability of proxy materials, or on the voting instruction form accompanying your proxy materials. If you wish to ask questions during the Q&A session, you must follow instructions set forth in response to Question 5.** 

The virtual meeting platform is fully supported across browsers (Microsoft Edge, Firefox, Chrome and Safari) and devices (desktops, laptops, tablets and cell phones), if running the most updated version of applicable software and plugins. Participants should ensure that they have a strong Internet connection wherever they intend to participate in the Virtual Annual Meeting of Shareholders.

We will have technicians ready to assist you with any technical difficulties you may have accessing and participating in the virtual meeting. If you encounter any difficulties during the check-in or throughout the course of the meeting, please call 1-844-976-0738 toll-free (from within the United States or Canada), or 1-303-562-9301 (from outside the United States or Canada). Technical support will be available starting at 8:30 a.m. EDT, on May 3, 2023.

For further information about the Virtual Annual Meeting of Shareholders, please call toll-free 1-866-713-8075.

5. #### MAY SHAREHOLDERS ASK QUESTIONS AT THE MEETING?
Yes. In fact, we encourage questions from our shareholders. For full transparency, during the Q&A session, which will be publicly webcast, our shareholders will be able to ask questions live, on a first-come, first-served basis.

---

| | |
|:---|:---|
| **82** | ***D e l i v e r i n g a S m o k e - F r e e F u t u r e***  |

---

------

[**TABLE OF CONTENTS**](#TOC2)

EXHIBIT A: QUESTIONS & ANSWERS

The Q&A session will follow the conclusion of the formal meeting.

Shareholders of record who have accessed the Virtual Annual Meeting of Shareholders as described in the instructions set forth in response to Question 4, may ask questions live during the Q&A session of the meeting by calling the number posted on the Virtual Annual Meeting of Shareholders webpage under the section "Questions." In order to ask a question, you will be required to provide your 16-digit control number to the operator. Because this is a meeting of shareholders, only shareholders of record as of the Record Date with a valid control number will be allowed to ask questions at our Virtual Annual Meeting of Shareholders.

In order to provide an opportunity for everyone who wishes to speak, shareholders will be limited to two minutes. Shareholders may speak a second time only after all others who wish to speak have had their turn. When speaking, shareholders must direct questions and comments to the Executive Chairman and confine their remarks to matters that relate directly to the business of the meeting.

We reserve the right to reject redundant questions or questions that we deem profane or otherwise inappropriate. The meeting is not to be used as a forum to discuss personal grievances, business disputes or to present general political, social or economic views that are not directly related to the business of the meeting.

A full webcast replay will be posted to our Investor Relations website at *www.pmi.com/investor-relations/overview* following the meeting.

6. #### WHAT ARE THE BENEFITS OF THE VIRTUAL ANNUAL MEETING OF SHAREHOLDERS?
Meaningful shareholder engagement is important to us, and we believe that this format helps facilitate participation of our shareholders worldwide, regardless of their resources, size or physical location, while saving us and our shareholders time and travel expenses, and, importantly, reducing our environmental impact.

Shareholders will have the same rights and opportunities to participate in our Virtual Annual Meeting of Shareholders as they would at an in-person meeting. For full transparency, during the Q&A session, which will be publicly webcast, shareholders with a valid control number will be able to ask questions live, on a first-come, first-served basis. In addition, a full webcast replay will be posted to our Investor Relations website at *www.pmi.com/investor-relations/overview* following the meeting.

If you plan to participate in our 2023 Virtual Annual Meeting of Shareholders, you must follow the instructions set forth in response to Question 4.

If you wish to ask questions during the Q&A session, you must follow the instructions set forth in response to Question 5.

7. #### WHAT ARE THE DIFFERENT METHODS THAT I CAN USE TO VOTE MY SHARES OF COMMON STOCK?
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; a)

In Writing: All shareholders of record can vote by mailing their completed and signed proxy card (in the case of registered shareholders) or their completed and signed voting instruction form (in the case of street name holders).

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; b)

By Telephone and Internet Proxy: All shareholders of record also can vote their shares of common stock by touch-tone telephone using the telephone number on the proxy card, or by Internet, using the procedures and instructions described on the proxy card and other enclosures. Street name holders of record may vote by telephone or Internet if their brokers or banks make those methods available. If that is the case, each broker or bank will enclose instructions with the proxy statement. The telephone and Internet voting procedures, including the use of control numbers, are designed to authenticate shareholders' identities, to allow shareholders to vote their shares, and to confirm that their instructions have been properly recorded. Proxies submitted by Internet or telephone must be received by 11:59 p.m. EDT, on May 2, 2023.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; c)

In Person at the Virtual Annual Meeting of Shareholders: All shareholders of record may vote at the virtual meeting online at *www.virtualshareholdermeeting.com/PM2023*. If you wish to vote at our Virtual Annual Meeting of Shareholders, you must follow the instructions set forth in response to Question 4. You may vote until the Executive Chairman declares the polls closed. Shareholders participating in the Virtual Annual Meeting of Shareholders are considered to be attending the meeting "in person."

---

| | |
|:---|:---|
| P M I **2 0 2 3** P r o x y S t a t e m e n t  | **83**  |

---

------

[**TABLE OF CONTENTS**](#TOC2)

EXHIBIT A: QUESTIONS & ANSWERS

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

8. #### HOW CAN I REVOKE A PROXY?
You can revoke a proxy prior to the completion of voting at the meeting by:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; a)

giving written notice to the Vice President, Associate General Counsel and Corporate Secretary of the Company;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; b)

delivering a later-dated proxy; or

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; c)

voting at the virtual meeting.

9. #### ARE VOTES CONFIDENTIAL? WHO COUNTS THE VOTES?
We have established and will maintain a practice of holding the votes of individual shareholders in confidence except: (a)as necessary to meet applicable legal requirements and to assert or defend claims for or against the Company; (b) in case of a contested proxy solicitation; (c) if a shareholder makes a written comment on the proxy card or otherwise communicates their vote to management; or (d) to allow the independent inspectors of election to certify the results of the vote. We will retain an independent tabulator to receive and tabulate the proxies and independent inspectors of election to certify the results.

10. #### WHAT ARE THE CHOICES WHEN VOTING ON DIRECTOR NOMINEES, AND WHAT VOTE IS NEEDED TO ELECT DIRECTORS?
Shareholders may:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; a)

vote in favor of a nominee;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; b)

vote against a nominee; or

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; c)

abstain from voting on a nominee.

Directors will be elected by a majority of the votes cast, which will occur if the number of votes cast "FOR" a director nominee exceeds the number of votes "AGAINST" that nominee. See "Election of Directors—Majority Vote Standard in Uncontested Elections" on page [20](#tMVSI).

#### The Board recommends a vote "FOR" all twelve of the nominees.
11. #### WHAT ARE THE CHOICES WHEN VOTING ON THE ADVISORY SAY-ON-PAY RESOLUTION APPROVING THE COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS?
Shareholders may:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; a)

vote in favor of the resolution;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; b)

vote against the resolution; or

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; c)

abstain from voting on the resolution.

The resolution will be approved if the votes cast "FOR" exceed the votes cast "AGAINST."

#### The Board recommends a vote "FOR" this resolution.
The advisory vote on this matter is non-binding. However, the Board and the Compensation and Leadership Development Committee value the opinions of our shareholders and will consider the outcome of the vote when making future executive compensation decisions.

---

| | |
|:---|:---|
| **84** | ***D e l i v e r i n g a S m o k e - F r e e F u t u r e***  |

---

------

[**TABLE OF CONTENTS**](#TOC2)

EXHIBIT A: QUESTIONS & ANSWERS

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

12. #### WHAT ARE THE CHOICES WHEN VOTING ON THE ADVISORY RESOLUTION REGARDING THE FREQUENCY OF SAY-ON-PAY VOTES?
Shareholders may:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; a)

vote to have future say-on-pay votes every

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; • one year,

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; • two years, or

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; • three years; or

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; b)

abstain from voting on the resolution.

The option that receives the highest number of votes cast will be regarded as the one selected by the shareholders.

#### The Board recommends a vote of "ONE YEAR" on this proposal.
The resolution is non-binding. However, the Board of Directors will consider the outcome of the vote when determining the frequency of future advisory say-on-pay votes.

13. **WHAT ARE THE CHOICES WHEN VOTING ON THE RATIFICATION OF THE SELECTION OF PRICEWATERHOUSECOOPERS SA AS THE COMPANY'S INDEPENDENT AUDITORS, AND WHAT VOTE IS NEEDED TO RATIFY THEIR SELECTION?** 

Shareholders may:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; a)

vote in favor of the ratification;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; b)

vote against the ratification; or

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; c)

abstain from voting on the ratification.

The selection of the independent auditors will be ratified if the votes cast "FOR" exceed the votes cast "AGAINST."

#### The Board recommends a vote "FOR" this proposal.
14. #### WHAT ARE THE CHOICES WHEN VOTING ON THE SHAREHOLDER PROPOSAL?
Shareholders may:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; a)

vote in favor of the Shareholder Proposal;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; b)

vote against the Shareholder Proposal; or

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; c)

abstain from voting on the Shareholder Proposal.

The Shareholder Proposal will be approved if the votes cast "FOR" exceed the votes cast "AGAINST."

#### The Board recommends a vote "AGAINST" this proposal.
15. #### WHAT IF A SHAREHOLDER DOES NOT SPECIFY A CHOICE FOR A MATTER WHEN RETURNING A PROXY?
Shareholders should specify their choice for each matter on the enclosed proxy. If no specific instructions are given, proxies that are signed and returned will be voted "FOR" the election of all twelve director nominees, "FOR" the advisory say-on-pay resolution approving the compensation of our named executive officers, "ONE YEAR" for the advisory resolution on the frequency of say-on-pay votes, "FOR" the proposal to ratify the selection of PricewaterhouseCoopers SA as the Company's independent auditors, and "AGAINST" the shareholder proposal to make nicotine level information available to customers and begin reducing nicotine levels, if properly presented at the meeting.

---

| | |
|:---|:---|
| P M I **2 0 2 3** P r o x y S t a t e m e n t  | **85**  |

---

------

[**TABLE OF CONTENTS**](#TOC2)

EXHIBIT A: QUESTIONS & ANSWERS

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

16. #### WHO IS ENTITLED TO VOTE?
You may vote if you owned stock as of the close of business on March 10, 2023. Each share of common stock is entitled to one vote. As of March 10, 2023, the Company had 1,552,147,867 shares of common stock outstanding.

17. #### HOW DO I VOTE IF I PARTICIPATE IN THE DIVIDEND REINVESTMENT PLAN?
The proxy card you have received includes your dividend reinvestment plan shares. You may vote your shares through the Internet, by telephone or by mail, all as described on the enclosed proxy card.

18. #### WHAT DOES IT MEAN IF I RECEIVE MORE THAN ONE PROXY CARD?
It means that you have multiple accounts with brokers and/or our transfer agent. Please vote all of these shares. We recommend that you contact your broker and/or our transfer agent to consolidate as many accounts as possible under the same name and address. Our transfer agent is Computershare Trust Company, N.A., P.O. Box 505005, Louisville, KY 40233-5005 or you can reach Computershare at 1-877-745-9350 (from within the United States or Canada) or 1-781-575-4310 (from outside the United States or Canada), or via e-mail at pmi@computershare.com.

19. #### WHAT IS HOUSEHOLDING?
To reduce the expense of delivering duplicate proxy materials to shareholders who may have more than one account holding Common Stock but sharing the same address, we have adopted a procedure approved by the SEC called ''householding.'' Under this procedure, certain shareholders of record who have the same address and last name, and who do not participate in electronic delivery of proxy materials, will receive only one copy of our notice of Internet availability and, as applicable, any additional proxy materials that are delivered until such time as one or more of these shareholders notifies us that they want to receive separate copies. Shareholders who participate in householding will continue to have access to and utilize separate proxy voting instructions.

If you are a shareholder of record and would like to have separate copies of the notice of Internet availability or proxy materials mailed to you in the future, you must submit a request to opt out of householding in writing to Broadridge Financial Solutions, Inc., Householding Department, 51 Mercedes Way, Edgewood, New York 11717 or call Broadridge at 1-866-540-7095, and we will cease householding all such documents within 30 days.

If you are a beneficial owner, information regarding householding of proxy materials should have been forwarded to you by your bank, broker or nominee. However, please note that if you want to receive a paper proxy card or vote instruction form or other proxy materials for purposes of the 2023 Annual Meeting of Shareholders, you should follow the instructions included in the notice of Internet availability that was sent to you.

20. #### WILL MY SHARES BE VOTED IF I DO NOT PROVIDE MY PROXY?
If you are a street name holder of shares, you should have received a voting instruction form from your broker or bank. Your shares held in street name may be voted only on certain "routine" matters when you do not provide your broker or bank with voting instructions. For example, the ratification of the selection of PricewaterhouseCoopers SA as independent auditors of the Company is considered a "routine" matter for which brokers or banks may vote uninstructed shares. When a proposal is not a "routine" matter (such as the election of director nominees and say-on-pay advisory votes) and the broker or bank has not received voting instructions from the street name holder with respect to that proposal, that broker or bank cannot vote the shares on that proposal. This is called a broker non-vote. Therefore, it is important that you provide instructions to your broker or bank with respect to your vote on these "non-routine" matters.

21. #### ARE ABSTENTIONS AND BROKER NON-VOTES COUNTED?
Abstentions will not be included in the vote totals for any matter. Broker non-votes will not be included in vote totals and will not affect the outcome of the vote.

22. #### HOW MANY VOTES MUST BE PRESENT TO HOLD THE MEETING?
Your shares are counted as present at the meeting if you attend the virtual meeting and vote in person during the Virtual Annual Meeting of Shareholders, or if you properly return a proxy by Internet, telephone or mail. In order for us to conduct

---

| | |
|:---|:---|
| **86** | ***D e l i v e r i n g a S m o k e - F r e e F u t u r e***  |

---

------

[**TABLE OF CONTENTS**](#TOC2)

EXHIBIT A: QUESTIONS & ANSWERS

our meeting, a majority of our outstanding shares of common stock as of March 10, 2023, must be present in person at the Virtual Annual Meeting of Shareholders or by proxy. This is referred to as a quorum. Abstentions and shares of record held by a broker, bank or other agent ("Broker Shares") that are voted on any matter are included in determining the number of votes present. Broker Shares that are not voted on any matter will not be included in determining whether a quorum is present.

---

| | |
|:---|:---|
| P M I **2 0 2 3** P r o x y S t a t e m e n t  | **87**  |

---

------

[**TABLE OF CONTENTS**](#TOC2)

E X H I B I T B: R E C O N C I L I A T I O N S

![[MISSING IMAGE: tm2136562d1-icon_topbarpn.jpg]](tm2136562d1-icon_topbarpn.jpg)

## EXHIBIT B: RECONCILIATIONS

#### PHILIP MORRIS INTERNATIONAL INC. and Subsidiaries Reconciliation of Non-GAAP Measures
Net Revenues by Product Category & Adjustments of Net Revenues for the Impact of Currency and Acquisitions

**For the Years Ended December 31,**

(in millions) (Unaudited)

---

| | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **2022**  | **2022**  | **2022**  | **2022**  | **2022**  |  | **2021**  | **% Change in Net Revenues**  | **% Change in Net Revenues**  | **% Change in Net Revenues**  |
| **Net <br> Revenues**  | **Less <br> Currency**  | **Net <br> Revenues <br> excluding <br> Currency**  | **Less <br> Acquisitions**  | **Net <br> Revenues <br> excluding <br> Currency & <br> Acquisitions**  |  | **Net <br> Revenues**  | **Total**  | **Excluding <br> Currency**  | **Excluding <br> Currency & <br> Acquisitions**  |
| $21572 | $(1643) | $23214 | $70 | $23144 | Combustible Tobacco  | $22067 | (2.2)% | 5.2% | 4.9% |
| 10190 | (1013) | 11204 | 445 | 10759 | Smoke-Free  | 9338 | 9.1% | 20.0% | 15.2% |
| $**31762** | $**(2656)** | $**34418** | $**515** | $**33903** | **Total PMI**  | $**31405** | **1.1%** | **9.6%** | **8.0%** |

---

Note: Sum of product categories might not foot to Total PMI due to rounding.

Adjustments to Net Revenues & Operating Income

**For the Years Ended December 31,**

(in millions) (Unaudited)

---

| | | | |
|:---|:---|:---|:---|
| | **2022**  | **2021**  | **% Change**  |
| **Net Revenues** | $**31762** | $**31405** | **1.1%** |
| Less: Saudi Arabia customs assessments |  | (246) |  |
| **Adjusted Net Revenues** | **31762** | **31651** | **0.4%** |
| Less: Net Revenues attributable to Russia and Ukraine | 2591 | 2471 |  |
| **Adjusted Net Revenues excl. Russia and Ukraine** | **29171** | **29180** | **—%** |
| Less: Currency | (2779) |  |  |
| Less: Acquisitions | 515 |  |  |
| **Adjusted Net Revenues, excl. Russia, Ukraine, Currency & Acquisitions** | $**31435** | $**29180** | **7.7%<sup>(1)</sup>** |

---

---

| | | | |
|:---|:---|:---|:---|
| **Operating Income** | $**12246** | $**12975** | **(5.6)%** |
| Less: |  |  |  |
| &nbsp;&nbsp;&nbsp; Asset impairment and exit costs  |  | (216) |  |
| &nbsp;&nbsp;&nbsp; Amortization and impairment of intangibles  | (271) | (96) |  |
| &nbsp;&nbsp;&nbsp; Charges related to the war in Ukraine  | (151) |  |  |
| &nbsp;&nbsp;&nbsp; Saudi Arabia customs assessments  |  | (246) |  |
| &nbsp;&nbsp;&nbsp; Asset acquisition costs  |  | (51) |  |
| &nbsp;&nbsp;&nbsp; Swedish Match AB acquisition accounting related item  | (125) |  |  |
| &nbsp;&nbsp;&nbsp; Costs associated with Swedish Match AB offer  | (115) |  |  |
| **Adjusted Operating Income** | $**12908** | $**13584** | **(5.0)%** |
| Less: Operating Income attributable to Russia and Ukraine | 1170 | 1068 |  |
| **Adjusted Operating Income, excl. Russia and Ukraine** | **11738** | **12516** | **(6.2)%** |
| Less: Currency | (1652) |  |  |
| Less: Acquisitions | 99 |  |  |
| **Adjusted Operating Income, excl. Russia, Ukraine, Currency & Acquisitions**  | $**13291** | $**12516** | **6.2%<sup>(1)</sup>** |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (1)

On an organic basis

---

| | |
|:---|:---|
| **88** | ***D e l i v e r i n g a S m o k e - F r e e F u t u r e***  |

---

------

[**TABLE OF CONTENTS**](#TOC2)

E X H I B I T B: R E C O N C I L I A T I O N S

Adjustments to Operating Cash Flow

**For the Years Ended December 31,**

(in millions) (Unaudited)

---

| | | | |
|:---|:---|:---|:---|
| | **2022**  | **2021**  | **% Change**  |
| **Net cash provided by operating activities<sup>(1)</sup>** | $**10803** | $**11967** | **(9.7)%** |
| Less: Net cash provided by operating activities attributable to Russia and Ukraine | 784 | 834 |  |
| **Net cash provided by operating activities, excl. Russia and Ukraine** | **10019** | **11133** | **(10.0)%** |
| Less: Currency | (1678) |  |  |
| **Net cash provided by operating activities, excl. Russia, Ukraine and Currency**  | $**11697** | $**11133** | **5.1%** |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (1)

Operating cash flow

Calculation of Three-Year Adjusted Diluted EPS Compound Annual Growth Rate (CAGR), Excluding Currency

**For the Years Ended December 31,**

(Unaudited)

---

| | | | |
|:---|:---|:---|:---|
| | **2020**  | **2019**  | **% Change**  |
| **Reported Diluted EPS** | $**5.16** | $**4.61** | **11.9%** |
| Adjustments: |  |  |  |
| &nbsp;&nbsp;&nbsp; Asset impairment and exit costs  | 0.08 | 0.23 |  |
| &nbsp;&nbsp;&nbsp; Amortization and impairment of intangibles  | 0.04 | 0.03 |  |
| &nbsp;&nbsp;&nbsp; Canadian tobacco litigation-related expense  |  | 0.09 |  |
| &nbsp;&nbsp;&nbsp; Loss on deconsolidation of RBH  |  | 0.12 |  |
| &nbsp;&nbsp;&nbsp; Russia excise and VAT audit charge  |  | 0.20 |  |
| &nbsp;&nbsp;&nbsp; Brazil indirect tax credit  | (0.05) |  |  |
| &nbsp;&nbsp;&nbsp; Fair value adjustment for equity security investments  | 0.04 | (0.02) |  |
| &nbsp;&nbsp;&nbsp; Tax items  | (0.06) | (0.04) |  |
| &nbsp;&nbsp;&nbsp; Net earnings attributable to RBH<sup>(1)</sup>  |  | (0.06) |  |
| **Adjusted Diluted EPS** | **5.21** | **5.16** | **1.0%** |
| Less: Currency | (0.32) |  |  |
| **Adjusted Diluted EPS, excluding Currency** | $**5.53** | $**5.16** | **7.2%** |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (1)

Represents the impact of net earnings attributable to RBH from January 1, 2019 through March 21, 2019

**For the Years Ended December 31,**

(Unaudited)

---

| | | | |
|:---|:---|:---|:---|
| | **2021**  | **2020**  | **% Change**  |
| **Reported Diluted EPS** | $**5.83** | $**5.16** | **13.0%** |
| Adjustments: |  |  |  |
| &nbsp;&nbsp;&nbsp; Asset impairment and exit costs  | 0.12 | 0.08 |  |
| &nbsp;&nbsp;&nbsp; Amortization and impairment of intangibles  | 0.05 | 0.04 |  |
| &nbsp;&nbsp;&nbsp; Saudi Arabia customs assessments  | 0.14 |  |  |
| &nbsp;&nbsp;&nbsp; Equity investee ownership dilution  | (0.04) |  |  |
| &nbsp;&nbsp;&nbsp; Asset acquisition cost  | 0.03 |  |  |
| &nbsp;&nbsp;&nbsp; Fair value adjustment for equity security investments  |  | 0.04 |  |
| &nbsp;&nbsp;&nbsp; Tax items  |  | (0.06) |  |
| &nbsp;&nbsp;&nbsp; Brazil indirect tax credit  |  | (0.05) |  |
| **Adjusted Diluted EPS** | **6.13** | **5.21** | **17.7%** |
| Less: Currency | 0.12 |  |  |
| **Adjusted Diluted EPS, excluding Currency** | $**6.01** | $**5.21** | **15.4%** |

---

---

| | |
|:---|:---|
| P M I **2 0 2 3** P r o x y S t a t e m e n t  | **89**  |

---

------

[**TABLE OF CONTENTS**](#TOC2)

E X H I B I T B: R E C O N C I L I A T I O N S

**For the Years Ended December 31,**

(Unaudited)

---

| | | | |
|:---|:---|:---|:---|
| | **2022**  | **2021**  | **% Change**  |
| **Reported Diluted EPS** | $**5.81** | $**5.83** | **(0.3)%** |
| Adjustments: |  |  |  |
| &nbsp;&nbsp;&nbsp; Asset impairment and exit costs  |  | 0.12 |  |
| &nbsp;&nbsp;&nbsp; Amortization and impairment of intangibles  | 0.15 | 0.05 |  |
| &nbsp;&nbsp;&nbsp; Saudi Arabia customs assessments  |  | 0.14 |  |
| &nbsp;&nbsp;&nbsp; Equity investee ownership dilution  |  | (0.04) |  |
| &nbsp;&nbsp;&nbsp; Asset acquisition cost  |  | 0.03 |  |
| &nbsp;&nbsp;&nbsp; Costs associated with Swedish Match AB offer  | 0.06 |  |  |
| &nbsp;&nbsp;&nbsp; Swedish Match AB acquisition accounting related item  | 0.06 |  |  |
| &nbsp;&nbsp;&nbsp; Tax benefit associated with Swedish Match AB financing  | (0.13) |  |  |
| &nbsp;&nbsp;&nbsp; Charges related to the war in Ukraine  | 0.08 |  |  |
| &nbsp;&nbsp;&nbsp; Fair value adjustment for equity security investments  | (0.02) |  |  |
| &nbsp;&nbsp;&nbsp; Tax items  | (0.03) |  |  |
| **Adjusted Diluted EPS** | **5.98** | **6.13** | **(2.4)%** |
| Less: Currency | (0.77) |  |  |
| **Adjusted Diluted EPS, excluding Currency** | $**6.75** | $**6.13** | **10.1%** |
| **Three-Year Adjusted Diluted EPS CAGR, excluding Currency** |  |  | **10.8%** |

---

---

| | |
|:---|:---|
| **90** | ***D e l i v e r i n g a S m o k e - F r e e F u t u r e***  |

---

------

[**TABLE OF CONTENTS**](#TOC2)

E X H I B I T C: G L O S S A R Y O F T E R M S

![[MISSING IMAGE: tm2136562d1-icon_topbarpn.jpg]](tm2136562d1-icon_topbarpn.jpg)

## EXHIBIT C: GLOSSARY OF TERMS

---

| | |
|:---|:---|
| **Financial**  | **Other**  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; • **Net revenues** exclude excise taxes. <br>• **Net revenues from smoke-free products** are defined as operating revenues generated from the sale of these products, including shipping and handling charges billed to customers, net of sales and promotion incentives, and excise taxes, if applicable. These net revenue amounts consist of the sale of all of our products that are not combustible tobacco products, such as heat-not-burn, e-vapor, and oral nicotine, also including wellness and healthcare products, as well as consumer accessories such as lighters and matches. <br>• **Net revenues from Wellness & Healthcare** are defined as operating revenues generated from the sale of products primarily associated with inhaled therapeutics, and oral and intra-oral delivery systems that are included in the operating results of PMI's new Wellness & Healthcare business, Vectura Fertin Pharma. <br>• **Operating Income ("OI")** is defined as gross profit minus operating expenses. <br>• **Adjusted Net Revenues** exclude the impact related to the Saudi Arabia customs assessments in 2021. <br>• **Adjusted OI** is defined as reported OI adjusted for asset impairment and exit costs and other special items. <br>• **EPS** stands for Earnings Per Share. <br>• **Adjusted Diluted EPS** is defined as reported diluted EPS adjusted for asset impairment and exit costs, tax items and other special items. <br>• **Operating cash flow** is defined as net cash provided by operating activities. <br>&nbsp;&nbsp;&nbsp;&nbsp; • **Organic growth** is defined as growth rates presented on an organic basis that reflect adjusted results, excluding currency, acquisitions and disposals. <br>• Adjustments, other calculations and reconciliations to the most directly comparable U.S. GAAP measures are included in Exhibit B. <br>| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; • **Smoke-Free Products ("SFPs")** is the term we primarily use to refer to all of our products that are not combustible tobacco products, such as heat-not-burn, e-vapor, and oral nicotine. In addition, SFPs include wellness and healthcare products as well as consumer accessories such as lighters and matches. <br>• **Reduced-risk products ("RRPs")** is the term we use to refer to products that present, are likely to present, or have the potential to present less risk of harm to smokers who switch to these products versus continuing smoking. PMI has a range of RRPs in various stages of development, scientific assessment and commercialization. PMI's RRPs are smoke-free products that contain and/or generate far lower quantities of harmful and potentially harmful constituents than found in cigarette smoke. <br>• **Heated tobacco units ("HTUs")** is the term PMI uses to refer to heated tobacco consumables, which include the company's BLENDS, HEETS, HEETS Creations, HEETS Dimensions, HEETS Marlboro and HEETS FROM MARLBORO (defined collectively as HEETS), Marlboro Dimensions, Marlboro HeatSticks, Parliament HeatSticks, SENTIA and TEREA, as well as the KT&G-licensed brands, Fiit and Miix (outside of South Korea). <br>• **PSUs** are Performance Share Units. <br>• **RSUs** are Restricted Share Units and may be issued in the form of deferred share awards. <br>• **TSR** stands for Total Shareholder Return. <br>• **"PMI,"** the **"Company," "we," "us,"** and **"our"** refer to Philip Morris International Inc. and its subsidiaries. <br>• Trademarks and service marks in this proxy statement are the registered property of, or licensed by, the subsidiaries of Philip Morris International Inc. and are italicized. <br>&nbsp;&nbsp;&nbsp;&nbsp; • **"Platform 1"** is the term we use to refer to our reduced-risk product that uses a precisely controlled heating device into which a specially designed and proprietary tobacco unit is inserted and heated to generate an aerosol. <br>• Unless otherwise stated, all references to ***IQOS*** are to PMI's Platform 1 *IQOS* devices and heated tobacco consumables. <br>• **ESG** stands for environmental, social, and governance, which are key factors used by investors to measure corporate social responsibility. <br>|

---

---

| | |
|:---|:---|
| P M I **2 0 2 3** P r o x y S t a t e m e n t  | **91**  |

---

------

[**TABLE OF CONTENTS**](#TOC)

![[MISSING IMAGE: lg_philipmorrisint-pn.jpg]](lg_philipmorrisint-pn.jpg)

 **2023 PROXY STATEMENT** <br> And Notice of Annual Meeting of Shareholders <br> To be held on Wednesday, May 3, 2023 <br>

![[MISSING IMAGE: ic_recycle-bw.jpg]](ic_recycle-bw.jpg)

------

[**TABLE OF CONTENTS**](#TOC)

![[MISSING IMAGE: px_page01proxy02-bw.jpg]](px_page01proxy02-bw.jpg)

Signature [PLEASE SIGN WITHIN BOX] Date Signature (Joint Owners) Date TO VOTE, MARK BLOCKS BELOW IN BLUE OR BLACK INK AS FOLLOWS: KEEP THIS PORTION FOR YOUR RECORDS THIS PROXY CARD IS VALID ONLY WHEN SIGNED AND DATED. DETACH AND RETURN THIS PORTION ONLY V02471-P86480-Z84340 ! ! ! ! ! ! ! ! ! ! ! ! ! ! ! ! ! ! ! ! ! ! ! ! ! ! ! ! ! ! ! ! ! ! ! ! For Against Abstain 1e. Werner Geissler 1d. Juan José Daboub 1b. André Calantzopoulos 1a. Brant Bonin Bough 1c. Michel Combes 1g. Jun Makihara 1f. Lisa A. Hook 1h. Kalpana Morparia 1i. Jacek Olczak 1. Election of Directors: PHILIP MORRIS INTERNATIONAL INC. Proposals — The Board of Directors recommends a vote FOR all of the nominees listed in Proposal 1, FOR Proposal 2, for 1 YEAR on Proposal 3, FOR Proposal 4, and AGAINST Proposal 5. A 4. Ratification of the Selection of Independent Auditors 5. Shareholder Proposal to make nicotine level information available to customers and begin reducing nicotine levels 1j. Robert B. Polet 1l. Shlomo Yanai 1k. Dessislava Temperley 2. Advisory Vote Approving Executive Compensation 3. Advisory Vote on the Frequency of Future Say-On-Pay Votes, with the Board of Directors Recommending a Say-On-Pay Vote The Board of Directors recommends a vote FOR: The Board of Directors

recommends a vote for every 1 YEAR on Proposal 3: The Board of Directors recommends a vote FOR: The Board of Directors recommends a vote AGAINST: Please sign this proxy exactly as name(s) appear(s) hereon. When shares are held by joint tenants, both should sign. When signing as attorney, administrator, trustee or guardian, please give full title as such. The signer hereby revokes all proxies heretofore given by the signer to vote at said meeting or any adjournments thereof. Authorized Signatures — This section must be completed for your vote to be counted. — Date and Sign Below PHILIP MORRIS INTERNATIONAL INC. ATTN: DARLENE QUASHIE HENRY VICE PRESIDENT, ASSOCIATE GENERAL COUNSEL AND CORPORATE SECRETARY 677 WASHINGTON BLVD. STAMFORD, CT 06901 SCAN TO VIEW MATERIALS & VOTE w VOTE BY INTERNET Before The Meeting — Go to www.proxyvote.com or scan the QR Barcode above Use the Internet to transmit your voting instructions up until 11:59 P.M. Eastern Daylight Time on May 2, 2023. Please have your proxy card in hand when you access the website and follow the instructions to obtain your records and create an electronic voting instruction form. During The Meeting — Go to www.virtualshareholdermeeting.com/PM2023 You may participate in the Meeting solely via the Internet and vote during the Meeting online until the Chairman declares the polls closed. We recommend, however, that you vote before the Meeting even if you plan to participate in the Meeting. You can change your vote during the Meeting by voting when the polls are open. Have the information that is printed in the box marked by the arrow available and follow the instructions. VOTE BY PHONE — 1-800-690-6903 Use any touch-tone telephone to transmit your voting instructions up until 11:59 P.M. Eastern Daylight Time on May 2, 2023. Please have your proxy card in hand when you call and then follow the instructions. VOTE BY MAIL Mark, sign and date your proxy card and return it in the postage-paid envelope we have provided or return it to Vote Processing, c/o Broadridge, 51 Mercedes Way, Edgewood, NY 11717. XXXX XXXX XXXX XXXX B For Against Abstain For Against Abstain 1 Year 2 Years 3 Years Abstain ! ! ! For Against Abstain ! ! ! ! ! ! ! ! ! !

------

[**TABLE OF CONTENTS**](#TOC)

![[MISSING IMAGE: px_page02proxy02-bw.jpg]](px_page02proxy02-bw.jpg)

V02472-P86480-Z84340 Important Notice Regarding the Availability of Proxy Materials for the Annual Meeting: The Notice, Proxy Statement and 2022 Annual Report are available at www.proxyvote.com. PHILIP MORRIS INTERNATIONAL INC. 2023 ANNUAL MEETING OF SHAREHOLDERS Wednesday, May 3, 2023 9:00 A.M. EDT www.virtualshareholdermeeting.com/PM2023 It is important that your shares are represented at this Meeting, whether or not you attend the Meeting. To make sure your shares are represented, we urge you to complete and mail this proxy card OR vote your shares over the Internet or by telephone in accordance with the instructions provided on the reverse side. Sign Up Today For Electronic Delivery If you prefer to receive your future proxy statements, proxy cards and annual reports electronically via e-mail or the Internet, sign up today at www.proxyvote.com. You are cordially invited to join us at the 2023 Virtual Annual Meeting of Shareholders of Philip Morris International Inc. to be held on Wednesday, May 3, 2023, at 9:00 a.m. Eastern Daylight Time. Shareholders will have the same rights and opportunities to participate in our virtual meeting as they would at an in-person meeting. For full transparency, during the Q&A session, which will be publicly webcast, our shareholders will be able to ask questions live, on a first-come, first-served basis. In addition, a full webcast replay will be posted to our Investor Relations website at www.pmi.com/investor-relations/overview for one year following the meeting. The meeting will be hosted solely online at www.virtualshareholdermeeting.com/PM2023. To participate, you will need to enter the 16-digit control number included on your proxy card, notice of Internet availability of proxy materials, or on the voting instruction form accompanying your proxy materials. For more information, see the instructions set forth in Question 4 in the Questions & Answers section of the Proxy Statement. Philip Morris International Inc. Proxy Solicited on Behalf of the Board of Directors Annual Meeting of Shareholders — May 3, 2023 André Calantzopoulos and Darlene Quashie Henry, and each of them, are appointed proxies, with power of substitution, to vote, as indicated on the matters set forth on the reverse hereof and in their discretion upon such other business as may properly come before the Meeting, all shares of common stock held by the undersigned in Philip Morris International Inc. (the "Company") at the Annual Meeting of Shareholders, which will be held online via a live webcast at 9:00 a.m. EDT, on Wednesday, May 3, 2023, and at all adjournments or postponements thereof. There will be no physical location

for shareholders to attend. This proxy when properly executed will be voted as specified. If no specification is made, this proxy will be voted FOR all nominees in Proposal 1, FOR Proposal 2, FOR 1 YEAR in Proposal 3, FOR Proposal 4 and AGAINST Proposal 5. This card also serves to instruct the administrator of the Company's Direct Stock Purchase and Dividend Reinvestment Plan, and the trustee of each such defined contribution plan sponsored by the Company or any of its subsidiaries how to vote shares held for a participant in any such plan. Unless your proxy for your defined contribution plan shares is received by April 30, 2023, the trustee of such defined contribution plan will vote your plan shares in the same proportion as those plan shares for which instructions have been received, unless contrary to law. If you have voted by Internet or telephone, please DO NOT mail back this proxy card. THANK YOU FOR VOTING Continued and to be signed on reverse side

------